data_1t1h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t1h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.557 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.743 HG22 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.531 ' HB2' HG21 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 5.0 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.547 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.435 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.743 ' HB3' HG22 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.405 HG21 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.405 ' H ' HG21 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.586 ' HB ' HG23 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.462 HD21 HG22 ' A' ' 272' ' ' THR . 45.0 t30 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.436 HG11 ' ND2' ' A' ' 304' ' ' ASN . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.514 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.805 ' HB3' HD21 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.814 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.688 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.544 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HD12 ' A' ' 301' ' ' LEU . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' ' HB ' ' A' ' 269' ' ' THR . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.63 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.423 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.478 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 278' ' ' ILE . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HG ' ' CD ' ' A' ' 294' ' ' GLU . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.473 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.486 ' CD ' ' HG ' ' A' ' 289' ' ' CYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.701 HG21 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.614 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.701 ' H ' HG21 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.646 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.536 ' O ' HD21 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.531 ' O ' HG12 ' A' ' 311' ' ' ILE . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.814 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 307' ' ' LEU . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.502 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.738 HD12 HD21 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.433 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.449 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.767 HD12 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 252' ' ' PHE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 301' ' ' LEU . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.424 ' H ' HG11 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.445 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.594 HE22 HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.511 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.594 HG12 HE22 ' A' ' 271' ' ' GLN . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.767 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 281' ' ' TRP . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.445 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.455 HD12 HG23 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.477 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.571 HD21 HD13 ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.502 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.494 ' O ' ' HB1' ' A' ' 312' ' ' ALA . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.786 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.548 HD12 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 314' ' ' TRP . 15.5 m-85 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.473 ' NE ' HD12 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.604 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.787 HG22 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.473 HD12 ' NE ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.526 ' HB2' HG12 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.915 ' HE1' HD23 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.42 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 272' ' ' THR . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.566 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 301' ' ' LEU . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.489 ' O ' ' HB ' ' A' ' 269' ' ' THR . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.677 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.2 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.787 ' HB3' HG22 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.737 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.583 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.585 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.677 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.52 HD21 HG21 ' A' ' 272' ' ' THR . 36.4 t30 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.514 HG11 ' ND2' ' A' ' 304' ' ' ASN . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.915 HD23 ' HE1' ' A' ' 261' ' ' MET . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.769 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.572 HD13 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 308' ' ' LYS . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.501 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.42 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.806 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.617 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.806 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 261' ' ' MET . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.573 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.865 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.508 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.508 ' HD3' HD13 ' A' ' 311' ' ' ILE . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.467 HG22 HD11 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 269' ' ' THR . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.46 ' HG1' HD22 ' A' ' 296' ' ' LEU . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 266' ' ' ILE . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.624 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.465 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.676 HG23 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.624 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.475 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.475 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.535 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.531 ' HB2' HD23 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.535 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 29.5 mm-40 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.482 ' HB2' HG11 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.655 HD23 ' HE2' ' A' ' 261' ' ' MET . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.508 HD13 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.673 ' HZ3' HD12 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.505 ' HB2' HD22 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.673 HD12 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.771 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.852 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.771 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.847 ' HE3' HD23 ' A' ' 307' ' ' LEU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.555 ' HB2' HG23 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.571 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.464 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 270' ' ' GLY . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.839 HE22 HD12 ' A' ' 278' ' ' ILE . 30.8 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.597 ' HG1' HG13 ' A' ' 266' ' ' ILE . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.69 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.852 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.839 HD12 HE22 ' A' ' 271' ' ' GLN . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.466 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.431 ' O ' HD22 ' A' ' 282' ' ' LEU . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.466 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.588 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.521 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.521 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.419 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.405 ' H ' HG23 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.512 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.658 ' OD1' HG11 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.658 HG11 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.847 HD23 ' HE3' ' A' ' 261' ' ' MET . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.421 ' N ' HD13 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.785 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.452 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 . . . . . 0 C--O 1.228 -0.068 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.441 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.624 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.441 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.618 HD23 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.631 ' HE1' HD21 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.597 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.4 HG11 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.4 ' H ' HG11 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.62 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 1.5 tt0 -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.73 HG23 HD21 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.62 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.682 HG21 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.73 HD21 HG23 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.631 HD21 ' HE1' ' A' ' 261' ' ' MET . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.618 ' SG ' HD23 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.404 ' HA ' HG22 ' A' ' 311' ' ' ILE . 41.9 m-85 . . . . . 0 C--O 1.222 -0.363 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.688 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.735 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.85 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.735 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.548 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.66 HD12 HD21 ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 271' ' ' GLN . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.642 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.575 ' HG1' HG13 ' A' ' 266' ' ' ILE . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.565 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 264' ' ' PRO . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.642 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.85 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 282' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.483 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.8 m-70 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.45 ' HZ1' ' HB2' ' A' ' 287' ' ' LYS . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD22 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.554 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG21 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.587 HD22 ' SG ' ' A' ' 289' ' ' CYS . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.506 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.66 HD21 HD12 ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.429 ' N ' HG11 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.625 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.824 ' HB3' HD22 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.666 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 311' ' ' ILE . 11.5 m-85 . . . . . 0 C--O 1.225 -0.188 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.545 ' HG ' ' CD ' ' A' ' 259' ' ' GLU . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.556 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.545 ' CD ' ' HG ' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.589 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.995 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.472 ' CG ' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.613 HG13 HG22 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 301' ' ' LEU . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.679 HG23 ' HG ' ' A' ' 289' ' ' CYS . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.752 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 12.2 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.613 HG22 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.752 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.995 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.49 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.408 ' HG ' ' HB3' ' A' ' 274' ' ' GLU . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.615 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.534 ' HB ' HE21 ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.679 ' HG ' HG23 ' A' ' 269' ' ' THR . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.534 HE21 ' HB ' ' A' ' 288' ' ' THR . 0.2 OUTLIER 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.52 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.507 ' ND2' HD11 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.482 HG11 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.609 ' O ' HG12 ' A' ' 311' ' ' ILE . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.485 ' N ' HD11 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.479 ' HG ' HG22 ' A' ' 320' ' ' ILE . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.495 ' H ' HG13 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.549 ' HE ' HD11 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.592 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.908 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.582 ' HG ' HD12 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.592 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.457 ' N ' ' SG ' ' A' ' 254' ' ' CYS . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.644 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.689 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD22 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.634 HD11 HD21 ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 271' ' ' GLN . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 270' ' ' GLY . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.585 ' OE1' HD11 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.676 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.908 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.539 HG21 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.539 ' H ' HG21 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.44 HD22 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.634 HD21 HD11 ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.553 HG11 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 311' ' ' ILE . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.713 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.689 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.582 HD12 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.508 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.606 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.531 ' HB2' HG23 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.863 HG22 HE21 ' A' ' 271' ' ' GLN . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.96 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.863 HE21 HG22 ' A' ' 267' ' ' VAL . 5.0 pp0? -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.673 HG22 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.515 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.661 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.449 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.404 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.661 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.479 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 295' ' ' THR . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 293' ' ' GLN . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.96 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.5 ' HA ' HG13 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.518 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.743 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.401 ' HE1' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.605 ' HA ' HD23 ' A' ' 260' ' ' LEU . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.514 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.688 HD11 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' A' ' 311' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.934 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 261' ' ' MET . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG23 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.412 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.484 HG23 HD13 ' A' ' 301' ' ' LEU . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 269' ' ' THR . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.661 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 15.3 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.772 HG21 HD22 ' A' ' 307' ' ' LEU . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.934 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.688 ' HZ3' HD11 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.411 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.428 ' C ' HE21 ' A' ' 293' ' ' GLN . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.512 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.473 HD23 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.484 HD13 HG23 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.622 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.574 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.772 HD22 HG21 ' A' ' 272' ' ' THR . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.554 ' O ' ' HB1' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.807 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.6 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.635 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.538 ' HA ' HG21 ' A' ' 311' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.61 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.944 HG22 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.61 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.622 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.684 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.862 HE22 HG12 ' A' ' 278' ' ' ILE . 4.4 tt0 -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' SER . . . . . 0.944 ' HB3' HG22 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.862 HG12 HE22 ' A' ' 271' ' ' GLN . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.408 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 278' ' ' ILE . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.408 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 44.1 m-70 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.51 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.684 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.51 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 0.1 OUTLIER 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.412 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.67 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.496 ' HB3' HG23 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.634 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.564 HG11 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.828 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.828 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.546 ' HA ' HG23 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.487 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.551 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.927 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HD3' HD12 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.572 HE22 HG12 ' A' ' 278' ' ' ILE . 7.0 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.927 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.418 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 274' ' ' GLU . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.495 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.448 HD12 HG21 ' A' ' 267' ' ' VAL . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.556 ' HA ' HG11 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.618 HD22 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.618 HG12 HD22 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.858 HD23 ' HE2' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.422 ' N ' HD11 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.585 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.641 HG23 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.843 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.843 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.794 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.721 ' HZ1' ' HB3' ' A' ' 321' ' ' GLU . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.458 ' CG2' HE21 ' A' ' 271' ' ' GLN . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.407 ' H ' HG11 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 289' ' ' CYS . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.709 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 10.2 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.539 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.507 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.433 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.507 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.446 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 261' ' ' MET . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.475 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.672 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.721 ' HB3' ' HZ1' ' A' ' 262' ' ' LYS . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.538 ' HB2' HG21 ' A' ' 311' ' ' ILE . 40.8 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.493 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.766 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.515 HD21 HG22 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.711 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.596 ' HZ1' ' HB2' ' A' ' 321' ' ' GLU . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.608 ' HB2' HG23 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.734 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 9.3 tt0 -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.608 HG23 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.583 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.549 ' HA ' HD23 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.656 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.656 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . 0.734 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.572 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.423 ' HB3' HD22 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.585 ' HA ' HG21 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.766 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 8.2 m-85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.578 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 314' ' ' TRP . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.459 ' C ' HD13 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.456 HG21 HD12 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.0 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.568 ' HG1' HG13 ' A' ' 266' ' ' ILE . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.436 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 274' ' ' GLU . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.511 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.453 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.408 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.564 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.564 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.628 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.628 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.595 ' O ' HG12 ' A' ' 311' ' ' ILE . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.513 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.716 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.514 ' CD1' ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.933 ' HE2' HD23 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.794 HG13 HG22 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.673 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.794 HG22 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.714 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.718 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . 0.714 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.718 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.673 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.566 ' OD1' HG11 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.566 HG11 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.933 HD23 ' HE2' ' A' ' 261' ' ' MET . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.463 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.538 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.51 ' HA ' HG21 ' A' ' 311' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.228 -0.073 0 CA-C-O 121.038 0.447 . . . . 0.0 111.207 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.735 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.735 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.53 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.49 HG23 ' CG ' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.459 HG23 ' HG ' ' A' ' 289' ' ' CYS . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.653 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.753 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.653 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.468 ' HB2' ' HG ' ' A' ' 289' ' ' CYS . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.627 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.475 ' HA ' HG11 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.569 ' HB2' HG11 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.599 ' O ' HG12 ' A' ' 311' ' ' ILE . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.429 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.425 ' C ' HD11 ' A' ' 313' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.771 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.522 ' O ' HD11 ' A' ' 260' ' ' LEU . 16.9 m-85 . . . . . 0 C--O 1.228 -0.043 0 CA-C-O 120.581 0.229 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ARG . . . . . 0.505 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' CYS . . . . . 0.684 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' MET . . . . . 0.684 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LYS . . . . . 0.763 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.457 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.71 HG13 HG22 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.57 HG23 HD13 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 270' ' ' GLY . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 10.1 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' THR . . . . . 0.71 HG22 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' TRP . . . . . 0.463 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.564 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' SER . . . . . 0.564 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.535 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 11.4 m170 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ALA . . . . . 0.424 ' HB2' ' HD2' ' A' ' 287' ' ' LYS . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.57 HD13 HG23 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' THR . . . . . 0.574 ' HB ' HG21 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 266' ' ' ILE . 5.1 p-10 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.499 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ILE . . . . . 0.5 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.529 ' HB3' HD22 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . 0.763 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.476 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 24.5 p -136.75 138.21 25.63 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.249 . . . . 0.0 110.367 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 3.5 Cg_exo -80.83 40.47 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.173 2.582 . . . . 0.0 112.353 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.72 121.6 37.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.594 . . . . 0.0 110.875 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -152.57 134.22 8.4 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.752 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.455 ' HA ' ' HG3' ' A' ' 255' ' ' PRO . 28.0 Cg_exo -62.56 -65.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.827 2.351 . . . . 0.0 112.231 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -106.22 -159.2 0.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.897 0.379 . . . . 0.0 110.481 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 1.009 ' HA ' HD11 ' A' ' 307' ' ' LEU . 2.9 t80 76.67 -42.96 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 112.073 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.557 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 -132.19 -94.16 0.36 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.67 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.743 HG22 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.531 ' HB2' HG21 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.612 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.554 HG23 HD11 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.612 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 5.0 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.547 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.435 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.743 ' HB3' HG22 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.405 HG21 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.405 ' H ' HG21 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.586 ' HB ' HG23 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.462 HD21 HG22 ' A' ' 272' ' ' THR . 45.0 t30 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.436 HG11 ' ND2' ' A' ' 304' ' ' ASN . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 1.009 HD11 ' HA ' ' A' ' 251' ' ' TYR . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.445 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.701 HG23 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.805 ' HB3' HD21 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.54 HG21 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.577 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 35.0 m -71.48 -50.04 11.02 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 5.8 Cg_exo -79.61 158.66 25.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.178 1.919 . . . . 0.0 111.418 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.34 102.28 4.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.425 ' CE2' ' HD3' ' A' ' 253' ' ' ARG . 6.3 p90 -149.78 91.92 4.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.752 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -75.07 -73.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 112.975 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.93 106.9 9.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.131 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.65 ' O ' HD12 ' A' ' 307' ' ' LEU . 15.4 t80 -174.03 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.898 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.814 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -117.54 33.9 5.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.688 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.738 HD21 HD12 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.69 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.544 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.569 ' HB2' HG23 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.485 HG22 HD12 ' A' ' 301' ' ' LEU . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.564 ' O ' ' HB ' ' A' ' 269' ' ' THR . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.614 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.68 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.63 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.69 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.423 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.642 HG21 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.478 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 278' ' ' ILE . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.842 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HG ' ' CD ' ' A' ' 294' ' ' GLU . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.473 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.486 ' CD ' ' HG ' ' A' ' 289' ' ' CYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.701 HG21 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.614 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.701 ' H ' HG21 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.485 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.537 ' O ' HG23 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.646 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.536 ' O ' HD21 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 251' ' ' TYR . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.544 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.814 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 307' ' ' LEU . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.502 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.634 ' HA ' HG23 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.738 HD12 HD21 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.541 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 3.0 m -71.3 -53.5 7.9 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 4.0 Cg_endo -86.96 33.19 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.751 2.3 . . . . 0.0 112.525 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.83 102.22 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.45 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 21.2 p90 -108.97 134.82 20.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.416 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.465 ' HG2' ' HE1' ' A' ' 251' ' ' TYR . 5.8 Cg_exo -77.08 161.58 32.48 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.93 2.42 . . . . 0.0 111.141 170.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -73.74 91.35 1.91 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 111.755 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.523 ' HB2' HD12 ' A' ' 307' ' ' LEU . 27.4 p90 -172.41 -33.13 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.259 171.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.433 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 -83.39 -75.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.449 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.767 HD12 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.595 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 252' ' ' PHE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.523 ' O ' HD11 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.571 ' HB2' HG23 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.455 HG23 HD12 ' A' ' 301' ' ' LEU . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.424 ' H ' HG11 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.445 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.594 HE22 HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.571 HG23 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.511 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.594 HG12 HE22 ' A' ' 271' ' ' GLN . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.767 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 281' ' ' TRP . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.538 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.538 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.445 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.455 HD12 HG23 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.477 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.571 HD21 HD13 ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 251' ' ' TYR . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.494 ' O ' ' HB1' ' A' ' 312' ' ' ALA . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.786 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.548 HD12 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.595 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 26.4 m 70.77 116.88 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 121.237 0.541 . . . . 0.0 111.381 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -70.42 88.55 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.334 . . . . 0.0 112.405 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.86 -48.49 37.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.314 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 61.1 t80 64.84 91.39 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.968 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.709 ' HD2' ' HD2' ' A' ' 252' ' ' PHE . 3.0 Cg_exo -79.08 -180.0 5.95 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.269 2.646 . . . . 0.0 111.837 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.16 -1.21 43.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.581 ' CD1' HD13 ' A' ' 310' ' ' LEU . 7.2 p90 -128.35 63.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.709 ' HD2' ' HD2' ' A' ' 249' ' ' PRO . 15.5 m-85 -150.93 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.473 ' NE ' HD12 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.604 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.787 HG22 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.473 HD12 ' NE ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.526 ' HB2' HG12 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.915 ' HE1' HD23 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.42 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.574 ' HB2' HG23 ' A' ' 272' ' ' THR . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.566 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.657 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG23 ' HG ' ' A' ' 301' ' ' LEU . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.489 ' O ' ' HB ' ' A' ' 269' ' ' THR . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.677 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.657 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.2 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.607 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.787 ' HB3' HG22 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.737 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.585 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.583 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.585 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.677 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.566 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.52 HD21 HG21 ' A' ' 272' ' ' THR . 36.4 t30 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.514 HG11 ' ND2' ' A' ' 304' ' ' ASN . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.915 HD23 ' HE1' ' A' ' 261' ' ' MET . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.769 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.572 HD13 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 308' ' ' LYS . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.769 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.501 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.42 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.6 p -154.9 102.28 2.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.42 -1.63 11.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.646 2.231 . . . . 0.0 111.666 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 48.48 81.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.689 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.94 75.17 11.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.364 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 250' ' ' GLU . 58.5 Cg_endo -92.3 -40.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.529 2.152 . . . . 0.0 112.047 172.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.644 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 7.5 tp10 173.27 -174.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.644 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 45.2 p90 48.91 32.49 3.82 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.43 1.092 . . . . 0.0 113.283 172.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -139.6 -75.86 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.806 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.617 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.806 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.461 ' C ' ' H ' ' A' ' 261' ' ' MET . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.573 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.865 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.508 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.508 ' HD3' HD13 ' A' ' 311' ' ' ILE . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.538 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.467 HG22 HD11 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 269' ' ' THR . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.46 ' HG1' HD22 ' A' ' 296' ' ' LEU . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 266' ' ' ILE . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.624 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.465 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.676 HG23 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.624 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.475 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.475 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.535 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.531 ' HB2' HD23 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.416 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.535 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 29.5 mm-40 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.493 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.416 ' HA ' HG23 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.467 HD11 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.482 ' HB2' HG11 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.655 HD23 ' HE2' ' A' ' 261' ' ' MET . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.614 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.508 HD13 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.673 ' HZ3' HD12 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.505 ' HB2' HD22 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.673 HD12 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.0 m -81.39 133.0 54.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 11.5 Cg_exo -71.02 79.57 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.798 2.332 . . . . 0.0 111.463 177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.408 ' HA ' ' NH2' ' A' ' 253' ' ' ARG . 6.1 tp10 -90.52 104.53 17.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.917 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 253' ' ' ARG . 0.3 OUTLIER -154.99 82.63 3.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.334 0.587 . . . . 0.0 111.145 178.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -94.25 16.33 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.178 2.586 . . . . 0.0 113.423 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.38 -68.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.379 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -121.07 24.81 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 112.097 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -135.09 -84.16 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.771 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.852 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.771 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.497 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.847 ' HE3' HD23 ' A' ' 307' ' ' LEU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.619 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.555 ' HB2' HG23 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.571 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.464 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 270' ' ' GLY . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.839 HE22 HD12 ' A' ' 278' ' ' ILE . 30.8 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.597 ' HG1' HG13 ' A' ' 266' ' ' ILE . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.69 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.69 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.852 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.839 HD12 HE22 ' A' ' 271' ' ' GLN . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.466 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.431 ' O ' HD22 ' A' ' 282' ' ' LEU . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.466 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.588 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.521 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.521 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.419 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.405 ' H ' HG23 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.571 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.512 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.658 ' OD1' HG11 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.658 HG11 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.847 HD23 ' HE3' ' A' ' 261' ' ' MET . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.693 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.623 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.421 ' N ' HD13 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.785 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.583 HG23 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.8 m -129.85 164.35 40.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.67 -45.75 36.14 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.587 2.191 . . . . 0.0 111.536 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.758 ' HG2' ' HG3' ' A' ' 249' ' ' PRO . 6.4 tt0 74.99 -71.18 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 124.046 0.841 . . . . 0.0 112.291 167.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.675 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 79.8 m-85 70.2 20.5 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.758 ' HG3' ' HG2' ' A' ' 247' ' ' GLU . 90.2 Cg_endo -103.64 142.5 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.432 1.904 . . . . 0.0 114.034 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 53.26 -87.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 170.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.692 ' O ' HD12 ' A' ' 307' ' ' LEU . 10.5 p90 -71.13 -29.38 65.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.578 -174.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.452 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 -78.44 -76.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.434 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.441 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.624 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.441 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.618 HD23 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.631 ' HE1' HD21 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.597 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.493 HG22 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.619 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.4 HG11 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.4 ' H ' HG11 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.62 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 1.5 tt0 -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.73 HG23 HD21 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.62 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.682 HG21 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.623 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.614 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.66 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.66 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.493 ' HB3' HG22 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.73 HD21 HG23 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 251' ' ' TYR . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.434 ' CZ3' HD12 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.618 ' SG ' HD23 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.522 HG22 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.473 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.4 m -67.1 133.03 93.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 122.034 0.134 . . . . 0.0 110.76 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.521 ' HA ' ' CE2' ' A' ' 248' ' ' PHE . 7.4 Cg_exo -72.63 66.98 3.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.039 2.492 . . . . 0.0 113.087 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.443 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 38.8 tt0 -112.73 -70.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.593 ' CB ' ' HB2' ' A' ' 252' ' ' PHE . 6.2 m-85 46.79 65.39 6.97 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.886 0.874 . . . . 0.0 112.796 174.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.69 126.63 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.155 1.904 . . . . 0.0 112.09 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 69.56 13.73 8.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -136.67 -31.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.638 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.593 ' HB2' ' CB ' ' A' ' 248' ' ' PHE . 41.9 m-85 -138.48 -76.09 0.38 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.186 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.688 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.735 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.85 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.455 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.735 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.548 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.627 ' HA ' ' HA ' ' A' ' 274' ' ' GLU . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.66 HD12 HD21 ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 271' ' ' GLN . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.429 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.642 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.575 ' HG1' HG13 ' A' ' 266' ' ' ILE . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.565 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 264' ' ' PRO . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.642 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.423 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.85 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 282' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.483 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.8 m-70 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.45 ' HZ1' ' HB2' ' A' ' 287' ' ' LYS . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD22 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.554 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG21 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.587 HD22 ' SG ' ' A' ' 289' ' ' CYS . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . 0.429 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.506 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.66 HD21 HD12 ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.429 HG11 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.429 ' N ' HG11 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.471 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.56 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.625 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.824 ' HB3' HD22 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.666 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.6 p -94.26 123.59 58.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.833 0.316 . . . . 0.0 110.939 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.21 -35.82 50.08 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.648 2.232 . . . . 0.0 111.751 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.448 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 58.2 mm-40 64.36 110.42 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.975 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.93 74.25 26.43 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.436 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 247' ' ' GLU . 1.1 Cg_endo -84.18 -60.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.638 2.225 . . . . 0.0 111.606 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.625 ' HG3' ' CD2' ' A' ' 251' ' ' TYR . 13.5 pt-20 -165.11 -176.87 4.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.636 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.633 ' HA ' HD12 ' A' ' 307' ' ' LEU . 36.3 p90 48.02 28.9 1.57 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.349 1.06 . . . . 0.0 113.683 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.497 ' HA ' HG21 ' A' ' 311' ' ' ILE . 11.5 m-85 -128.01 -79.59 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.556 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.545 ' HG ' ' CD ' ' A' ' 259' ' ' GLU . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.555 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.556 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.545 ' CD ' ' HG ' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.589 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.995 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.472 ' CG ' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.613 HG13 HG22 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.463 HG22 HD12 ' A' ' 301' ' ' LEU . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.679 HG23 ' HG ' ' A' ' 289' ' ' CYS . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.752 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 12.2 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.613 HG22 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.752 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.995 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.49 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.408 ' HG ' ' HB3' ' A' ' 274' ' ' GLU . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.683 HG21 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.615 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.553 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.615 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.534 ' HB ' HE21 ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.679 ' HG ' HG23 ' A' ' 269' ' ' THR . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.501 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.534 HE21 ' HB ' ' A' ' 288' ' ' THR . 0.2 OUTLIER 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.463 HD12 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.52 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.507 ' ND2' HD11 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.482 HG11 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.633 HD12 ' HA ' ' A' ' 251' ' ' TYR . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.55 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.485 ' N ' HD11 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.479 ' HG ' HG22 ' A' ' 320' ' ' ILE . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.514 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.589 HG23 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.495 ' H ' HG13 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.8 m 69.74 133.32 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.208 0 C-N-CA 123.339 0.656 . . . . 0.0 111.455 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.1 -28.47 48.84 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.595 2.197 . . . . 0.0 112.84 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 61.92 90.04 0.08 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.475 0.655 . . . . 0.0 110.323 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.4 128.46 21.14 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.268 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.97 175.7 6.48 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.9 2.4 . . . . 0.0 112.021 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 251' ' ' TYR . 0.3 OUTLIER -67.51 110.02 3.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.893 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 23.2 t80 166.41 -16.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -163.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 -135.09 -56.73 0.81 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.549 ' HE ' HD11 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.592 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.908 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.582 ' HG ' HD12 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.592 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.457 ' N ' ' SG ' ' A' ' 254' ' ' CYS . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.644 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.689 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD22 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.634 HD11 HD21 ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 271' ' ' GLN . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 270' ' ' GLY . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.585 ' OE1' HD11 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.585 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.676 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.908 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.49 HG21 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.583 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.583 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.539 HG21 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.539 ' H ' HG21 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.44 HD22 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.634 HD21 HD11 ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.553 HG11 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 311' ' ' ILE . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.893 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.541 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.689 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.582 HD12 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.6 m -102.88 112.38 65.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.85 114.3 3.92 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.476 2.117 . . . . 0.0 112.704 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.23 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.709 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -121.39 79.86 37.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -106.25 40.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.082 3.188 . . . . 0.0 111.198 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.508 ' HG2' ' H ' ' A' ' 251' ' ' TYR . 23.7 tt0 62.74 -140.08 0.4 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.75 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 1.6 t80 71.14 -73.71 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.079 0.399 . . . . 0.0 111.363 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.518 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 -98.7 -75.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.508 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.743 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.606 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.655 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.531 ' HB2' HG23 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.673 HG13 HG22 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.863 HG22 HE21 ' A' ' 271' ' ' GLN . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.484 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.96 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.863 HE21 HG22 ' A' ' 267' ' ' VAL . 5.0 pp0? -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.673 HG22 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.515 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.639 ' O ' HG23 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.661 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.449 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.404 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.661 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.479 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.417 ' C ' ' H ' ' A' ' 295' ' ' THR . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 293' ' ' GLN . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.96 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.5 ' HA ' HG13 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.538 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.522 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.75 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.743 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.77 ' HB2' ' HG3' ' A' ' 249' ' ' PRO . 3.4 m -92.17 106.16 16.71 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -80.67 -19.73 8.45 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.936 2.424 . . . . 0.0 113.712 -172.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.5 -97.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.637 ' CE1' ' HD2' ' A' ' 253' ' ' ARG . 62.5 m-85 -133.57 75.17 69.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.771 ' HG2' ' HB2' ' A' ' 252' ' ' PHE . 97.5 Cg_endo -97.45 153.57 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.005 2.47 . . . . 0.0 111.205 168.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.16 11.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.159 -0.338 . . . . 0.0 111.64 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.797 ' HA ' HD13 ' A' ' 307' ' ' LEU . 35.4 p90 -118.6 13.85 13.46 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.657 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.771 ' HB2' ' HG2' ' A' ' 249' ' ' PRO . 0.9 OUTLIER -140.79 -87.11 0.18 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.637 ' HD2' ' CE1' ' A' ' 248' ' ' PHE . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.514 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.688 HD11 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.738 ' O ' ' HB ' ' A' ' 311' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.934 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 261' ' ' MET . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG23 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.412 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.661 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.484 HG23 HD13 ' A' ' 301' ' ' LEU . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.516 ' O ' ' HB ' ' A' ' 269' ' ' THR . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.661 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 15.3 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.772 HG21 HD22 ' A' ' 307' ' ' LEU . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.934 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.613 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.688 ' HZ3' HD11 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.431 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.411 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.428 ' C ' HE21 ' A' ' 293' ' ' GLN . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.512 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.473 HD23 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.484 HD13 HG23 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.622 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.574 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.797 HD13 ' HA ' ' A' ' 251' ' ' TYR . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.554 ' O ' ' HB1' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.807 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.738 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.807 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.6 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.635 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.619 HG22 ' H ' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -53.75 17.08 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.31 123.96 12.25 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.255 1.97 . . . . 0.0 112.164 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.54 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 1.6 mp0 -52.32 160.62 0.77 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.019 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.508 ' HD1' ' HD2' ' A' ' 253' ' ' ARG . 77.1 t80 -112.4 90.18 13.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.996 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.702 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.3 Cg_endo -90.39 148.03 4.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.182 2.588 . . . . 0.0 111.459 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.34 -24.28 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.17 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.731 ' HA ' HD12 ' A' ' 307' ' ' LEU . 12.2 p90 -90.06 18.86 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.461 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.702 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 3.7 m-85 -130.56 -80.52 0.54 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.508 ' HD2' ' HD1' ' A' ' 248' ' ' PHE . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.61 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.944 HG22 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.606 HD13 HD12 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.516 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.54 HD12 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.61 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.622 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.707 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.684 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.862 HE22 HG12 ' A' ' 278' ' ' ILE . 4.4 tt0 -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.621 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.499 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' SER . . . . . 0.944 ' HB3' HG22 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.862 HG12 HE22 ' A' ' 271' ' ' GLN . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.408 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.401 ' HG ' ' CD1' ' A' ' 278' ' ' ILE . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.408 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 44.1 m-70 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.51 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.684 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.51 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 0.1 OUTLIER 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.412 ' HA ' HG21 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.67 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.496 ' HB3' HG23 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.601 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.634 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.564 HG11 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 251' ' ' TYR . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.828 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.828 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.546 ' HA ' HG23 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.606 HD12 HD13 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.2 m 66.33 91.44 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.214 0 C-N-CA 123.393 0.677 . . . . 0.0 111.94 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.99 150.47 29.9 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.328 2.685 . . . . 0.0 111.653 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.92 -33.79 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 54.03 73.53 0.89 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.01 -58.47 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.237 1.958 . . . . 0.0 111.085 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.705 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 6.4 tp10 -179.84 -169.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.705 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 44.9 p90 50.27 29.92 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.232 1.013 . . . . 0.0 112.961 176.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.487 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 -132.01 -77.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 176.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.541 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.551 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.551 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.641 ' HB3' HG23 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.927 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HD3' HD12 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.572 HE22 HG12 ' A' ' 278' ' ' ILE . 7.0 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.776 HG22 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.434 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.927 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.418 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 274' ' ' GLU . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . 0.406 ' HB1' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.495 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.448 HD12 HG21 ' A' ' 267' ' ' VAL . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.556 ' HA ' HG11 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.618 HD22 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.618 HG12 HD22 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.858 HD23 ' HE2' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.451 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.615 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.422 ' N ' HD11 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.585 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.641 HG23 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.551 ' N ' HG21 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.494 ' O ' ' HD3' ' A' ' 246' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.3 m -82.47 107.26 8.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 244' ' ' GLY . 93.6 Cg_endo -93.23 53.9 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.995 2.463 . . . . 0.0 111.833 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.544 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.6 mt-10 -70.13 126.16 28.87 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -102.61 107.09 52.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.73 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.715 ' HG2' ' CE1' ' A' ' 251' ' ' TYR . 1.8 Cg_endo -86.9 -166.62 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.421 2.747 . . . . 0.0 110.895 169.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -73.11 -19.39 61.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.715 ' CE1' ' HG2' ' A' ' 249' ' ' PRO . 16.5 p90 -91.77 25.33 2.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.572 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.79 -82.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.843 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.417 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.843 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.794 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.721 ' HZ1' ' HB3' ' A' ' 321' ' ' GLU . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.534 ' HB2' HG21 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.709 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.458 ' CG2' HE21 ' A' ' 271' ' ' GLN . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.407 ' H ' HG11 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.474 HG23 ' HG ' ' A' ' 289' ' ' CYS . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.709 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 10.2 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.539 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.657 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.794 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.507 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.433 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.507 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.54 HD22 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.446 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.529 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.431 HD21 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.767 HD23 ' HE3' ' A' ' 261' ' ' MET . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.557 ' O ' ' HB3' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.697 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.475 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.672 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.721 ' HB3' ' HZ1' ' A' ' 262' ' ' LYS . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.8 m -103.79 107.98 58.27 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.73 -0.277 . . . . 0.0 110.313 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 247' ' ' GLU . 16.5 Cg_exo -67.38 -76.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.482 2.122 . . . . 0.0 110.883 176.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.422 ' H ' ' HB2' ' A' ' 246' ' ' PRO . 6.8 mm-40 44.82 42.53 6.13 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.795 0.685 . . . . 0.0 112.655 172.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.443 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 41.7 m-85 -64.73 122.28 78.04 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.186 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.26 -17.48 31.01 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.456 2.104 . . . . 0.0 111.724 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.82 -167.22 2.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.916 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.676 ' HD2' ' HD1' ' A' ' 252' ' ' PHE . 0.3 OUTLIER 65.18 -103.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.774 178.347 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.676 ' HD1' ' HD2' ' A' ' 251' ' ' TYR . 40.8 p90 -123.78 9.61 8.89 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -165.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.493 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.564 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.766 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.515 HD21 HG22 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.711 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.596 ' HZ1' ' HB2' ' A' ' 321' ' ' GLU . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.608 ' HB2' HG23 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.445 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.734 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.712 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 9.3 tt0 -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.608 HG23 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.711 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.583 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.427 ' N ' HG22 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.549 ' HA ' HD23 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.656 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.656 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . 0.734 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.536 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.569 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.572 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.533 HD13 ' O ' ' A' ' 251' ' ' TYR . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.423 ' HB3' HD22 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.585 ' HA ' HG21 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.766 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 112.204 -0.359 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.2 m -75.9 152.32 84.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.505 0.193 . . . . 0.0 110.492 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.32 -20.27 66.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.456 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.552 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.1 tt0 71.72 154.72 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.121 0.568 . . . . 0.0 110.2 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -109.66 93.62 14.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.328 . . . . 0.0 110.847 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.771 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.0 Cg_exo -83.57 133.63 6.21 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.883 2.389 . . . . 0.0 111.087 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.31 -5.37 49.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.466 -175.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.703 ' HA ' HD13 ' A' ' 307' ' ' LEU . 40.4 p90 -101.72 22.95 12.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.825 0.345 . . . . 0.0 110.999 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.771 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 8.2 m-85 -131.21 -64.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.578 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.626 HD21 HD13 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' A' ' 314' ' ' TRP . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.459 ' C ' HD13 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.58 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.456 HG21 HD12 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.532 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.581 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.0 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.568 ' HG1' HG13 ' A' ' 266' ' ' ILE . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.436 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.616 HG21 ' O ' ' A' ' 274' ' ' GLU . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.511 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.453 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.408 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.564 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.564 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.534 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.628 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.628 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 251' ' ' TYR . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.513 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.716 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . 0.469 ' O ' HG21 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.69 HD11 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' SER . . . . . 0.679 ' HB3' ' HD3' ' A' ' 246' ' ' PRO . 35.5 t -60.71 -51.7 77.79 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 117.006 0.403 . . . . 0.0 110.46 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 245' ' ' SER . 57.4 Cg_endo -101.4 166.2 0.35 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.942 2.428 . . . . 0.0 111.447 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -73.08 144.3 47.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -119.34 89.47 40.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 251' ' ' TYR . 70.7 Cg_endo -96.44 -164.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.098 2.532 . . . . 0.0 110.869 169.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.16 26.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 0.0 110.03 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.401 ' H ' ' C ' ' A' ' 249' ' ' PRO . 19.7 t80 -95.26 -17.16 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.735 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 -149.93 -55.22 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.465 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.514 ' CD1' ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.742 HD22 HD13 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.933 ' HE2' HD23 ' A' ' 307' ' ' LEU . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.605 ' HB2' HG23 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.794 HG13 HG22 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.462 ' N ' HG11 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.673 ' HG1' ' HA ' ' A' ' 296' ' ' LEU . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.58 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.794 HG22 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.751 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.714 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.718 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . 0.714 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.718 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.673 ' HA ' ' HG1' ' A' ' 269' ' ' THR . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.566 ' OD1' HG11 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.566 HG11 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.933 HD23 ' HE2' ' A' ' 261' ' ' MET . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.463 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.44 ' HZ2' ' CG ' ' A' ' 246' ' ' PRO . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.538 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . 0.442 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.742 HD13 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 32.6 t -97.54 148.42 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.7 8.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.65 2.233 . . . . 0.0 112.965 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.87 94.41 1.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.235 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.4 ' HB2' ' HB2' ' A' ' 253' ' ' ARG . 16.8 m-85 -97.37 123.47 52.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.358 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.496 ' HB2' ' HD1' ' A' ' 251' ' ' TYR . 23.4 Cg_exo -66.43 -179.66 1.63 Allowed 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.368 2.046 . . . . 0.0 110.671 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.428 ' HB2' ' CE1' ' A' ' 273' ' ' TYR . 12.5 pt-20 -79.91 14.72 1.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -173.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.941 ' HA ' HD12 ' A' ' 307' ' ' LEU . 9.1 p90 -98.41 5.87 47.74 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.166 0.507 . . . . 0.0 109.825 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.51 ' HA ' HG21 ' A' ' 311' ' ' ILE . 1.0 OUTLIER -138.3 -67.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.207 176.406 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.735 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.735 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.532 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.53 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.753 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.49 HG23 ' CG ' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.459 HG23 ' HG ' ' A' ' 289' ' ' CYS . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.653 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.753 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.443 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.653 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.404 HG23 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.468 ' HB2' ' HG ' ' A' ' 289' ' ' CYS . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.426 HD12 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.627 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.475 ' HA ' HG11 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.569 ' HB2' HG11 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.569 HG11 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.941 HD12 ' HA ' ' A' ' 251' ' ' TYR . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.429 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.425 ' C ' HD11 ' A' ' 313' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.578 ' HA ' HG21 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.771 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 67.2 m 71.64 135.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.22 0.608 . . . . 0.0 111.125 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.36 -66.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.631 2.221 . . . . 0.0 112.622 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 57.25 81.01 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.561 0.538 . . . . 0.0 112.077 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.63 118.2 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.498 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' A' ' 251' ' ' TYR . 8.1 Cg_exo -75.26 -172.83 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.56 2.84 . . . . 0.0 112.145 173.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.77 70.09 4.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.715 0.769 . . . . 0.0 112.04 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.632 ' HA ' HD13 ' A' ' 307' ' ' LEU . 42.8 p90 -147.22 2.48 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.88 163.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.522 ' O ' HD11 ' A' ' 260' ' ' LEU . 16.9 m-85 -130.59 4.75 4.66 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.649 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . 0.505 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' CYS . . . . . 0.684 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.668 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' MET . . . . . 0.684 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LYS . . . . . 0.763 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . 0.508 ' HB2' HG23 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.457 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.71 HG13 HG22 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.57 HG23 HD13 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 270' ' ' GLY . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 268' ' ' SER . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLN . . . . . 0.676 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 10.1 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' THR . . . . . 0.71 HG22 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.4 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.578 HG23 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . 0.436 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' TRP . . . . . 0.463 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' HIS . . . . . 0.463 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.564 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' SER . . . . . 0.564 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.535 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 11.4 m170 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ALA . . . . . 0.424 ' HB2' ' HD2' ' A' ' 287' ' ' LYS . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.57 HD13 HG23 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' THR . . . . . 0.574 ' HB ' HG21 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 266' ' ' ILE . 5.1 p-10 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 251' ' ' TYR . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ILE . . . . . 0.5 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.529 ' HB3' HD22 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.53 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.763 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.623 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.71 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.578 ' HB2' HG22 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 267' ' ' VAL . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.8 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.756 ' HB3' HG21 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.465 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 295' ' ' THR . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.488 ' H ' HG22 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.451 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 1.9 t-20 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.734 HG21 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.841 ' HB3' HD22 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.822 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.454 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.74 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 261' ' ' MET . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.74 ' HG3' ' HB2' ' A' ' 254' ' ' CYS . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.56 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 308' ' ' LYS . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 268' ' ' SER . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 267' ' ' VAL . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 268' ' ' SER . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.602 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.479 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.924 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.476 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.476 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.784 ' H ' HG22 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.679 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' HD23 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 311' ' ' ILE . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.822 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 252' ' ' PHE . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.51 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.473 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.782 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.605 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 320' ' ' ILE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.535 ' O ' HD12 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.618 ' HB2' HG22 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 268' ' ' SER . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.582 ' H ' HG12 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 268' ' ' SER . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.0 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.782 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.589 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.407 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.553 ' HA ' HD11 ' A' ' 311' ' ' ILE . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.792 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.57 HD11 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.605 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 314' ' ' TRP . 15.5 m-85 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.449 ' NE ' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.804 HG21 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.583 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HD3' HD11 ' A' ' 311' ' ' ILE . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 268' ' ' SER . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 267' ' ' VAL . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 268' ' ' SER . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.0 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.804 ' HB3' HG21 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.765 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.579 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.415 HG22 ' HG ' ' A' ' 297' ' ' LEU . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 295' ' ' THR . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.588 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 1.9 t-20 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 311' ' ' ILE . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.621 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.593 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.803 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.627 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.803 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.613 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.891 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 272' ' ' THR . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 267' ' ' VAL . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 268' ' ' SER . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 264' ' ' PRO . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.891 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.631 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.475 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.621 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.631 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.518 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.518 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 295' ' ' THR . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.554 ' HB2' HD21 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.439 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.512 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.617 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.489 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 311' ' ' ILE . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.523 HD11 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.692 ' HZ3' HD13 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.521 ' HB2' HD23 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.692 HD13 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.79 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.879 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.79 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.58 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.6 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.688 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.879 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.467 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.421 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.467 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.584 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.566 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 297' ' ' LEU . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.58 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.669 ' OD1' HG12 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.669 HG12 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.426 ' N ' HD12 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.798 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.718 HG21 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 . . . . . 0 C--O 1.228 -0.068 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.62 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.453 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 320' ' ' ILE . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.635 HD22 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.635 ' H ' HG12 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.616 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.791 HG21 HD22 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.616 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.693 ' O ' HG22 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.762 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.608 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.762 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.407 HD12 HD21 ' A' ' 282' ' ' LEU . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.791 HD22 HG21 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.462 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.222 -0.363 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.703 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.886 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.703 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.77 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.565 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.64 ' HB3' ' SD ' ' A' ' 261' ' ' MET . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.609 HG21 HD13 ' A' ' 296' ' ' LEU . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.64 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 278' ' ' ILE . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.64 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.886 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 296' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 63.1 m80 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.573 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG22 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 267' ' ' VAL . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' HIS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.627 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.473 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.571 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.407 ' HA ' ' SG ' ' A' ' 315' ' ' CYS . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.834 ' HB3' HD21 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.664 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 311' ' ' ILE . 11.5 m-85 . . . . . 0 C--O 1.225 -0.188 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.532 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 256' ' ' ILE . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.532 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.674 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 261' ' ' MET . . . . . 1.012 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.503 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 268' ' ' SER . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 267' ' ' VAL . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.77 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 3.8 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.77 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 1.012 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.468 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.468 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.493 ' HB3' HD21 ' A' ' 296' ' ' LEU . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 288' ' ' THR . 11.1 mm-40 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.51 ' ND2' HD12 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.51 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 311' ' ' ILE . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.491 ' N ' HD12 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' CYS . . . . . . . . . . . . . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.586 ' HE ' HD13 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.583 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.666 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.704 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD21 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 268' ' ' SER . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 267' ' ' VAL . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.619 ' HB3' HG12 ' A' ' 267' ' ' VAL . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.589 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.94 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 18.4 mm-40 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.44 HD21 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.724 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.548 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.601 HD11 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.751 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.624 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.654 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.565 ' HB2' HG22 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 296' ' ' LEU . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.467 ' NE2' ' CD2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.668 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.519 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.666 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.481 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.409 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.666 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 297' ' ' LEU . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.628 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.452 ' H ' HG22 ' A' ' 295' ' ' THR . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.515 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.751 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.404 ' HE1' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.629 ' HA ' HD22 ' A' ' 260' ' ' LEU . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.556 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.694 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 1.032 ' HB2' HG21 ' A' ' 320' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.944 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 262' ' ' LYS . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.731 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.417 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 268' ' ' SER . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 267' ' ' VAL . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 16.8 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 264' ' ' PRO . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.944 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.694 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.48 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 7.4 mp0 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.489 HD21 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.591 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.714 HD23 ' H ' ' A' ' 307' ' ' LEU . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.812 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.599 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 1.032 HG21 ' HB2' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.564 ' HA ' HG22 ' A' ' 311' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.659 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.614 HD12 HD11 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.508 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.659 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.666 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.648 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.704 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.716 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 0.6 OUTLIER -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.648 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.502 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.952 ' HB3' HG21 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 278' ' ' ILE . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 282' ' ' LEU . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.3 m80 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 295' ' ' THR . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.704 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 289' ' ' CYS . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.654 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.583 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.834 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 252' ' ' PHE . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.834 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.614 HD11 HD12 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.493 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.546 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.543 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.543 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.79 ' HB3' HG21 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.948 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.538 ' HD3' HD11 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.522 ' HG2' HG22 ' A' ' 267' ' ' VAL . 2.6 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.425 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG2' HD21 ' A' ' 301' ' ' LEU . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.439 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.517 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.631 HD21 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.604 HD21 ' HE3' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.443 ' N ' HD12 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.546 ' H ' HG13 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.867 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.419 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.867 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.581 ' HB2' HD13 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.806 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.691 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 268' ' ' SER . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.618 ' H ' HG12 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.8 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.806 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 265' ' ' VAL . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.577 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.439 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.504 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 291' ' ' LYS . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 65.8 m80 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.483 HD22 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 262' ' ' LYS . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.48 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.691 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.651 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 311' ' ' ILE . 40.8 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.506 ' HA ' HH11 ' A' ' 253' ' ' ARG . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 277' ' ' SER . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.734 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.636 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.479 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.719 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 0.8 OUTLIER -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.584 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' SER . . . . . 0.405 ' HB3' HG21 ' A' ' 256' ' ' ILE . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 284' ' ' ALA . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.417 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.418 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.67 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.67 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.418 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.407 HD11 HE22 ' A' ' 271' ' ' GLN . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' HIS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.458 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.614 ' HA ' HG22 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.78 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 8.2 m-85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.615 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 320' ' ' ILE . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.462 ' CB ' HD12 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.524 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.83 HE22 HD13 ' A' ' 278' ' ' ILE . 5.9 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.83 HD13 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.5 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.574 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.644 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.644 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.725 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.731 HD13 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.551 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.778 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 268' ' ' SER . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.722 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.506 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 295' ' ' THR . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.727 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' PRO . . . . . 0.722 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.727 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 297' ' ' LEU . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 289' ' ' CYS . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.587 HG12 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.602 HD22 ' HB ' ' A' ' 272' ' ' THR . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.48 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.583 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.765 HD11 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' A' ' 311' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.228 -0.073 0 CA-C-O 121.038 0.447 . . . . 0.0 111.207 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.732 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.798 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 320' ' ' ILE . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.693 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.748 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.463 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.693 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 18.3 mm-40 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.709 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.463 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' ASN . . . . . 0.579 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.599 ' O ' HG12 ' A' ' 311' ' ' ILE . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.462 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.621 ' HA ' HG22 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.798 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.529 ' O ' HD13 ' A' ' 260' ' ' LEU . 16.9 m-85 . . . . . 0 C--O 1.228 -0.043 0 CA-C-O 120.581 0.229 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ARG . . . . . 0.503 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' CYS . . . . . 0.683 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LYS . . . . . 0.772 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' PRO . . . . . 0.535 ' HB2' HG22 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.453 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.697 HG13 HG23 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 267' ' ' VAL . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLN . . . . . 0.689 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 3.4 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' THR . . . . . 0.697 HG23 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 273' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.588 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' TRP . . . . . 0.471 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 282' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' HIS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.544 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 2.3 m80 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' THR . . . . . 0.609 ' HB ' HG22 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ILE . . . . . 0.497 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.553 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.772 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 24.5 p -136.75 138.21 25.63 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.249 . . . . 0.0 110.367 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 3.5 Cg_exo -80.83 40.47 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.173 2.582 . . . . 0.0 112.353 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.72 121.6 37.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.594 . . . . 0.0 110.875 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -152.57 134.22 8.4 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.752 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 255' ' ' PRO . 28.0 Cg_exo -62.56 -65.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.827 2.351 . . . . 0.0 112.231 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -106.22 -159.2 0.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.897 0.379 . . . . 0.0 110.481 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 1.014 ' HA ' HD11 ' A' ' 307' ' ' LEU . 2.9 t80 76.67 -42.96 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 112.073 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.623 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 -132.19 -94.16 0.36 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.71 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 249' ' ' PRO . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.578 ' HB2' HG22 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 267' ' ' VAL . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.8 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.756 ' HB3' HG21 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.465 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.5 ' HD3' ' N ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 295' ' ' THR . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.488 ' H ' HG22 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.451 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 1.9 t-20 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 1.014 HD11 ' HA ' ' A' ' 251' ' ' TYR . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.734 HG21 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.841 ' HB3' HD22 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 35.0 m -71.48 -50.04 11.02 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 5.8 Cg_exo -79.61 158.66 25.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.178 1.919 . . . . 0.0 111.418 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.34 102.28 4.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.43 ' CE2' ' HD3' ' A' ' 253' ' ' ARG . 6.3 p90 -149.78 91.92 4.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.752 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -75.07 -73.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 112.975 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.93 106.9 9.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.131 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.61 ' HE2' ' HG ' ' A' ' 310' ' ' LEU . 15.4 t80 -174.03 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.898 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.822 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -117.54 33.9 5.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.454 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.74 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 261' ' ' MET . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.74 ' HG3' ' HB2' ' A' ' 254' ' ' CYS . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.56 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 308' ' ' LYS . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 268' ' ' SER . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 267' ' ' VAL . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 268' ' ' SER . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.602 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.479 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.924 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.476 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.476 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.784 ' H ' HG22 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.679 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' HD23 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 251' ' ' TYR . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.822 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 252' ' ' PHE . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.51 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 3.0 m -71.3 -53.5 7.9 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 4.0 Cg_endo -86.96 33.19 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.751 2.3 . . . . 0.0 112.525 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.83 102.22 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.47 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 21.2 p90 -108.97 134.82 20.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.416 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' PHE . 5.8 Cg_exo -77.08 161.58 32.48 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.93 2.42 . . . . 0.0 111.141 170.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -73.74 91.35 1.91 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 111.755 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.514 ' O ' HD11 ' A' ' 307' ' ' LEU . 27.4 p90 -172.41 -33.13 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.259 171.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 -83.39 -75.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.473 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.782 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.605 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 320' ' ' ILE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.535 ' O ' HD12 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.618 ' HB2' HG22 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 268' ' ' SER . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.582 ' H ' HG12 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 268' ' ' SER . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.0 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.782 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.589 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.407 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.553 ' HA ' HD11 ' A' ' 311' ' ' ILE . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.792 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.57 HD11 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.605 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 26.4 m 70.77 116.88 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 121.237 0.541 . . . . 0.0 111.381 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 10.8 Cg_exo -70.42 88.55 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.334 . . . . 0.0 112.405 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.86 -48.49 37.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.314 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 61.1 t80 64.84 91.39 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.968 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.705 ' HD2' ' HD2' ' A' ' 252' ' ' PHE . 3.0 Cg_exo -79.08 -180.0 5.95 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.269 2.646 . . . . 0.0 111.837 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.16 -1.21 43.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 310' ' ' LEU . 7.2 p90 -128.35 63.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.705 ' HD2' ' HD2' ' A' ' 249' ' ' PRO . 15.5 m-85 -150.93 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.449 ' NE ' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.804 HG21 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.583 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HD3' HD11 ' A' ' 311' ' ' ILE . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 268' ' ' SER . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 267' ' ' VAL . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 268' ' ' SER . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.0 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.804 ' HB3' HG21 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.765 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.579 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.415 HG22 ' HG ' ' A' ' 297' ' ' LEU . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 295' ' ' THR . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.588 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.427 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 1.9 t-20 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 311' ' ' ILE . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.621 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.593 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.6 p -154.9 102.28 2.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.42 -1.63 11.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.646 2.231 . . . . 0.0 111.666 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 48.48 81.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.689 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.94 75.17 11.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.364 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 250' ' ' GLU . 58.5 Cg_endo -92.3 -40.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.529 2.152 . . . . 0.0 112.047 172.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 7.5 tp10 173.27 -174.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.639 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 45.2 p90 48.91 32.49 3.82 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.43 1.092 . . . . 0.0 113.283 172.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -139.6 -75.86 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.803 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.627 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.803 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.613 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.891 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 272' ' ' THR . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 267' ' ' VAL . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 268' ' ' SER . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 264' ' ' PRO . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.891 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.631 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.475 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.621 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.631 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.518 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.518 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 295' ' ' THR . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.554 ' HB2' HD21 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.439 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.512 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.617 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.489 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 311' ' ' ILE . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.523 HD11 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.692 ' HZ3' HD13 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.521 ' HB2' HD23 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.692 HD13 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.0 m -81.39 133.0 54.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 11.5 Cg_exo -71.02 79.57 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.798 2.332 . . . . 0.0 111.463 177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.414 ' HA ' ' NH2' ' A' ' 253' ' ' ARG . 6.1 tp10 -90.52 104.53 17.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.917 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 253' ' ' ARG . 0.3 OUTLIER -154.99 82.63 3.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.334 0.587 . . . . 0.0 111.145 178.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -94.25 16.33 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.178 2.586 . . . . 0.0 113.423 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.38 -68.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.379 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -121.07 24.81 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 112.097 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -135.09 -84.16 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.79 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.879 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.79 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.58 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.6 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.688 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.879 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.625 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.467 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.421 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.467 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.584 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.566 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 297' ' ' LEU . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.58 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.669 ' OD1' HG12 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.669 HG12 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.426 ' N ' HD12 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.798 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.718 HG21 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.8 m -129.85 164.35 40.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.67 -45.75 36.14 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.587 2.191 . . . . 0.0 111.536 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.771 ' HG2' ' HG3' ' A' ' 249' ' ' PRO . 6.4 tt0 74.99 -71.18 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 124.046 0.841 . . . . 0.0 112.291 167.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.686 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 79.8 m-85 70.2 20.5 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.771 ' HG3' ' HG2' ' A' ' 247' ' ' GLU . 90.2 Cg_endo -103.64 142.5 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.432 1.904 . . . . 0.0 114.034 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 53.26 -87.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 170.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.702 ' O ' HD11 ' A' ' 307' ' ' LEU . 10.5 p90 -71.13 -29.38 65.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.578 -174.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 -78.44 -76.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.434 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.62 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.453 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 320' ' ' ILE . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.635 HD22 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.635 ' H ' HG12 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.616 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.791 HG21 HD22 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.616 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.693 ' O ' HG22 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.762 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.608 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.762 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.407 HD12 HD21 ' A' ' 282' ' ' LEU . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.791 HD22 HG21 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.462 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.702 HD11 ' O ' ' A' ' 251' ' ' TYR . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.4 m -67.1 133.03 93.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 122.034 0.134 . . . . 0.0 110.76 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.547 ' HA ' ' CE2' ' A' ' 248' ' ' PHE . 7.4 Cg_exo -72.63 66.98 3.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.039 2.492 . . . . 0.0 113.087 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 38.8 tt0 -112.73 -70.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.6 ' CB ' ' HB2' ' A' ' 252' ' ' PHE . 6.2 m-85 46.79 65.39 6.97 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.886 0.874 . . . . 0.0 112.796 174.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.69 126.63 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.155 1.904 . . . . 0.0 112.09 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 69.56 13.73 8.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -136.67 -31.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.638 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.6 ' HB2' ' CB ' ' A' ' 248' ' ' PHE . 41.9 m-85 -138.48 -76.09 0.38 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.186 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.703 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.886 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.703 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.77 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.565 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.64 ' HB3' ' SD ' ' A' ' 261' ' ' MET . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.609 HG21 HD13 ' A' ' 296' ' ' LEU . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.64 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 278' ' ' ILE . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.64 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.886 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 296' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 63.1 m80 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.573 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG22 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 267' ' ' VAL . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' HIS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.627 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.473 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.571 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.407 ' HA ' ' SG ' ' A' ' 315' ' ' CYS . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.834 ' HB3' HD21 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.664 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.6 p -94.26 123.59 58.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.833 0.316 . . . . 0.0 110.939 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.21 -35.82 50.08 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.648 2.232 . . . . 0.0 111.751 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 58.2 mm-40 64.36 110.42 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.975 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.93 74.25 26.43 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.436 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 247' ' ' GLU . 1.1 Cg_endo -84.18 -60.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.638 2.225 . . . . 0.0 111.606 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.639 ' HG3' ' CD2' ' A' ' 251' ' ' TYR . 13.5 pt-20 -165.11 -176.87 4.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.636 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.639 ' CD2' ' HG3' ' A' ' 250' ' ' GLU . 36.3 p90 48.02 28.9 1.57 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.349 1.06 . . . . 0.0 113.683 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 311' ' ' ILE . 11.5 m-85 -128.01 -79.59 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.532 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 256' ' ' ILE . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.532 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.674 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 261' ' ' MET . . . . . 1.012 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.503 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 268' ' ' SER . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 267' ' ' VAL . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.77 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 3.8 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.77 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 1.012 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.468 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.468 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.689 ' HD3' ' H ' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.403 ' HB ' ' HA ' ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.493 ' HB3' HD21 ' A' ' 296' ' ' LEU . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.403 ' HA ' ' HB ' ' A' ' 288' ' ' THR . 11.1 mm-40 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.51 ' ND2' HD12 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.51 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.638 HD11 ' HA ' ' A' ' 251' ' ' TYR . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.491 ' N ' HD12 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' CYS . . . . . . . . . . . . . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.8 m 69.74 133.32 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.208 0 C-N-CA 123.339 0.656 . . . . 0.0 111.455 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.1 -28.47 48.84 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.595 2.197 . . . . 0.0 112.84 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 61.92 90.04 0.08 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.475 0.655 . . . . 0.0 110.323 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.4 128.46 21.14 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.268 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.97 175.7 6.48 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.9 2.4 . . . . 0.0 112.021 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 251' ' ' TYR . 0.3 OUTLIER -67.51 110.02 3.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.903 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 23.2 t80 166.41 -16.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -163.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 -135.09 -56.73 0.81 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.586 ' HE ' HD13 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.583 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.666 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.704 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD21 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 268' ' ' SER . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 267' ' ' VAL . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.619 ' HB3' HG12 ' A' ' 267' ' ' VAL . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.589 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.94 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 18.4 mm-40 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.44 HD21 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.903 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.548 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.601 HD11 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.6 m -102.88 112.38 65.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.85 114.3 3.92 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.476 2.117 . . . . 0.0 112.704 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.23 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.709 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -121.39 79.86 37.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -106.25 40.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.082 3.188 . . . . 0.0 111.198 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 251' ' ' TYR . 23.7 tt0 62.74 -140.08 0.4 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.76 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 1.6 t80 71.14 -73.71 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.079 0.399 . . . . 0.0 111.363 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 -98.7 -75.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.751 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.624 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.654 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.565 ' HB2' HG22 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.545 HG21 HD13 ' A' ' 296' ' ' LEU . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.467 ' NE2' ' CD2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.668 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.519 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.666 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.481 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.409 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.666 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 297' ' ' LEU . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.628 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.452 ' H ' HG22 ' A' ' 295' ' ' THR . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.515 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.76 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.751 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.782 ' HB2' ' HG3' ' A' ' 249' ' ' PRO . 3.4 m -92.17 106.16 16.71 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 2.6 Cg_endo -80.67 -19.73 8.45 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.936 2.424 . . . . 0.0 113.712 -172.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.5 -97.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.648 ' CE1' ' HD2' ' A' ' 253' ' ' ARG . 62.5 m-85 -133.57 75.17 69.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.788 ' HG2' ' HB2' ' A' ' 252' ' ' PHE . 97.5 Cg_endo -97.45 153.57 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.005 2.47 . . . . 0.0 111.205 168.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.16 11.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.159 -0.338 . . . . 0.0 111.64 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.821 ' HA ' HD13 ' A' ' 307' ' ' LEU . 35.4 p90 -118.6 13.85 13.46 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.657 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.788 ' HB2' ' HG2' ' A' ' 249' ' ' PRO . 0.9 OUTLIER -140.79 -87.11 0.18 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.324 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.648 ' HD2' ' CE1' ' A' ' 248' ' ' PHE . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.556 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.694 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 1.032 ' HB2' HG21 ' A' ' 320' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.944 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 262' ' ' LYS . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.731 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.417 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 268' ' ' SER . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 267' ' ' VAL . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 16.8 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 264' ' ' PRO . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.944 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.694 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.48 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 7.4 mp0 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.489 HD21 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.591 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 251' ' ' TYR . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.812 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.599 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 1.032 HG21 ' HB2' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -53.75 17.08 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.31 123.96 12.25 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.255 1.97 . . . . 0.0 112.164 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 1.6 mp0 -52.32 160.62 0.77 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.019 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.52 ' HD1' ' HD2' ' A' ' 253' ' ' ARG . 77.1 t80 -112.4 90.18 13.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.996 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.704 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.3 Cg_endo -90.39 148.03 4.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.182 2.588 . . . . 0.0 111.459 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.34 -24.28 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.17 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.774 ' HA ' HD11 ' A' ' 307' ' ' LEU . 12.2 p90 -90.06 18.86 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.461 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.704 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 3.7 m-85 -130.56 -80.52 0.54 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.52 ' HD2' ' HD1' ' A' ' 248' ' ' PHE . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.659 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.614 HD12 HD11 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.508 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.659 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.666 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.648 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.704 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.716 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 0.6 OUTLIER -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.648 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.502 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.952 ' HB3' HG21 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 278' ' ' ILE . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 282' ' ' LEU . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.3 m80 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 295' ' ' THR . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.704 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 289' ' ' CYS . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.654 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.583 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 251' ' ' TYR . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.834 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 252' ' ' PHE . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.834 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.614 HD11 HD12 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.2 m 66.33 91.44 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.214 0 C-N-CA 123.393 0.677 . . . . 0.0 111.94 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.99 150.47 29.9 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.328 2.685 . . . . 0.0 111.653 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.92 -33.79 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 54.03 73.53 0.89 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.01 -58.47 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.237 1.958 . . . . 0.0 111.085 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.686 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 6.4 tp10 -179.84 -169.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 44.9 p90 50.27 29.92 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.232 1.013 . . . . 0.0 112.961 176.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.493 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 -132.01 -77.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 176.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.546 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.543 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.543 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.79 ' HB3' HG21 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.948 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.538 ' HD3' HD11 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.522 ' HG2' HG22 ' A' ' 267' ' ' VAL . 2.6 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.425 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG2' HD21 ' A' ' 301' ' ' LEU . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.439 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.517 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.631 HD21 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.604 HD21 ' HE3' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.443 ' N ' HD12 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.546 ' H ' HG13 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' ' 246' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.3 m -82.47 107.26 8.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 244' ' ' GLY . 93.6 Cg_endo -93.23 53.9 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.995 2.463 . . . . 0.0 111.833 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.6 mt-10 -70.13 126.16 28.87 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -102.61 107.09 52.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.73 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.717 ' HG2' ' CE1' ' A' ' 251' ' ' TYR . 1.8 Cg_endo -86.9 -166.62 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.421 2.747 . . . . 0.0 110.895 169.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -73.11 -19.39 61.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.717 ' CE1' ' HG2' ' A' ' 249' ' ' PRO . 16.5 p90 -91.77 25.33 2.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.572 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.79 -82.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.867 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.419 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.867 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.581 ' HB2' HD13 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.806 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.691 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 268' ' ' SER . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.618 ' H ' HG12 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 3.8 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.806 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 265' ' ' VAL . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.577 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.439 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.504 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 291' ' ' LYS . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 65.8 m80 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.483 HD22 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 262' ' ' LYS . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.48 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.691 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.651 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.8 m -103.79 107.98 58.27 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.73 -0.277 . . . . 0.0 110.313 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.38 -76.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.482 2.122 . . . . 0.0 110.883 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 44.82 42.53 6.13 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.795 0.685 . . . . 0.0 112.655 172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 41.7 m-85 -64.73 122.28 78.04 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.186 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.26 -17.48 31.01 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.456 2.104 . . . . 0.0 111.724 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.82 -167.22 2.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.916 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.677 ' HD2' ' HD1' ' A' ' 252' ' ' PHE . 0.3 OUTLIER 65.18 -103.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.774 178.347 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.677 ' HD1' ' HD2' ' A' ' 251' ' ' TYR . 40.8 p90 -123.78 9.61 8.89 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -165.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.506 ' HA ' HH11 ' A' ' 253' ' ' ARG . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 277' ' ' SER . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.734 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.636 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.479 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.719 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 0.8 OUTLIER -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.584 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' SER . . . . . 0.405 ' HB3' HG21 ' A' ' 256' ' ' ILE . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 284' ' ' ALA . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.417 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.418 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.67 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.67 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.418 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.407 HD11 HE22 ' A' ' 271' ' ' GLN . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' HIS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.458 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.614 ' HA ' HG22 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.78 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 112.204 -0.359 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.2 m -75.9 152.32 84.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.505 0.193 . . . . 0.0 110.492 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.32 -20.27 66.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.456 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.57 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.1 tt0 71.72 154.72 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.121 0.568 . . . . 0.0 110.2 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -109.66 93.62 14.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.328 . . . . 0.0 110.847 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.761 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.0 Cg_exo -83.57 133.63 6.21 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.883 2.389 . . . . 0.0 111.087 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 250' ' ' GLU . 0.9 OUTLIER -77.31 -5.37 49.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.466 -175.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.737 ' HA ' HD11 ' A' ' 307' ' ' LEU . 40.4 p90 -101.72 22.95 12.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.825 0.345 . . . . 0.0 110.999 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.761 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 8.2 m-85 -131.21 -64.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.615 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 320' ' ' ILE . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.462 ' CB ' HD12 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.524 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.83 HE22 HD13 ' A' ' 278' ' ' ILE . 5.9 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.83 HD13 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.5 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.574 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.644 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.644 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 251' ' ' TYR . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.725 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.731 HD13 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 245' ' ' SER . . . . . 0.7 ' HB3' ' HD3' ' A' ' 246' ' ' PRO . 35.5 t -60.71 -51.7 77.79 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 117.006 0.403 . . . . 0.0 110.46 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 245' ' ' SER . 57.4 Cg_endo -101.4 166.2 0.35 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.942 2.428 . . . . 0.0 111.447 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -73.08 144.3 47.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -119.34 89.47 40.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -96.44 -164.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.098 2.532 . . . . 0.0 110.869 169.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.16 26.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 0.0 110.03 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -95.26 -17.16 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.735 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 -149.93 -55.22 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.46 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.551 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.778 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 268' ' ' SER . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.722 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.506 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 295' ' ' THR . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.727 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PRO . . . . . 0.722 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.727 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 297' ' ' LEU . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 289' ' ' CYS . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.587 HG12 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.602 HD22 ' HB ' ' A' ' 272' ' ' THR . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.48 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.441 ' HZ2' ' CG ' ' A' ' 246' ' ' PRO . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.583 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.765 HD11 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 32.6 t -97.54 148.42 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.7 8.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.65 2.233 . . . . 0.0 112.965 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.87 94.41 1.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.235 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 253' ' ' ARG . 16.8 m-85 -97.37 123.47 52.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.358 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.505 ' HB2' ' HD1' ' A' ' 251' ' ' TYR . 23.4 Cg_exo -66.43 -179.66 1.63 Allowed 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.368 2.046 . . . . 0.0 110.671 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 273' ' ' TYR . 12.5 pt-20 -79.91 14.72 1.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -173.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.965 ' HA ' HD11 ' A' ' 307' ' ' LEU . 9.1 p90 -98.41 5.87 47.74 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.166 0.507 . . . . 0.0 109.825 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' A' ' 311' ' ' ILE . 1.0 OUTLIER -138.3 -67.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.207 176.406 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.732 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.798 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 320' ' ' ILE . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.693 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.748 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.463 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.693 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 18.3 mm-40 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.709 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.463 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASN . . . . . 0.579 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.965 HD11 ' HA ' ' A' ' 251' ' ' TYR . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.462 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.621 ' HA ' HG22 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.798 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 67.2 m 71.64 135.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.22 0.608 . . . . 0.0 111.125 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.36 -66.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.631 2.221 . . . . 0.0 112.622 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 57.25 81.01 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.561 0.538 . . . . 0.0 112.077 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 29.6 p90 -155.63 118.2 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.498 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 248' ' ' PHE . 8.1 Cg_exo -75.26 -172.83 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.56 2.84 . . . . 0.0 112.145 173.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.77 70.09 4.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.715 0.769 . . . . 0.0 112.04 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.684 ' HA ' HD11 ' A' ' 307' ' ' LEU . 42.8 p90 -147.22 2.48 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.88 163.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.529 ' O ' HD13 ' A' ' 260' ' ' LEU . 16.9 m-85 -130.59 4.75 4.66 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.649 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ARG . . . . . 0.503 ' HD2' ' C ' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' CYS . . . . . 0.683 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LYS . . . . . 0.772 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' PRO . . . . . 0.535 ' HB2' HG22 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.453 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.697 HG13 HG23 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 267' ' ' VAL . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLN . . . . . 0.689 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 3.4 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' THR . . . . . 0.697 HG23 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 273' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.588 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' TRP . . . . . 0.471 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 282' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' HIS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.544 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 2.3 m80 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' THR . . . . . 0.609 ' HB ' HG22 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 251' ' ' TYR . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ILE . . . . . 0.497 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.553 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.772 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.623 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.71 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.578 ' HB2' HG22 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 267' ' ' VAL . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 5.0 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.756 ' HB3' HG21 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.465 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.5 ' N ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 295' ' ' THR . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.488 ' H ' HG22 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.538 HD22 HG21 ' A' ' 272' ' ' THR . 45.0 t30 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.44 HG12 ' ND2' ' A' ' 304' ' ' ASN . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.542 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.734 HG21 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.841 ' HB3' HD22 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.822 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.227 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.454 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.74 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 261' ' ' MET . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.74 ' HG3' ' HB2' ' A' ' 254' ' ' CYS . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.56 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 308' ' ' LYS . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 268' ' ' SER . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 267' ' ' VAL . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 268' ' ' SER . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.602 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.479 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.924 ' H ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.476 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.476 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.784 ' H ' HG22 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.679 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' HD23 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 311' ' ' ILE . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.822 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 252' ' ' PHE . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.51 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.473 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.782 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.605 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 320' ' ' ILE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.535 ' O ' HD12 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.618 ' HB2' HG22 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 268' ' ' SER . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.582 ' H ' HG12 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 268' ' ' SER . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.613 HE22 HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.525 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.613 HG12 HE22 ' A' ' 271' ' ' GLN . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.782 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.589 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.407 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.553 ' HA ' HD11 ' A' ' 311' ' ' ILE . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.792 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.57 HD11 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.605 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 314' ' ' TRP . 15.5 m-85 . . . . . 0 N--CA 1.463 0.194 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.449 ' NE ' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.804 HG21 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.583 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HD3' HD11 ' A' ' 311' ' ' ILE . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 268' ' ' SER . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 267' ' ' VAL . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 268' ' ' SER . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.2 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.804 ' HB3' HG21 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.765 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.579 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.415 HG22 ' HG ' ' A' ' 297' ' ' LEU . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 295' ' ' THR . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.588 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.572 HD22 HG21 ' A' ' 272' ' ' THR . 36.4 t30 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.529 HG12 ' ND2' ' A' ' 304' ' ' ASN . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 311' ' ' ILE . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.621 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.593 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.803 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.627 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.803 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.613 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.891 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 272' ' ' THR . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 267' ' ' VAL . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 268' ' ' SER . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 264' ' ' PRO . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.891 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.631 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.475 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.621 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.631 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.518 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.518 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.554 ' HB2' HD21 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.439 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 29.5 mm-40 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.512 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.617 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.489 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 311' ' ' ILE . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.523 HD11 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.692 ' HZ3' HD13 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.521 ' HB2' HD23 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.692 HD13 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.79 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.879 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.79 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.58 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.864 HE22 HD13 ' A' ' 278' ' ' ILE . 30.8 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.688 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.879 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.864 HD13 HE22 ' A' ' 271' ' ' GLN . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.467 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.421 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.467 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.584 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.566 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 293' ' ' GLN . 0.0 OUTLIER 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 297' ' ' LEU . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.58 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.669 ' OD1' HG12 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.669 HG12 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.426 ' N ' HD12 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.798 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.718 HG21 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 . . . . . 0 C--O 1.228 -0.068 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.62 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.453 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 320' ' ' ILE . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.635 HD22 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.635 ' H ' HG12 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.616 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 1.5 tt0 -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.791 HG21 HD22 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.616 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.693 ' O ' HG22 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.762 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.608 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.762 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.407 HD12 HD21 ' A' ' 282' ' ' LEU . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.791 HD22 HG21 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.462 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 . . . . . 0 C--O 1.222 -0.363 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.703 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.886 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.703 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.77 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.565 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.64 ' HB3' ' SD ' ' A' ' 261' ' ' MET . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.609 HG21 HD13 ' A' ' 296' ' ' LEU . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.64 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 278' ' ' ILE . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.64 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.886 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 296' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.8 m-70 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.573 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG22 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 267' ' ' VAL . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.627 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.473 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.571 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.407 ' HA ' ' SG ' ' A' ' 315' ' ' CYS . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.834 ' HB3' HD21 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.664 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 311' ' ' ILE . 11.5 m-85 . . . . . 0 C--O 1.225 -0.188 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.532 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 256' ' ' ILE . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.532 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.674 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 1.012 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.503 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 268' ' ' SER . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 267' ' ' VAL . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.77 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 12.2 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.77 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 1.012 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.468 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.468 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.689 ' H ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.591 ' HB ' HE21 ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.493 ' HB3' HD21 ' A' ' 296' ' ' LEU . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.591 HE21 ' HB ' ' A' ' 288' ' ' THR . 0.2 OUTLIER 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.51 ' ND2' HD12 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.51 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 311' ' ' ILE . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.491 ' N ' HD12 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . . . . . . . . . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 . . . . . 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.586 ' HE ' HD13 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.583 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.666 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.704 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD21 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 268' ' ' SER . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 267' ' ' VAL . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.619 ' HB3' HG12 ' A' ' 267' ' ' VAL . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.589 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.94 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.44 HD21 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.724 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.548 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.601 HD11 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 . . . . . 0 N--CA 1.463 0.205 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.751 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.624 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.654 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.565 ' HB2' HG22 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.912 HG22 HE21 ' A' ' 271' ' ' GLN . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.912 HE21 HG22 ' A' ' 267' ' ' VAL . 5.0 pp0? -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.668 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.519 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.666 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.481 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.409 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.666 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 297' ' ' LEU . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.628 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.452 ' H ' HG22 ' A' ' 295' ' ' THR . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.515 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.523 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.751 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.404 ' HE1' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.135 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.629 ' HA ' HD22 ' A' ' 260' ' ' LEU . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.556 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.694 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 1.032 ' HB2' HG21 ' A' ' 320' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.944 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 262' ' ' LYS . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.731 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.417 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 268' ' ' SER . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 267' ' ' VAL . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 15.3 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 264' ' ' PRO . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.944 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.694 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.48 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.475 ' C ' HE21 ' A' ' 293' ' ' GLN . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.489 HD21 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.591 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.714 ' H ' HD23 ' A' ' 307' ' ' LEU . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.812 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.599 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 1.032 HG21 ' HB2' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.564 ' HA ' HG22 ' A' ' 311' ' ' ILE . 3.7 m-85 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.659 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.614 HD12 HD11 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.508 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.659 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.666 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.648 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.704 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.894 HE22 HG12 ' A' ' 278' ' ' ILE . 4.4 tt0 -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.648 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.502 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.952 ' HB3' HG21 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.894 HG12 HE22 ' A' ' 271' ' ' GLN . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 278' ' ' ILE . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 282' ' ' LEU . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 44.1 m-70 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.513 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.704 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 0.1 OUTLIER 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 289' ' ' CYS . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.654 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.583 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.834 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 252' ' ' PHE . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.834 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.614 HD11 HD12 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.493 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 . . . . . 0 CA--C 1.522 -0.109 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.546 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.543 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.543 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.79 ' HB3' HG21 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.948 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.538 ' HD3' HD11 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.594 HE22 HG12 ' A' ' 278' ' ' ILE . 7.0 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.425 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.594 HG12 HE22 ' A' ' 271' ' ' GLN . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG2' HD21 ' A' ' 301' ' ' LEU . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.439 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.517 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.631 HD21 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.604 HD21 ' HE3' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.443 ' N ' HD12 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.546 ' H ' HG13 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 N--CA 1.46 0.065 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.867 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.419 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.867 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.581 ' HB2' HD13 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.806 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.691 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 268' ' ' SER . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.618 ' H ' HG12 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 10.2 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.806 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 265' ' ' VAL . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.577 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.439 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.504 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 291' ' ' LYS . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.483 HD22 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 262' ' ' LYS . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.48 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.691 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.651 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.667 ' HB2' HG22 ' A' ' 311' ' ' ILE . 40.8 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.506 ' HA ' HH11 ' A' ' 253' ' ' ARG . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 277' ' ' SER . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.734 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.636 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.479 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.719 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 9.3 tt0 -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.584 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . 0.405 ' HB3' HG21 ' A' ' 256' ' ' ILE . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 284' ' ' ALA . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.417 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.418 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.67 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.67 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.418 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.458 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.614 ' HA ' HG22 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.78 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 8.2 m-85 . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.615 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 320' ' ' ILE . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.462 ' CB ' HD12 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.524 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.0 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.5 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.574 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.644 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.644 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.725 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.731 HD13 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.551 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.778 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 268' ' ' SER . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.722 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.506 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.456 HG21 HE21 ' A' ' 293' ' ' GLN . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.727 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . 0.722 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.456 HE21 HG21 ' A' ' 288' ' ' THR . 0.0 OUTLIER 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.727 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 297' ' ' LEU . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 289' ' ' CYS . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.587 HG12 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.602 HD22 ' HB ' ' A' ' 272' ' ' THR . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.48 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.583 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.765 HD11 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' A' ' 311' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--O 1.228 -0.073 0 CA-C-O 121.038 0.447 . . . . 0.0 111.207 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.732 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.798 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 320' ' ' ILE . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.693 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.748 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.463 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.693 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.709 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.463 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . 0.579 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.599 ' O ' HG12 ' A' ' 311' ' ' ILE . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.462 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.621 ' HA ' HG22 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.798 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.529 ' O ' HD13 ' A' ' 260' ' ' LEU . 16.9 m-85 . . . . . 0 C--O 1.228 -0.043 0 CA-C-O 120.581 0.229 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' CYS . . . . . 0.683 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LYS . . . . . 0.772 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' PRO . . . . . 0.535 ' HB2' HG22 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.453 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.697 HG13 HG23 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 267' ' ' VAL . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLN . . . . . 0.689 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 10.1 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . 0.697 HG23 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.588 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' TRP . . . . . 0.471 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' HIS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.544 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LEU . . . . . 0.468 HD13 ' CD2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' HIS . . . . . 0.468 ' CD2' HD13 ' A' ' 297' ' ' LEU . 11.4 m170 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' THR . . . . . 0.609 ' HB ' HG22 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ILE . . . . . 0.497 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.553 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.772 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 24.5 p -136.75 138.21 25.63 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-O 120.622 0.249 . . . . 0.0 110.367 178.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 3.5 Cg_exo -80.83 40.47 0.99 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.173 2.582 . . . . 0.0 112.353 -178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.72 121.6 37.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.594 . . . . 0.0 110.875 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -152.57 134.22 8.4 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.752 177.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 255' ' ' PRO . 28.0 Cg_exo -62.56 -65.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.827 2.351 . . . . 0.0 112.231 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 31.9 mp0 -106.22 -159.2 0.69 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.897 0.379 . . . . 0.0 110.481 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 1.014 ' HA ' HD11 ' A' ' 307' ' ' LEU . 2.9 t80 76.67 -42.96 0.44 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.061 0.944 . . . . 0.0 112.073 175.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.623 ' HA ' HG22 ' A' ' 311' ' ' ILE . 31.5 m-85 -132.19 -94.16 0.36 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -80.67 147.85 30.46 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.49 -175.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.71 ' HB3' HG12 ' A' ' 256' ' ' ILE . 76.5 m -80.48 140.05 51.81 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.156 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 249' ' ' PRO . 2.9 Cg_exo -75.24 -1.18 10.95 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.892 2.395 . . . . 0.0 111.143 177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.756 HG21 ' HB3' ' A' ' 277' ' ' SER . 7.8 mm -66.24 -58.87 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.253 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 29.8 m -149.12 20.75 0.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.608 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 59.76 37.26 22.14 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 109.892 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.1 pm0 -89.09 -24.45 22.27 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.03 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 315' ' ' CYS . 3.7 tt 67.54 152.07 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.16 -174.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.786 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.6 ptt? -105.9 152.3 23.46 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.221 -173.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 308' ' ' LYS . 0.1 OUTLIER -104.91 -69.83 0.8 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -93.8 105.59 17.49 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.342 -0.845 . . . . 0.0 108.918 167.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.578 ' HB2' HG22 ' A' ' 272' ' ' THR . 92.1 Cg_endo -87.97 133.9 3.05 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.412 2.075 . . . . 0.0 112.386 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.81 131.99 61.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.267 0.556 . . . . 0.0 110.91 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.644 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.3 OUTLIER -90.73 142.7 12.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.571 176.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.605 HG22 HD12 ' A' ' 301' ' ' LEU . 5.1 t -129.18 172.22 15.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 174.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.514 ' H ' HG12 ' A' ' 267' ' ' VAL . 16.2 m -59.27 152.79 20.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 9.0 m 87.27 -12.4 0.52 Allowed 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.079 0.862 . . . . 0.0 109.284 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.29 33.28 23.39 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.255 173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.617 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 5.0 pt20 -90.8 137.54 32.28 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.878 -0.189 . . . . 0.0 111.29 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.578 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -127.17 100.83 6.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 110.404 173.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 33.7 m-85 -129.01 175.58 8.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.786 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 32.0 tt0 -75.14 136.98 41.05 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.531 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -52.49 -41.85 63.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.355 -178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 49.4 m -65.41 -21.16 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.817 0.341 . . . . 0.0 111.678 -177.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.756 ' HB3' HG21 ' A' ' 256' ' ' ILE . 27.6 m -95.57 -42.6 8.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.853 0.358 . . . . 0.0 111.159 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.5 tp -83.97 -48.6 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.451 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 12.7 mm100 -75.55 -10.32 59.35 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.693 0.759 . . . . 0.0 109.919 -175.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -62.07 -44.81 95.88 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.562 -1.199 . . . . 0.0 109.755 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.465 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.65 -28.96 13.3 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.53 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 16.2 mt -62.97 -40.18 96.93 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.508 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.76 -28.16 69.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -63.32 -13.1 35.11 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.907 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.29 1.07 22.11 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.533 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 87.3 m-70 -97.33 146.96 24.65 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.5 ' N ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -139.56 71.29 1.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.394 0.616 . . . . 0.0 110.244 176.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 295' ' ' THR . 18.6 p -140.52 143.69 35.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.581 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 1.5 m -68.69 151.35 97.29 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 120.816 0.341 . . . . 0.0 111.034 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.02 -1.21 11.24 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.715 2.277 . . . . 0.0 112.745 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -84.34 -59.31 2.42 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.124 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 293' ' ' GLN . 50.4 m -137.0 10.03 3.05 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.787 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 2.0 mp0 71.93 32.37 1.87 Allowed 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.432 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -58.53 111.53 1.28 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 297' ' ' LEU . 12.4 m -60.35 122.63 15.03 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.411 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.0 -16.33 62.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.417 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.488 ' H ' HG22 ' A' ' 295' ' ' THR . 49.8 tp 66.66 -77.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.105 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -95.73 107.74 19.99 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -83.56 92.93 7.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.396 0.617 . . . . 0.0 110.542 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -132.88 135.7 8.27 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.605 HD12 HG22 ' A' ' 267' ' ' VAL . 11.3 tp -95.44 109.31 21.51 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.0 110.148 -174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.644 ' HB ' HG22 ' A' ' 266' ' ' ILE . 89.2 m -106.83 106.89 59.34 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.088 -178.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 20.0 Cg_endo -60.6 120.28 7.92 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.488 2.125 . . . . 0.0 112.685 -176.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.538 HD22 HG21 ' A' ' 272' ' ' THR . 45.0 t30 -106.39 105.21 15.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.233 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -83.66 -4.96 59.03 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.44 HG12 ' ND2' ' A' ' 304' ' ' ASN . 4.7 p -64.96 -30.49 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-O 121.311 0.577 . . . . 0.0 111.087 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 1.014 HD11 ' HA ' ' A' ' 251' ' ' TYR . 6.9 tp -95.92 -19.99 19.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.667 -166.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 262' ' ' LYS . 64.5 tttp -60.12 -50.2 74.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 117.73 0.241 . . . . 0.0 111.212 -174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.4 m -63.51 -22.02 66.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.98 0.419 . . . . 0.0 111.139 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.451 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 2.4 mp -85.07 -50.7 7.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.517 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.734 HG21 ' HG3' ' A' ' 261' ' ' MET . 3.3 pt -67.22 -35.98 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.927 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.64 0.733 . . . . 0.0 110.403 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.6 OUTLIER -76.73 -34.76 58.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.813 177.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -80.43 -40.94 25.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.961 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.841 ' HB3' HD22 ' A' ' 260' ' ' LEU . 14.8 p -70.57 -9.43 56.81 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.281 0.562 . . . . 0.0 110.585 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -83.36 -31.66 26.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.559 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 44.2 t -72.72 -41.54 65.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.49 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.432 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 26.6 t-20 -138.7 126.0 21.6 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.299 176.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.55 88.66 0.1 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.13 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 315' ' ' CYS . 11.5 tt -113.92 124.81 70.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.24 0.543 . . . . 0.0 112.222 -172.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 38.2 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.856 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.56 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 35.0 m -71.48 -50.04 11.02 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 5.8 Cg_exo -79.61 158.66 25.24 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.178 1.919 . . . . 0.0 111.418 177.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -138.34 102.28 4.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.259 0.552 . . . . 0.0 110.882 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.43 ' CE2' ' HD3' ' A' ' 253' ' ' ARG . 6.3 p90 -149.78 91.92 4.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.752 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -75.07 -73.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.575 2.183 . . . . 0.0 112.975 -176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.93 106.9 9.62 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.278 0.561 . . . . 0.0 111.131 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.61 ' HE2' ' HG ' ' A' ' 310' ' ' LEU . 15.4 t80 -174.03 -86.66 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.898 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.822 ' HD2' ' HB3' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -117.54 33.9 5.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.454 ' HA ' HD22 ' A' ' 260' ' ' LEU . 11.6 ttp180 -117.71 130.15 56.15 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.209 -0.597 . . . . 0.0 111.028 176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.74 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 53.9 t -81.58 117.33 67.82 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.7 Cg_exo -77.29 6.38 4.4 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.382 2.721 . . . . 0.0 112.445 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.6 mt -87.59 -51.64 12.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.402 -176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.3 m -130.22 4.56 4.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 320' ' ' ILE . 0.3 OUTLIER 59.18 37.65 23.86 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.516 0.674 . . . . 0.0 109.204 -173.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 261' ' ' MET . 1.7 pm0 -88.32 -10.08 50.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.296 -176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.2 OUTLIER 68.35 3.28 3.66 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.068 175.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.74 ' HG3' ' HB2' ' A' ' 254' ' ' CYS . 61.8 mtm 61.59 165.53 0.09 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.907 0.861 . . . . 0.0 112.909 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.56 ' O ' ' HE3' ' A' ' 308' ' ' LYS . 20.5 mmtt -128.52 -48.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.961 175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 308' ' ' LYS . 38.9 t70 -144.78 101.21 4.6 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.602 ' HB2' HG22 ' A' ' 272' ' ' THR . 84.4 Cg_endo -93.72 156.57 2.35 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.83 2.353 . . . . 0.0 114.517 -165.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 23.7 m -120.06 143.87 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.161 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.1 tt -106.73 153.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.902 -178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 268' ' ' SER . 2.6 t -139.66 177.71 4.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 267' ' ' VAL . 13.3 t -60.22 158.21 11.92 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 175.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 268' ' ' SER . 87.7 m 88.95 -18.98 0.21 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.392 0.677 . . . . 0.0 110.484 -172.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 96.28 19.04 29.23 Favored Glycine 0 CA--C 1.511 -0.21 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.443 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.691 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 8.9 tt0 -77.11 124.97 28.57 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.886 -0.657 . . . . 0.0 111.564 -177.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.602 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.6 m -133.01 100.26 4.83 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 173.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 25.5 m-85 -135.42 173.77 11.35 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.71 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 7.8 tp10 -72.77 135.77 45.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.248 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.422 ' HD2' ' N ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -66.83 -32.11 73.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.754 -169.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.422 ' N ' ' HD2' ' A' ' 275' ' ' ARG . 48.0 m -67.19 -21.42 65.78 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.385 0.612 . . . . 0.0 110.086 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.9 m -95.57 -39.72 9.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.35 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.65 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.6 tp -92.23 -53.54 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.808 0.669 . . . . 0.0 112.808 -175.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 37.0 mt-30 -61.05 -29.55 69.79 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 120.789 0.328 . . . . 0.0 110.775 -175.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.479 ' HG2' ' N ' ' A' ' 281' ' ' TRP . 0.0 OUTLIER -53.44 -41.6 66.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.902 178.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.479 ' N ' ' HG2' ' A' ' 280' ' ' LYS . 0.0 OUTLIER -98.72 -32.58 11.32 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.083 -179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 12.1 mt -57.07 -39.24 74.57 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.071 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.2 -28.77 69.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.079 0.466 . . . . 0.0 110.632 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.54 -29.09 68.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.981 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 113.64 48.66 0.58 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.697 -0.764 . . . . 0.0 113.423 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 94.4 m-70 -137.33 89.67 2.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.17 0.51 . . . . 0.0 110.692 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.924 ' H ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -80.42 72.79 7.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.637 0.732 . . . . 0.0 111.427 -176.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 9.6 p -141.97 141.28 32.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.51 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.8 OUTLIER -85.0 145.26 43.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.513 0.197 . . . . 0.0 111.095 -179.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.88 3.79 4.15 Favored 'Trans proline' 0 N--CA 1.474 0.382 0 C-N-CA 123.076 2.517 . . . . 0.0 113.242 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.476 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 35.2 mtmt -80.04 -67.04 0.8 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.842 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 13.4 m -137.91 12.62 2.89 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.311 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 60.83 49.23 6.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.464 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.476 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.2 mp0 -72.12 -3.75 25.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.122 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.784 HG22 ' H ' ' A' ' 297' ' ' LEU . 9.0 m 69.5 129.13 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.59 0.556 . . . . 0.0 110.4 -176.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.8 mt -87.25 -2.13 58.4 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.784 ' H ' HG22 ' A' ' 295' ' ' THR . 3.0 mm? 61.32 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.298 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 81.0 m-70 -102.78 113.08 26.2 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.96 90.89 4.77 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.433 0.635 . . . . 0.0 110.37 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -120.3 90.88 0.48 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 267' ' ' VAL . 2.5 tp -64.49 132.95 51.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.083 0.468 . . . . 0.0 110.317 -174.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 266' ' ' ILE . 98.3 m -136.47 142.35 39.07 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.625 -174.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 8.1 Cg_exo -73.47 122.45 7.91 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.008 1.805 . . . . 0.0 112.384 175.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.679 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 34.0 t30 -114.29 107.01 15.02 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.066 0.46 . . . . 0.0 110.044 176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -88.46 -4.44 58.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -171.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.546 ' O ' HD23 ' A' ' 310' ' ' LEU . 4.8 p -61.66 -27.98 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.416 0.627 . . . . 0.0 110.096 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.598 HD11 ' O ' ' A' ' 251' ' ' TYR . 4.3 tp -95.55 -35.85 11.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.224 -171.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.56 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 3.6 tmtp? -52.27 -47.96 65.55 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 123.355 0.662 . . . . 0.0 111.031 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.2 m -68.86 -23.54 64.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.873 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.822 ' HB3' ' HD2' ' A' ' 252' ' ' PHE . 4.4 mm? -91.95 -45.01 8.57 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 252' ' ' PHE . 3.7 pt -63.92 -35.59 73.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.41 0.624 . . . . 0.0 110.193 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.29 91.32 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.512 -176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -77.27 -27.39 53.15 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.883 0.373 . . . . 0.0 111.263 -177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.51 ' N ' HD12 ' A' ' 313' ' ' LEU . 5.2 t90 -80.82 -46.64 15.02 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.026 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.675 ' HA ' HG22 ' A' ' 320' ' ' ILE . 30.7 p -69.64 -27.12 64.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.089 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -54.64 -38.69 67.18 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.369 0.604 . . . . 0.0 110.547 172.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -77.07 -27.12 54.19 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.662 -171.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -124.55 -19.92 5.27 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -172.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 74.44 23.5 75.34 Favored Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.401 -173.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.755 HD11 HD22 ' A' ' 258' ' ' LEU . 16.9 tt -66.18 134.71 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.472 -0.364 . . . . 0.0 111.316 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.384 -0.817 . . . . 0.0 109.811 -177.197 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.113 -0.395 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 246' ' ' PRO . 3.0 m -71.3 -53.5 7.9 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 245' ' ' SER . 4.0 Cg_endo -86.96 33.19 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.751 2.3 . . . . 0.0 112.525 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.83 102.22 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.47 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 21.2 p90 -108.97 134.82 20.25 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.416 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 248' ' ' PHE . 5.8 Cg_exo -77.08 161.58 32.48 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.93 2.42 . . . . 0.0 111.141 170.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -73.74 91.35 1.91 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.983 0.42 . . . . 0.0 111.755 -176.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.514 ' O ' HD11 ' A' ' 307' ' ' LEU . 27.4 p90 -172.41 -33.13 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.259 171.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 12.7 m-85 -83.39 -75.26 0.33 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.584 0.706 . . . . 0.0 111.204 173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.473 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 13.2 tpp85 -68.8 127.46 33.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.61 -171.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 36.8 t -80.09 110.76 17.48 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 171.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.78 16.77 0.74 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 123.468 2.778 . . . . 0.0 113.601 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.782 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 45.7 mt -96.14 -58.64 3.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.994 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.2 m -139.02 21.23 2.63 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.431 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.605 ' CD2' HD11 ' A' ' 320' ' ' ILE . 0.7 OUTLIER 60.43 28.84 18.5 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.275 0.56 . . . . 0.0 110.079 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -79.01 -17.42 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 320' ' ' ILE . 2.0 tt 41.69 84.72 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 O-C-N 124.71 1.256 . . . . 0.0 110.48 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.535 ' O ' HD12 ' A' ' 311' ' ' ILE . 4.2 ptt? -34.65 145.39 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.293 1.437 . . . . 0.0 114.629 -174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.18 -53.62 4.04 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.839 0.828 . . . . 0.0 109.188 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -126.51 105.52 24.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.618 ' HB2' HG22 ' A' ' 272' ' ' THR . 91.3 Cg_endo -87.59 152.6 7.61 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.462 2.108 . . . . 0.0 113.325 -168.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.22 134.15 58.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.601 176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.1 tt -100.2 145.07 11.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 268' ' ' SER . 5.0 t -133.4 177.54 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.582 ' H ' HG12 ' A' ' 267' ' ' VAL . 2.3 p -60.65 157.38 14.67 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 268' ' ' SER . 18.9 m 86.17 -13.65 0.56 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.947 0.779 . . . . 0.0 110.087 -174.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.12 34.19 8.35 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.431 -0.89 . . . . 0.0 110.994 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.613 HE22 HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -93.5 130.82 39.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.929 -0.635 . . . . 0.0 110.393 -176.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.618 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.4 m -138.37 106.61 5.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.642 -0.133 . . . . 0.0 110.642 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.525 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 33.3 m-85 -138.21 178.71 6.93 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.065 0.46 . . . . 0.0 111.561 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.2 tp10 -65.73 131.68 46.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.718 176.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.4 -43.03 97.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.839 -171.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.9 m -71.07 -11.68 61.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.002 0.429 . . . . 0.0 110.84 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 13.2 m -95.33 -47.23 6.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.37 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.613 HG12 HE22 ' A' ' 271' ' ' GLN . 4.7 tp -77.06 -51.78 18.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.381 -175.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.488 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 28.6 mt-30 -69.87 -20.63 63.39 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.318 0.58 . . . . 0.0 110.214 -175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -53.63 -43.33 68.63 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.232 174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.782 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.85 -33.5 10.85 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.335 179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.3 mt -59.01 -47.94 83.38 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.184 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.6 OUTLIER -75.41 -12.06 60.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.188 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.84 76.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.289 0.566 . . . . 0.0 109.986 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.27 45.86 0.12 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.688 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.405 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.3 m-70 -133.49 172.87 12.14 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.742 0.306 . . . . 0.0 110.579 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -159.85 36.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.395 -172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 293' ' ' GLN . 1.6 m -138.15 144.12 40.62 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.869 -174.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 1.8 m -67.12 151.08 97.52 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.858 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.85 4.45 6.94 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.37 2.713 . . . . 0.0 112.219 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.489 ' HD3' ' OH ' ' A' ' 273' ' ' TYR . 3.6 mtmp? -96.34 -65.84 0.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.223 -170.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.24 4.21 4.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.876 0.37 . . . . 0.0 110.19 -176.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.589 ' HA ' HG22 ' A' ' 288' ' ' THR . 2.4 mp0 65.18 46.74 2.62 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.784 -176.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -66.6 -19.74 65.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.712 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 288' ' ' THR . 7.2 m 70.53 123.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.642 -176.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.407 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 4.3 mt -85.11 -17.59 36.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.616 -176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 297' ' ' LEU . 3.7 mm? 65.44 -87.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.935 -178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -90.37 107.42 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.63 93.69 4.91 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 110.778 -177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -124.76 119.04 3.51 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 111.337 -0.705 . . . . 0.0 111.337 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 267' ' ' VAL . 2.1 tp -85.44 136.94 33.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.867 0.365 . . . . 0.0 110.131 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.5 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 93.8 m -136.9 132.54 18.37 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.372 -176.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.91 120.47 8.19 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.391 2.061 . . . . 0.0 112.103 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.3 t-20 -95.03 116.44 28.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -90.95 -25.08 19.94 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 9.2 p -64.48 -39.86 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 121.125 0.488 . . . . 0.0 111.713 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.538 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -94.87 -26.02 16.35 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -162.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.553 ' HA ' HD11 ' A' ' 311' ' ' ILE . 6.8 ptmt -67.03 -18.78 65.52 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.093 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 -24.96 33.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.014 0.435 . . . . 0.0 110.544 177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.792 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 99.1 mt -92.82 -45.31 8.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.071 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.57 HD11 ' HD3' ' A' ' 264' ' ' PRO . 3.6 pt -64.51 -30.85 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.103 0.478 . . . . 0.0 110.751 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -66.19 -26.69 67.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.788 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.792 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -83.56 -23.42 32.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.925 0.393 . . . . 0.0 110.323 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -81.79 -48.27 11.82 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 318' ' ' ASN . 26.9 p -70.92 -10.81 60.36 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.522 0.677 . . . . 0.0 109.659 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 37.4 tt0 -76.18 -40.08 53.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.769 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 1.4 t -75.98 -49.08 18.66 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.452 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 315' ' ' CYS . 54.8 t-20 -123.19 119.06 29.09 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.442 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.02 102.74 0.31 Allowed Glycine 0 C--N 1.331 0.279 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.605 HD11 ' CD2' ' A' ' 258' ' ' LEU . 1.4 tp -126.05 129.83 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 CA-C-O 121.268 0.556 . . . . 0.0 111.911 -168.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 36.8 tt0 . . . . . 0 C--O 1.249 1.056 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.577 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 26.4 m 70.77 116.88 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.321 0 CA-C-O 121.237 0.541 . . . . 0.0 111.381 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 10.8 Cg_exo -70.42 88.55 0.61 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.802 2.334 . . . . 0.0 112.405 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -72.86 -48.49 37.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.314 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 61.1 t80 64.84 91.39 0.08 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.968 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.705 ' HD2' ' HD2' ' A' ' 252' ' ' PHE . 3.0 Cg_exo -79.08 -180.0 5.95 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.269 2.646 . . . . 0.0 111.837 169.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -81.16 -1.21 43.64 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 310' ' ' LEU . 7.2 p90 -128.35 63.9 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -172.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.705 ' HD2' ' HD2' ' A' ' 249' ' ' PRO . 15.5 m-85 -150.93 -69.95 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.449 ' NE ' HD11 ' A' ' 258' ' ' LEU . 0.0 OUTLIER -61.41 137.56 58.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -166.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.63 ' SG ' HG12 ' A' ' 256' ' ' ILE . 34.4 t -97.73 113.38 63.51 Favored Pre-proline 0 N--CA 1.442 -0.857 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 167.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.08 3.01 4.89 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.848 2.365 . . . . 0.0 113.443 -173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.804 HG21 ' HB3' ' A' ' 277' ' ' SER . 10.3 mm -72.64 -52.76 21.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.117 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 62.1 m -151.29 20.57 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 55.8 39.06 30.73 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 121.589 0.709 . . . . 0.0 109.859 -173.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 4.0 pm0 -83.73 -20.21 33.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.359 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.593 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.6 OUTLIER 59.58 90.85 0.05 Allowed 'General case' 0 C--N 1.339 0.118 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.098 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.583 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.18 154.59 0.37 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.0 OUTLIER -92.19 -49.6 6.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.495 175.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 264' ' ' PRO . 8.5 p-10 -145.12 108.47 4.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.29 -0.868 . . . . 0.0 108.875 173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.621 ' HD3' HD11 ' A' ' 311' ' ' ILE . 64.0 Cg_endo -94.82 153.86 1.83 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 122.949 2.433 . . . . 0.0 113.33 -169.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 301' ' ' LEU . 12.0 m -106.76 133.93 49.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.196 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.1 OUTLIER -87.11 143.32 11.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.27 175.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 268' ' ' SER . 11.4 t -137.88 177.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.588 ' H ' HG12 ' A' ' 267' ' ' VAL . 39.9 t -59.9 158.16 11.2 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 177.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 268' ' ' SER . 70.5 m 85.8 -19.73 0.29 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.556 0.742 . . . . 0.0 109.477 -166.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.47 22.28 34.89 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.051 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.2 pt20 -80.68 136.78 36.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.589 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.3 OUTLIER -127.95 99.29 5.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 170.076 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 16.4 m-85 -126.09 168.91 13.35 Favored 'General case' 0 CA--C 1.519 -0.23 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -176.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.614 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -58.84 130.17 45.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.996 0.426 . . . . 0.0 109.99 176.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -61.26 -38.6 87.28 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.37 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.7 m -76.2 -12.89 60.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.089 0.471 . . . . 0.0 110.615 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.804 ' HB3' HG21 ' A' ' 256' ' ' ILE . 39.9 m -95.83 -44.41 7.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.534 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.614 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.9 tp -72.5 -52.48 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.675 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.533 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 38.7 mt-30 -70.81 -18.19 62.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.294 0.569 . . . . 0.0 110.295 -175.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -58.24 -42.12 85.65 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.341 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.765 ' HZ3' HD12 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.12 -29.2 13.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.242 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.533 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.8 mt -60.8 -45.09 95.74 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.028 0.442 . . . . 0.0 110.303 175.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -66.26 -20.56 66.14 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.119 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.15 -24.01 64.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.928 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 121.41 21.87 2.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.98 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 57.7 m-70 -113.47 160.68 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.715 0.293 . . . . 0.0 110.428 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -146.67 45.79 1.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.587 0.708 . . . . 0.0 110.206 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.49 143.82 51.01 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.286 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 294' ' ' GLU . 27.4 p -77.98 153.33 80.15 Favored Pre-proline 0 C--O 1.236 0.345 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 175.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.579 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 83.8 Cg_endo -78.71 -7.38 15.63 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.624 2.216 . . . . 0.0 112.161 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -60.97 -54.8 40.55 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.403 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 7.6 p -162.14 14.88 0.08 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.591 -174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 60.13 70.5 0.63 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.421 0.629 . . . . 0.0 109.916 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 289' ' ' CYS . 3.4 tt0 -91.01 -2.82 57.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.749 -176.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.415 HG22 ' HG ' ' A' ' 297' ' ' LEU . 23.9 m 61.5 110.37 0.02 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.325 -177.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 14.1 mt -73.68 -27.43 61.22 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.399 -175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 295' ' ' THR . 87.1 mt 60.81 91.59 0.05 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.752 0.657 . . . . 0.0 111.357 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.659 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.05 92.42 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.255 0.55 . . . . 0.0 111.478 -174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.02 110.15 3.2 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 265' ' ' VAL . 6.0 mp -85.99 142.43 28.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.843 0.83 . . . . 0.0 111.878 -172.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.588 ' HB ' HG22 ' A' ' 266' ' ' ILE . 42.4 m -141.06 109.6 6.42 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.938 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 302' ' ' THR . 13.2 Cg_endo -56.68 121.85 10.77 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.555 2.17 . . . . 0.0 112.498 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.572 HD22 HG21 ' A' ' 272' ' ' THR . 36.4 t30 -108.5 108.93 20.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.58 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -88.51 -4.68 58.56 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.529 HG12 ' ND2' ' A' ' 304' ' ' ASN . 2.8 p -61.53 -30.32 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.576 0.703 . . . . 0.0 109.783 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.507 ' O ' HG12 ' A' ' 311' ' ' ILE . 15.4 tp -95.23 -31.13 13.63 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.239 -173.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -63.05 -37.78 88.57 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 123.139 0.576 . . . . 0.0 110.837 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -69.1 -24.01 64.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.004 0.43 . . . . 0.0 111.216 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 75.0 mt -95.06 -51.24 4.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.602 -174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.621 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.7 pt -59.94 -27.21 38.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.912 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.24 -20.74 64.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.185 -175.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -93.91 -28.57 15.75 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.062 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.509 ' HB2' ' CE1' ' A' ' 252' ' ' PHE . 4.5 t90 -74.96 -44.53 47.85 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.656 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.427 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 50.8 t -65.68 -15.53 62.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.267 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -81.01 -40.19 24.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.267 0.556 . . . . 0.0 109.972 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.0 m -68.52 -37.39 79.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.148 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -138.81 133.83 32.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.126 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -67.91 85.63 0.16 Allowed Glycine 0 C--N 1.332 0.347 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.593 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.6 tp -90.13 -15.86 8.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.094 0.474 . . . . 0.0 111.269 -173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.384 -176.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.6 p -154.9 102.28 2.31 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.42 -1.63 11.66 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.646 2.231 . . . . 0.0 111.666 174.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 48.48 81.88 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.944 -1.026 . . . . 0.0 112.689 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -146.94 75.17 11.93 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.364 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 250' ' ' GLU . 58.5 Cg_endo -92.3 -40.94 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.529 2.152 . . . . 0.0 112.047 172.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.639 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 7.5 tp10 173.27 -174.87 0.06 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.639 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 45.2 p90 48.91 32.49 3.82 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.43 1.092 . . . . 0.0 113.283 172.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -139.6 -75.86 0.35 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.803 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.1 ttm180 -76.74 145.25 38.74 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -162.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.627 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 23.9 t -94.99 121.71 61.89 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.125 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.2 Cg_exo -76.7 8.49 3.03 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 123.127 2.552 . . . . 0.0 113.596 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.621 HG21 ' HB3' ' A' ' 277' ' ' SER . 22.1 mm -78.54 -55.66 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.366 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 65.3 p -150.22 20.79 0.86 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.791 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.803 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 1.3 tt 62.45 45.55 6.35 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.686 0.755 . . . . 0.0 109.32 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 256' ' ' ILE . 3.8 pm0 -93.83 -8.91 39.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.965 177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.613 ' HB2' HG12 ' A' ' 320' ' ' ILE . 17.3 tp 69.72 -15.54 0.3 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 124.061 0.851 . . . . 0.0 112.189 177.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.891 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 38.8 mtm 69.68 145.64 0.06 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.468 0.651 . . . . 0.0 111.907 -175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.516 ' HE3' ' C ' ' A' ' 261' ' ' MET . 0.1 OUTLIER -116.19 -35.11 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 168.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -135.45 101.43 10.99 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.467 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.536 ' HB2' HG22 ' A' ' 272' ' ' THR . 66.4 Cg_endo -98.84 155.66 0.68 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 123.229 2.619 . . . . 0.0 112.865 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 20.0 m -128.94 145.75 35.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.131 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.617 HG22 ' HB ' ' A' ' 302' ' ' THR . 0.9 OUTLIER -97.55 146.05 8.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.304 -177.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.526 HG22 HD12 ' A' ' 301' ' ' LEU . 19.3 t -133.85 169.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 267' ' ' VAL . 47.7 m -60.53 162.22 6.65 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.425 ' CB ' ' O ' ' A' ' 268' ' ' SER . 24.2 m 89.49 -26.12 0.07 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.137 0.898 . . . . 0.0 109.195 -170.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.06 37.2 5.49 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.07 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -101.47 153.94 19.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.695 0.283 . . . . 0.0 110.662 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.536 HG22 ' HB2' ' A' ' 264' ' ' PRO . 1.6 m -139.89 101.09 4.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.984 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 278' ' ' ILE . 32.6 m-85 -119.88 166.0 13.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.312 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.891 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 19.9 tt0 -67.87 137.47 55.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.631 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 29.3 ttm-85 -48.53 -51.45 27.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.052 -175.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.475 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 48.0 m -69.37 -10.35 57.55 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.621 ' HB3' HG21 ' A' ' 256' ' ' ILE . 20.5 m -95.83 -42.28 8.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.993 0.425 . . . . 0.0 110.063 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.701 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.1 tp -89.29 -51.32 12.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.39 -175.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.631 ' OE1' ' HG3' ' A' ' 275' ' ' ARG . 38.7 mt-30 -74.26 -16.3 60.95 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.291 0.567 . . . . 0.0 110.347 -172.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 276' ' ' SER . 0.6 OUTLIER -55.08 -41.86 72.1 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.666 171.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.518 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -98.96 -32.2 11.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.681 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 17.3 mt -59.18 -42.6 91.21 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.164 0.438 . . . . 0.0 110.776 175.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.09 -7.23 56.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.18 -16.29 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.467 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 112.55 1.4 26.07 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.124 177.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.518 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.7 m-70 -100.24 146.14 27.24 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.501 -0.411 . . . . 0.0 110.072 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -142.2 67.92 1.32 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.288 0.566 . . . . 0.0 111.884 -174.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.529 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 6.5 p -139.42 143.96 37.87 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.5 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.554 ' HB2' HD21 ' A' ' 296' ' ' LEU . 6.5 t -86.04 123.43 71.89 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 27.3 Cg_exo -62.68 -19.24 67.61 Favored 'Trans proline' 0 N--CA 1.474 0.338 0 C-N-CA 122.993 2.462 . . . . 0.0 113.859 -174.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.439 ' HG3' ' SG ' ' A' ' 289' ' ' CYS . 0.6 OUTLIER -89.57 -8.1 53.39 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -171.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 49.5 m -154.48 -29.17 0.12 Allowed 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.529 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 29.5 mm-40 66.37 46.69 1.9 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.512 ' OE1' ' HB3' ' A' ' 289' ' ' CYS . 1.2 pm0 -86.66 -1.87 58.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.075 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 288' ' ' THR . 28.2 m 70.05 121.43 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.199 0 O-C-N 123.799 0.687 . . . . 0.0 111.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 289' ' ' CYS . 2.0 mt -83.52 86.07 7.15 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 297' ' ' LEU . 0.7 OUTLIER -47.9 -55.44 9.86 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.852 0.72 . . . . 0.0 111.289 -172.121 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -97.34 102.57 14.37 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -82.17 93.33 7.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.414 0.626 . . . . 0.0 110.632 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -147.67 139.22 7.65 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.94 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 267' ' ' VAL . 1.6 tp -89.58 142.29 27.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.147 0.498 . . . . 0.0 110.434 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.617 ' HB ' HG22 ' A' ' 266' ' ' ILE . 85.7 m -133.24 117.55 14.66 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.579 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.83 120.52 7.63 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.152 1.901 . . . . 0.0 112.616 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.489 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.0 p30 -104.64 130.93 52.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.754 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -92.18 -20.74 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.982 0.42 . . . . 0.0 110.405 173.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.489 HG12 ' HB2' ' A' ' 304' ' ' ASN . 5.1 p -54.43 -54.62 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.473 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.498 ' O ' HG12 ' A' ' 311' ' ' ILE . 12.0 tp -79.24 -41.54 27.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.987 -167.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -38.0 77.54 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 120.618 0.246 . . . . 0.0 111.226 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.5 m -67.24 -25.21 65.97 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.012 0.435 . . . . 0.0 111.088 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 6.5 mp -94.17 -48.1 6.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.424 -175.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.523 HD11 ' HD3' ' A' ' 264' ' ' PRO . 9.3 pt -67.11 -34.21 68.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.938 0.399 . . . . 0.0 111.635 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.96 -30.88 70.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.036 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.3 pp -83.49 -25.11 31.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.164 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.692 ' HZ3' HD13 ' A' ' 320' ' ' ILE . 9.4 t90 -84.46 -35.74 22.8 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.458 -175.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.521 ' HB2' HD23 ' A' ' 260' ' ' LEU . 51.2 t -67.62 -19.3 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 0.0 110.261 176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -76.28 -31.97 58.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.336 0.589 . . . . 0.0 109.743 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 33.3 t -71.53 -25.3 62.18 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.713 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -162.09 132.64 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.581 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -62.57 90.32 0.06 OUTLIER Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.692 HD13 ' HZ3' ' A' ' 314' ' ' TRP . 8.6 tp -84.03 -30.79 7.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -172.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.06 -175.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.506 0 N-CA-C 111.808 -0.517 . . . . 0.0 111.808 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.478 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.0 m -81.39 133.0 54.09 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 11.5 Cg_exo -71.02 79.57 1.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.798 2.332 . . . . 0.0 111.463 177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.414 ' HA ' ' NH2' ' A' ' 253' ' ' ARG . 6.1 tp10 -90.52 104.53 17.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.917 -174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 253' ' ' ARG . 0.3 OUTLIER -154.99 82.63 3.99 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.334 0.587 . . . . 0.0 111.145 178.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -94.25 16.33 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.178 2.586 . . . . 0.0 113.423 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.38 -68.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.379 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -121.07 24.81 9.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.665 -0.414 . . . . 0.0 112.097 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -135.09 -84.16 0.41 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.79 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 0.9 OUTLIER -73.15 139.23 46.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.343 0.592 . . . . 0.0 111.896 -166.203 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 46.9 t -82.83 108.45 12.42 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.99 12.04 0.8 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 122.771 2.314 . . . . 0.0 113.108 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.879 HG21 ' HB3' ' A' ' 277' ' ' SER . 27.0 mm -73.5 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.8 m -135.74 7.23 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.284 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.79 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.8 OUTLIER 59.19 43.29 17.32 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -170.765 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -87.52 -8.37 56.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.527 178.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.798 HD12 ' HB3' ' A' ' 315' ' ' CYS . 0.9 OUTLIER 54.41 88.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.072 178.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 2.8 ptt? -50.03 146.65 4.61 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.616 -1.175 . . . . 0.0 112.584 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.625 ' HE3' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -109.59 -46.05 3.59 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -118.65 101.57 50.53 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 272' ' ' THR . 48.2 Cg_endo -97.42 154.21 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.868 2.379 . . . . 0.0 113.943 -173.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.58 HG21 HD23 ' A' ' 301' ' ' LEU . 15.6 m -120.96 137.99 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.28 176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -100.01 149.72 5.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.476 ' CG1' ' HG ' ' A' ' 301' ' ' LEU . 26.9 m -140.16 -178.69 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.7 p -60.56 161.6 7.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.169 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 10.7 m 80.05 -25.62 0.18 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.142 0.577 . . . . 0.0 110.348 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 104.21 30.61 4.99 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.585 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.864 HE22 HD13 ' A' ' 278' ' ' ILE . 30.8 tt0 -87.2 133.82 33.61 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 122.934 -0.157 . . . . 0.0 111.406 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 6.8 m -133.94 98.76 4.24 Favored 'General case' 0 C--O 1.226 -0.143 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.676 169.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.688 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 21.8 m-85 -132.03 178.22 6.96 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 20.3 tt0 -73.68 140.66 46.22 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.82 0.343 . . . . 0.0 110.686 -179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -58.38 -38.04 76.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.058 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 43.9 m -71.77 -11.38 60.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.831 0.348 . . . . 0.0 111.234 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.879 ' HB3' HG21 ' A' ' 256' ' ' ILE . 15.2 m -96.05 -45.74 6.78 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.183 0.516 . . . . 0.0 110.061 178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.864 HD13 HE22 ' A' ' 271' ' ' GLN . 1.3 tp -77.36 -51.25 18.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.908 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 1.6 mt-30 -73.95 -16.83 61.08 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 121.271 0.558 . . . . 0.0 110.077 -173.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.4 ttmt -52.13 -42.16 63.1 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.849 170.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.467 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -98.69 -30.62 12.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.633 -179.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.613 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 29.8 mt -59.1 -41.94 89.29 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.057 0.456 . . . . 0.0 110.646 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -82.94 -3.88 57.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.642 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -84.29 -40.46 17.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.927 175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.29 29.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.363 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.421 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.1 m-70 -138.19 162.14 35.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 117.087 0.443 . . . . 0.0 109.812 177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -154.64 73.88 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.19 0.519 . . . . 0.0 111.663 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 295' ' ' THR . 11.4 p -138.39 138.04 37.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.407 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 6.1 m -66.63 123.42 85.74 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 110.42 -0.215 . . . . 0.0 110.42 176.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.467 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 54.1 Cg_endo -68.16 3.72 1.92 Allowed 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 123.161 2.574 . . . . 0.0 113.991 -171.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.584 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.68 -30.49 14.89 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.863 0.363 . . . . 0.0 111.043 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.566 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 17.4 m -142.88 -9.82 0.79 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.826 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 293' ' ' GLN . 0.0 OUTLIER 72.07 28.64 2.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.478 0.656 . . . . 0.0 110.057 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 58.8 mm-40 -70.92 119.27 14.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.22 173.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 297' ' ' LEU . 7.5 m -64.75 123.73 20.11 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.183 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 5.7 mt -67.46 -20.87 65.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.18 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.492 ' H ' HG22 ' A' ' 295' ' ' THR . 96.6 mt 67.94 -81.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.859 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -92.23 109.06 20.42 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -87.62 92.98 9.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.452 0.644 . . . . 0.0 111.062 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -130.78 120.29 2.93 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.58 HD23 HG21 ' A' ' 265' ' ' VAL . 6.3 mp -92.4 147.39 22.94 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.397 0.618 . . . . 0.0 111.416 -174.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.525 ' O ' HG22 ' A' ' 266' ' ' ILE . 18.0 m -141.87 132.16 12.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.068 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 23.5 Cg_exo -64.73 117.81 4.85 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.108 1.872 . . . . 0.0 112.379 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.669 ' OD1' HG12 ' A' ' 306' ' ' VAL . 49.3 t-20 -91.72 117.46 29.77 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -89.18 -11.4 43.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -172.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.669 HG12 ' OD1' ' A' ' 304' ' ' ASN . 9.7 p -76.06 -32.19 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.159 0.504 . . . . 0.0 111.132 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 16.1 tp -88.21 -44.9 10.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.6 -168.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -44.92 -55.19 5.69 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.654 0.781 . . . . 0.0 112.733 -173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.2 m -61.49 -31.8 71.8 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.692 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 81.9 mt -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.875 0.369 . . . . 0.0 111.352 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.9 pt -76.81 -31.78 19.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.997 0.427 . . . . 0.0 111.271 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -69.0 -13.89 62.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.74 -176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -92.16 -30.01 16.18 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.618 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.426 ' N ' HD12 ' A' ' 313' ' ' LEU . 16.9 t90 -78.67 -49.39 13.24 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.498 -175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.798 ' HB3' HD12 ' A' ' 260' ' ' LEU . 7.8 p -57.61 -35.0 69.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.144 0.497 . . . . 0.0 110.449 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -62.32 -34.86 77.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.013 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 7.9 t -70.9 -40.25 72.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.599 -173.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -109.16 -17.5 13.85 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -171.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 64.93 52.74 39.18 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.108 -1.044 . . . . 0.0 110.515 -173.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.718 HG21 ' HB3' ' A' ' 260' ' ' LEU . 1.1 tp -70.34 -42.53 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.062 -0.569 . . . . 0.0 112.375 -170.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 1.6 tm-20 . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.379 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.708 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.8 m -129.85 164.35 40.91 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.67 -45.75 36.14 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.587 2.191 . . . . 0.0 111.536 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.771 ' HG2' ' HG3' ' A' ' 249' ' ' PRO . 6.4 tt0 74.99 -71.18 0.13 Allowed 'General case' 0 CA--C 1.538 0.502 0 O-C-N 124.046 0.841 . . . . 0.0 112.291 167.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.686 ' N ' ' HD3' ' A' ' 249' ' ' PRO . 79.8 m-85 70.2 20.5 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.771 ' HG3' ' HG2' ' A' ' 247' ' ' GLU . 90.2 Cg_endo -103.64 142.5 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 CA-C-N 122.432 1.904 . . . . 0.0 114.034 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 53.26 -87.44 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 170.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.702 ' O ' HD11 ' A' ' 307' ' ' LEU . 10.5 p90 -71.13 -29.38 65.17 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.578 -174.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.458 ' O ' ' HG ' ' A' ' 260' ' ' LEU . 2.1 m-85 -78.44 -76.53 0.19 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.36 -0.536 . . . . 0.0 112.434 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.438 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 24.9 ttm180 -78.16 126.57 31.01 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -168.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.62 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 45.3 t -74.18 113.72 26.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 167.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 1.8 Cg_endo -80.95 22.28 0.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 123.125 2.55 . . . . 0.0 112.883 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.453 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 55.4 mt -96.0 -45.56 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 45.1 m -146.43 15.14 1.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.615 0.245 . . . . 0.0 111.18 176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 320' ' ' ILE . 0.8 OUTLIER 52.4 42.6 31.19 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 109.106 -171.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -81.31 -24.4 37.21 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.635 HD22 ' SG ' ' A' ' 315' ' ' CYS . 4.2 tt 55.03 93.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.161 0 O-C-N 124.504 1.128 . . . . 0.0 109.388 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.62 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -46.43 153.21 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.531 -1.213 . . . . 0.0 113.268 -173.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.0 -42.78 4.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.88 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -128.79 101.94 20.0 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 173.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.634 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -93.95 142.8 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.84 2.36 . . . . 0.0 114.078 -168.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 301' ' ' LEU . 11.2 p -107.6 133.38 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.002 176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 1.5 tt -90.34 150.31 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 174.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 268' ' ' SER . 6.1 t -136.97 178.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.635 ' H ' HG12 ' A' ' 267' ' ' VAL . 14.6 m -59.83 167.57 2.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.643 0.258 . . . . 0.0 110.534 177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 17.4 m 79.06 -49.5 0.43 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.384 0.674 . . . . 0.0 110.272 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 133.57 31.73 0.4 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.215 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.616 ' HG3' ' CD2' ' A' ' 273' ' ' TYR . 1.5 tt0 -92.59 140.76 29.22 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.4 0.28 . . . . 0.0 111.732 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.791 HG21 HD22 ' A' ' 304' ' ' ASN . 1.9 m -140.46 100.29 3.84 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 172.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.616 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 39.5 m-85 -138.61 178.7 6.95 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -175.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.693 ' O ' HG22 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -64.33 126.86 29.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 120.832 0.349 . . . . 0.0 110.249 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -61.11 -37.58 83.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.967 -176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.34 -17.14 61.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.298 0.571 . . . . 0.0 110.048 -177.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 20.1 m -95.32 -44.71 7.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.199 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.2 tp -72.55 -51.79 26.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.913 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.638 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 32.2 mt-30 -69.67 -18.51 63.57 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.18 0.514 . . . . 0.0 110.541 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -56.07 -42.6 76.94 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.576 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.453 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.52 -29.32 13.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.293 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 26.2 mt -55.69 -46.43 77.63 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.14 0.495 . . . . 0.0 110.108 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.96 -24.68 67.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.085 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -68.86 -18.59 64.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.977 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.14 0.95 20.77 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.56 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.622 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 74.2 m-70 -106.54 143.23 34.95 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -146.31 80.61 1.57 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.659 0.742 . . . . 0.0 111.241 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 295' ' ' THR . 24.4 p -139.18 151.49 46.63 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.992 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.762 ' HB2' ' H ' ' A' ' 294' ' ' GLU . 1.7 m -59.41 127.76 84.92 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 173.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -61.13 -32.34 91.21 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.783 2.322 . . . . 0.0 113.392 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.608 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.1 OUTLIER -91.2 -23.74 20.13 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -170.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 3.6 p -144.66 1.3 1.02 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -172.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 55.29 43.67 28.7 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.991 0.424 . . . . 0.0 111.477 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.762 ' H ' ' HB2' ' A' ' 289' ' ' CYS . 46.7 mt-10 -69.7 -7.08 36.16 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.155 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 288' ' ' THR . 16.8 m 66.69 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.32 0.581 . . . . 0.0 111.414 -179.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.407 HD12 HD21 ' A' ' 282' ' ' LEU . 11.6 mt -83.87 89.0 7.13 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 38.9 tp -67.65 115.88 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 64.83 102.92 0.04 OUTLIER 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.912 0.758 . . . . 0.0 110.381 -172.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.54 91.7 3.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.468 0.651 . . . . 0.0 109.632 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -99.58 84.64 0.62 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.403 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.499 ' HB3' HG21 ' A' ' 265' ' ' VAL . 1.6 mt -70.11 111.23 5.62 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.749 0.785 . . . . 0.0 111.24 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.602 ' HB ' HG22 ' A' ' 266' ' ' ILE . 17.7 m -129.61 122.21 20.59 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.617 -173.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -56.88 127.08 24.36 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.165 1.91 . . . . 0.0 112.582 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.791 HD22 HG21 ' A' ' 272' ' ' THR . 37.6 t30 -107.04 119.62 39.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 110.134 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -88.34 -16.19 33.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.017 -170.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.462 HG13 ' OD1' ' A' ' 304' ' ' ASN . 1.7 m -64.6 -28.21 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-O 121.213 0.53 . . . . 0.0 110.381 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.702 HD11 ' O ' ' A' ' 251' ' ' TYR . 11.8 tp -95.09 -42.57 8.54 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -163.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.4 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 16.1 ptpt -57.45 -28.33 63.24 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 120.659 0.266 . . . . 0.0 111.081 -175.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -73.28 -29.91 63.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.995 0.426 . . . . 0.0 110.855 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.551 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 11.2 mp -94.23 -32.84 13.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.705 -175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.9 pt -80.94 -38.54 17.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.813 0.339 . . . . 0.0 111.102 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.45 71.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -72.82 -26.38 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.683 0.278 . . . . 0.0 110.551 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.435 ' CZ3' HD13 ' A' ' 320' ' ' ILE . 4.0 t90 -80.23 -50.16 10.62 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.635 ' SG ' HD22 ' A' ' 260' ' ' LEU . 7.2 m -62.87 -24.51 67.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.41 0.624 . . . . 0.0 109.861 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.37 -33.44 74.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.681 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -83.87 -37.17 22.77 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.559 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -138.6 129.46 26.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.41 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -63.65 106.97 1.53 Allowed Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 176.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.612 HG21 ' HB3' ' A' ' 260' ' ' LEU . 8.2 tp -106.13 -28.39 2.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.629 0.252 . . . . 0.0 111.52 -170.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.357 -0.83 . . . . 0.0 109.475 178.258 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.496 ' HA ' ' HD3' ' A' ' 246' ' ' PRO . 16.4 m -67.1 133.03 93.63 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 122.034 0.134 . . . . 0.0 110.76 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.547 ' HA ' ' CE2' ' A' ' 248' ' ' PHE . 7.4 Cg_exo -72.63 66.98 3.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.039 2.492 . . . . 0.0 113.087 -177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 38.8 tt0 -112.73 -70.27 0.82 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.6 ' CB ' ' HB2' ' A' ' 252' ' ' PHE . 6.2 m-85 46.79 65.39 6.97 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 123.886 0.874 . . . . 0.0 112.796 174.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.69 126.63 10.95 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.155 1.904 . . . . 0.0 112.09 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 69.56 13.73 8.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 172.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -136.67 -31.35 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.076 -0.65 . . . . 0.0 111.638 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.6 ' HB2' ' CB ' ' A' ' 248' ' ' PHE . 41.9 m-85 -138.48 -76.09 0.38 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.186 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.703 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 28.3 ttp85 -73.02 123.27 23.19 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -165.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.77 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 39.5 t -63.68 120.4 62.71 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.592 168.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 2.7 Cg_endo -85.18 16.38 1.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.46 2.773 . . . . 0.0 112.644 -175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.886 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 54.7 mt -95.97 -51.82 10.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.424 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.6 m -127.64 2.27 6.14 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.093 -0.379 . . . . 0.0 111.015 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.703 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 61.38 38.97 15.77 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -170.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 261' ' ' MET . 1.3 pm0 -88.71 -5.07 58.35 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.721 -1.127 . . . . 0.0 108.245 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' A' ' 314' ' ' TRP . 9.2 tp 72.93 -23.9 0.2 Allowed 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.659 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.77 ' HB3' ' HB2' ' A' ' 254' ' ' CYS . 1.5 ttp 73.81 120.66 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 121.533 0.682 . . . . 0.0 110.073 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.565 ' HE2' ' OE1' ' A' ' 274' ' ' GLU . 15.2 mtmt -104.48 -33.04 8.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.379 -175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -143.73 103.15 4.93 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.64 ' HB3' ' SD ' ' A' ' 261' ' ' MET . 66.9 Cg_endo -96.35 132.38 0.43 Allowed 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 123.146 2.564 . . . . 0.0 113.878 -172.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.69 121.09 57.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.031 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 7.4 tt -87.08 148.31 4.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -174.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.609 HG21 HD13 ' A' ' 296' ' ' LEU . 30.1 m -133.78 179.32 4.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 174.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 298' ' ' HIS . 13.9 t -60.33 164.85 3.96 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.831 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 14.6 m 83.64 -28.6 0.09 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.604 0.761 . . . . 0.0 110.412 -172.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.04 34.64 4.22 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.433 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.64 ' NE2' HG12 ' A' ' 278' ' ' ILE . 0.6 OUTLIER -90.27 124.69 35.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.205 -0.497 . . . . 0.0 110.184 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.593 HG22 ' HB2' ' A' ' 264' ' ' PRO . 2.6 m -133.42 99.8 4.63 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.965 0.412 . . . . 0.0 110.798 173.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.573 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 52.8 m-85 -137.75 167.3 21.99 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.628 ' O ' HG22 ' A' ' 278' ' ' ILE . 4.9 pt-20 -74.21 148.66 41.39 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.871 -176.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 46.3 ttp180 -57.91 -34.8 70.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.284 -171.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 1.7 m -65.39 -28.14 69.05 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.664 0.268 . . . . 0.0 111.612 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 10.1 p -95.51 -39.95 9.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.001 -177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.64 HG12 ' NE2' ' A' ' 271' ' ' GLN . 5.3 tp -80.07 -53.6 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -175.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.442 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.3 mm100 -65.07 -31.41 72.61 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 120.597 0.237 . . . . 0.0 111.261 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -32.86 67.7 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.886 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -99.97 -34.29 10.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 176.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.5 HD21 HD12 ' A' ' 296' ' ' LEU . 12.2 mt -60.11 -39.02 84.75 Favored 'General case' 0 CA--C 1.516 -0.337 0 O-C-N 122.017 -0.427 . . . . 0.0 111.015 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.472 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -62.03 -35.45 78.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.966 174.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 110.99 50.17 0.64 Allowed Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.034 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.516 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 93.8 m-70 -108.9 -24.66 11.14 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.557 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.03 48.44 2.15 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 295' ' ' THR . 2.3 p -140.41 148.7 41.63 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 122.146 -0.346 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.587 ' SG ' HD21 ' A' ' 296' ' ' LEU . 0.8 OUTLIER -75.0 144.97 80.32 Favored Pre-proline 0 N--CA 1.462 0.163 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.076 173.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -78.99 3.8 7.09 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.116 2.544 . . . . 0.0 113.374 -178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.573 ' HD2' ' OH ' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -93.12 -59.7 1.97 Allowed 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -176.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.9 m -137.03 8.52 2.98 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.616 0.246 . . . . 0.0 110.644 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.09 37.55 5.15 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.886 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 3.1 mp0 -61.08 -14.81 26.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.412 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.492 ' HA ' HG22 ' A' ' 288' ' ' THR . 5.3 m 71.06 113.99 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.381 0.61 . . . . 0.0 110.938 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 267' ' ' VAL . 4.5 mt -83.23 89.11 6.94 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.22 -38.36 76.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.465 -175.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . 0.437 ' HB2' ' CB ' ' A' ' 268' ' ' SER . 70.8 m-70 -100.07 96.88 7.81 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.695 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -86.26 93.55 9.1 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.388 0.613 . . . . 0.0 110.125 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -165.65 138.58 5.31 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.111 -1.195 . . . . 0.0 110.111 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.535 HD13 ' CG1' ' A' ' 267' ' ' VAL . 1.8 mm? -91.92 138.32 31.65 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.202 0.525 . . . . 0.0 111.08 -170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 83.2 m -120.69 135.62 24.81 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.287 175.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.33 118.58 5.48 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.606 2.204 . . . . 0.0 112.419 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.627 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 24.5 t-20 -105.47 108.51 20.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.639 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -89.18 -25.72 21.65 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 307' ' ' LEU . 5.2 p -62.89 -55.33 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -175.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 306' ' ' VAL . 13.1 tp -76.17 -33.67 59.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.115 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.473 ' HA ' HD11 ' A' ' 311' ' ' ILE . 70.9 tttt -57.11 -47.57 80.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.6 m -61.29 -25.27 66.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.565 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.632 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 36.1 mt -89.26 -49.58 6.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 -178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.571 HD11 ' HD3' ' A' ' 264' ' ' PRO . 14.4 pt -65.28 -33.45 63.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.973 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.407 ' HA ' ' SG ' ' A' ' 315' ' ' CYS . . . -62.81 -24.52 67.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.429 0.633 . . . . 0.0 110.254 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.632 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 6.2 tt -68.29 -50.99 49.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.076 176.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.834 ' HB3' HD21 ' A' ' 260' ' ' LEU . 1.3 t90 -76.94 -42.31 39.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.721 -170.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.664 ' HB3' HD23 ' A' ' 260' ' ' LEU . 21.8 p -68.95 -15.83 63.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.992 0.425 . . . . 0.0 111.18 -176.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -82.93 -30.77 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.297 0.57 . . . . 0.0 109.523 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.6 t -78.14 -26.38 47.81 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.791 -176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -149.51 132.17 15.89 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.739 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -65.23 104.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.672 HG12 ' HB2' ' A' ' 260' ' ' LEU . 7.2 tp -103.73 -31.01 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -169.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.481 -176.245 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.834 0 N-CA-C 111.661 -0.575 . . . . 0.0 111.661 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 4.6 p -94.26 123.59 58.34 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.833 0.316 . . . . 0.0 110.939 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.21 -35.82 50.08 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.648 2.232 . . . . 0.0 111.751 177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 249' ' ' PRO . 58.2 mm-40 64.36 110.42 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.975 176.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -120.93 74.25 26.43 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.436 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 247' ' ' GLU . 1.1 Cg_endo -84.18 -60.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.638 2.225 . . . . 0.0 111.606 177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.639 ' HG3' ' CD2' ' A' ' 251' ' ' TYR . 13.5 pt-20 -165.11 -176.87 4.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.636 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.639 ' CD2' ' HG3' ' A' ' 250' ' ' GLU . 36.3 p90 48.02 28.9 1.57 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.349 1.06 . . . . 0.0 113.683 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.54 ' HA ' HG22 ' A' ' 311' ' ' ILE . 11.5 m-85 -128.01 -79.59 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.532 ' HD2' ' HG ' ' A' ' 258' ' ' LEU . 7.2 ptm180 -94.34 154.98 17.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.37 -175.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 256' ' ' ILE . 13.5 p -77.99 158.79 77.12 Favored Pre-proline 0 N--CA 1.446 -0.651 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 171.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 3.7 Cg_endo -87.25 12.23 3.01 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.544 2.83 . . . . 0.0 110.646 175.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 254' ' ' CYS . 28.0 mt -95.64 -56.42 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.485 -172.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.1 m -150.16 14.97 0.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.532 ' HG ' ' HD2' ' A' ' 253' ' ' ARG . 1.1 tt 53.03 72.57 0.41 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.426 0.632 . . . . 0.0 110.509 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.16 -20.7 13.43 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.12 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.674 ' HB3' HG21 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 54.17 70.6 0.59 Allowed 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.953 0.783 . . . . 0.0 108.894 -172.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 1.012 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 3.7 ptt? -36.46 154.02 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.879 -1.51 . . . . 0.0 114.33 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.46 -43.24 3.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.924 176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -120.15 102.28 46.29 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.503 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 90.1 Cg_endo -97.31 150.99 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.129 2.553 . . . . 0.0 113.228 -176.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 21.7 m -119.02 134.58 62.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.403 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.616 HG13 HG23 ' A' ' 272' ' ' THR . 0.2 OUTLIER -86.2 141.51 14.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.092 -0.706 . . . . 0.0 109.092 174.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.574 HG12 ' H ' ' A' ' 268' ' ' SER . 3.5 t -133.66 174.86 12.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 267' ' ' VAL . 5.2 m -59.63 156.53 13.41 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.167 0.292 . . . . 0.0 110.281 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 4.4 m 82.56 -0.1 1.31 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.561 0.744 . . . . 0.0 109.91 -174.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 73.96 45.39 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.119 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.77 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 12.2 pt20 -106.67 143.07 35.3 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.278 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 266' ' ' ILE . 1.0 OUTLIER -132.91 100.05 4.78 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 174.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.77 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 28.4 m-85 -135.88 167.61 20.87 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -175.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 1.012 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 30.2 tt0 -67.2 133.42 49.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.092 0.472 . . . . 0.0 110.874 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 279' ' ' GLN . 32.3 ttm180 -51.57 -41.9 61.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.888 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 14.8 m -67.77 -22.44 65.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.615 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 12.5 p -96.17 -37.69 10.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.679 0.276 . . . . 0.0 111.02 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.7 tp -85.51 -48.84 15.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' A' ' 283' ' ' ASP . 27.1 mt-30 -73.17 -16.22 61.44 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.185 0.517 . . . . 0.0 110.267 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -57.61 -43.29 84.6 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.605 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.468 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.06 -29.87 12.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.967 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.4 mt -60.55 -43.2 97.47 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.805 176.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.623 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.1 OUTLIER -67.56 -22.6 65.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.764 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.71 -22.04 62.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.588 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.23 31.35 3.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.402 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.468 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 60.7 m-70 -121.2 95.0 4.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.689 ' H ' ' HD3' ' A' ' 287' ' ' LYS . 0.0 OUTLIER -84.92 78.73 9.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.547 0.689 . . . . 0.0 110.911 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.591 ' HB ' HE21 ' A' ' 293' ' ' GLN . 8.5 p -143.87 147.65 34.35 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.024 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.493 ' HB3' HD21 ' A' ' 296' ' ' LEU . 20.0 p -85.19 148.29 49.78 Favored Pre-proline 0 C--N 1.334 -0.085 0 C-N-CA 121.123 -0.231 . . . . 0.0 110.475 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.58 -3.33 12.86 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.72 2.28 . . . . 0.0 111.95 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -79.12 -60.23 2.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.907 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 294' ' ' GLU . 15.3 m -142.77 12.38 1.87 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.025 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.591 HE21 ' HB ' ' A' ' 288' ' ' THR . 0.2 OUTLIER 55.9 43.38 27.58 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.091 0.472 . . . . 0.0 110.555 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 292' ' ' SER . 6.8 mm-40 -75.11 5.94 4.8 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 90.6 m 68.06 113.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.269 0.557 . . . . 0.0 111.143 -175.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 289' ' ' CYS . 8.2 mt -82.65 97.97 8.79 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 48.0 tp -55.87 117.91 4.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.486 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 30.2 p80 44.09 99.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 O-C-N 124.489 1.118 . . . . 0.0 111.784 -172.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -77.06 93.19 3.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.373 0.606 . . . . 0.0 111.053 -174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -113.48 107.83 2.0 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.958 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 267' ' ' VAL . 3.7 mm? -64.47 128.89 37.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.422 . . . . 0.0 110.453 -175.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.546 ' HB ' HG22 ' A' ' 266' ' ' ILE . 93.5 m -135.91 93.57 15.39 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.417 -177.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.2 Cg_exo -55.77 118.15 4.88 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.662 2.241 . . . . 0.0 112.671 -178.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.51 ' ND2' HD12 ' A' ' 266' ' ' ILE . 14.9 t-20 -99.44 135.58 40.65 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -89.3 -9.09 51.85 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.51 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.7 p -67.85 -31.83 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.342 0.591 . . . . 0.0 110.764 -177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.638 HD11 ' HA ' ' A' ' 251' ' ' TYR . 10.2 tp -84.26 -42.16 16.15 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.202 -170.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -49.67 -47.75 49.98 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.569 0.543 . . . . 0.0 111.854 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.0 t -69.49 -19.67 63.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 121.197 -0.201 . . . . 0.0 111.532 -175.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.548 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 87.7 mt -94.46 -44.67 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.139 0.495 . . . . 0.0 110.883 -177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 307' ' ' LEU . 9.3 pt -71.98 -34.91 52.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.502 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.84 -27.27 68.76 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.759 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.4 pp -84.53 -26.71 27.88 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.252 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.491 ' N ' HD12 ' A' ' 313' ' ' LEU . 3.7 t90 -73.65 -51.79 15.54 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.715 -0.394 . . . . 0.0 109.967 -176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . . . . . . . . . 4.8 t -62.31 -31.53 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.888 0.375 . . . . 0.0 110.424 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.46 -25.08 68.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 110.588 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.4 m -95.51 5.36 51.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.923 -175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -149.84 -64.35 0.21 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.008 0.432 . . . . 0.0 111.519 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.429 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 138.04 -60.79 0.59 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 -174.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 260' ' ' LEU . 2.2 tp 47.42 -162.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 124.113 0.965 . . . . 0.0 111.535 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.515 ' N ' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.022 -0.989 . . . . 0.0 111.402 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.8 m 69.74 133.32 0.04 OUTLIER Pre-proline 0 CA--C 1.53 0.208 0 C-N-CA 123.339 0.656 . . . . 0.0 111.455 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.1 -28.47 48.84 Favored 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 122.595 2.197 . . . . 0.0 112.84 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 61.92 90.04 0.08 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.475 0.655 . . . . 0.0 110.323 -177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -132.4 128.46 21.14 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.268 -175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -84.97 175.7 6.48 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.9 2.4 . . . . 0.0 112.021 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 251' ' ' TYR . 0.3 OUTLIER -67.51 110.02 3.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 174.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.903 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 23.2 t80 166.41 -16.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -163.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.576 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 64.0 m-85 -135.09 -56.73 0.81 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.585 0.707 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.586 ' HE ' HD13 ' A' ' 258' ' ' LEU . 1.3 tmt_? -75.04 108.36 7.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.294 -170.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 1.2 p -72.27 123.06 88.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.129 0.49 . . . . 0.0 111.37 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 11.1 Cg_exo -71.27 10.21 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 124.069 3.179 . . . . 0.0 113.164 -177.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.94 HG21 ' HB3' ' A' ' 277' ' ' SER . 17.2 mm -78.73 -61.07 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 9.5 t -156.33 22.85 0.36 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.48 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.601 ' HG ' HD11 ' A' ' 320' ' ' ILE . 44.9 tp 57.41 46.1 18.75 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.52 0.676 . . . . 0.0 109.783 -177.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.583 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 1.4 pm0 -89.45 -8.1 53.69 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.883 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.475 ' HB3' HG23 ' A' ' 320' ' ' ILE . 0.2 OUTLIER 42.73 75.6 0.09 Allowed 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.673 -175.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.666 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 4.7 ptt? -35.64 147.56 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.494 -1.23 . . . . 0.0 114.202 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.704 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 0.2 OUTLIER -96.69 -60.12 1.67 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.935 177.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -122.06 103.76 39.12 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.8 Cg_endo -88.8 140.79 4.27 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.622 2.215 . . . . 0.0 113.089 -168.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.44 HG11 HD21 ' A' ' 301' ' ' LEU . 24.3 m -106.79 133.1 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.1 177.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 304' ' ' ASN . 9.2 tt -101.62 149.52 6.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.102 -177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.651 HG22 ' H ' ' A' ' 268' ' ' SER . 10.0 p -140.97 178.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.651 ' H ' HG22 ' A' ' 267' ' ' VAL . 10.6 t -59.5 161.4 5.9 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.208 -0.294 . . . . 0.0 110.208 -177.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 19.9 m 77.92 -19.07 0.46 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.003 -167.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 94.82 27.61 11.08 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 121.047 -0.597 . . . . 0.0 111.852 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.619 ' HB3' HG12 ' A' ' 267' ' ' VAL . 0.0 OUTLIER -80.9 118.75 22.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.937 -175.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 264' ' ' PRO . 4.7 m -125.38 99.93 6.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.114 -0.234 . . . . 0.0 110.925 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.589 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 30.4 m-85 -137.67 178.48 7.07 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.685 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.4 tp10 -60.96 136.18 58.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.971 0.415 . . . . 0.0 110.649 -178.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -58.31 -50.24 74.31 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.047 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.1 m -70.01 -11.15 60.67 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.952 0.406 . . . . 0.0 110.975 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.94 ' HB3' HG21 ' A' ' 256' ' ' ILE . 28.0 m -95.22 -20.29 19.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.698 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.685 HG22 ' O ' ' A' ' 274' ' ' GLU . 1.7 tp -106.23 -55.11 5.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.284 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.464 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 22.1 mt-30 -66.43 -17.57 64.86 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -172.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.71 -29.97 66.4 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.032 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.426 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -97.98 -32.24 11.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.332 178.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.6 mt -59.09 -29.85 67.66 Favored 'General case' 0 C--N 1.343 0.317 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.707 171.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 13.7 t70 -61.52 -39.62 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.73 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.76 -17.48 64.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.522 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 97.23 37.54 4.57 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.587 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.426 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 97.5 m-70 -119.8 93.62 4.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.123 0.487 . . . . 0.0 110.636 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.437 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 22.1 pttt -90.5 79.05 6.25 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.642 0.734 . . . . 0.0 111.463 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 295' ' ' THR . 5.6 p -145.92 154.94 42.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.388 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 2.1 m -79.22 147.31 68.8 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.434 0.159 . . . . 0.0 110.651 177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.64 -2.95 12.59 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.35 2.033 . . . . 0.0 112.113 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.419 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 27.4 mtmt -81.33 -67.51 0.77 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.593 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 9.8 p -130.37 13.45 5.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.674 176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 69.8 35.45 2.34 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.879 173.39 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.75 123.7 20.02 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 170.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.601 HG22 ' H ' ' A' ' 297' ' ' LEU . 27.3 m -61.59 121.32 12.46 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.78 -14.44 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.995 0.426 . . . . 0.0 110.211 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 295' ' ' THR . 99.6 mt 66.02 -86.67 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.044 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.77 108.55 20.88 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.382 0.61 . . . . 0.0 109.585 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -80.86 92.93 6.18 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.419 0.628 . . . . 0.0 110.76 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.69 115.71 2.07 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.519 -1.033 . . . . 0.0 110.519 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.44 HD21 HG11 ' A' ' 265' ' ' VAL . 2.8 tp -82.7 144.8 29.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.047 0.451 . . . . 0.0 110.954 -173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.474 ' O ' HG22 ' A' ' 266' ' ' ILE . 55.3 m -141.91 137.42 16.01 Favored Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.435 -178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 18.9 Cg_exo -67.66 132.78 27.82 Favored 'Trans proline' 0 CA--C 1.533 0.434 0 C-N-CA 122.286 1.991 . . . . 0.0 112.183 176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.631 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 26.9 t-20 -110.72 109.13 19.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 111.273 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -90.75 -4.45 56.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.538 HG12 ' OD1' ' A' ' 304' ' ' ASN . 4.4 p -77.75 -32.52 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.67 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.552 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.0 tp -94.3 -35.98 12.18 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.612 -172.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.497 ' HA ' HD11 ' A' ' 311' ' ' ILE . 84.9 tttt -52.08 -48.5 64.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.172 0.589 . . . . 0.0 112.157 -175.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 18.5 t -62.97 -23.29 67.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.903 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.0 mm? -95.38 -46.29 6.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.626 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.548 HD11 ' HD3' ' A' ' 264' ' ' PRO . 5.5 pt -63.42 -32.2 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.314 0.578 . . . . 0.0 110.643 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.77 64.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.626 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -89.04 -24.86 22.23 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.481 178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -76.53 -48.64 18.72 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 24.7 p -66.62 -11.72 54.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -82.49 -32.81 28.61 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.918 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 34.3 p -67.19 -34.37 77.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.398 0.618 . . . . 0.0 109.532 178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -149.04 118.18 6.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.324 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -51.74 109.66 0.89 Allowed Glycine 0 C--N 1.332 0.313 0 O-C-N 123.606 0.566 . . . . 0.0 112.054 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.601 HD11 ' HG ' ' A' ' 258' ' ' LEU . 15.8 tt -144.36 121.02 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.316 0.579 . . . . 0.0 111.239 -174.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 C--O 1.244 0.79 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.544 177.344 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.754 0 N-CA-C 111.826 -0.51 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 15.6 m -102.88 112.38 65.7 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.85 114.3 3.92 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.476 2.117 . . . . 0.0 112.704 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.23 138.64 58.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.709 174.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -121.39 79.86 37.12 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -106.25 40.0 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 124.082 3.188 . . . . 0.0 111.198 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 251' ' ' TYR . 23.7 tt0 62.74 -140.08 0.4 Allowed 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -169.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.76 ' CE2' ' HG ' ' A' ' 310' ' ' LEU . 1.6 t80 71.14 -73.71 0.09 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.079 0.399 . . . . 0.0 111.363 174.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 70.2 m-85 -98.7 -75.4 0.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.121 0.486 . . . . 0.0 111.879 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.517 ' HG2' ' CD1' ' A' ' 258' ' ' LEU . 0.0 OUTLIER -62.18 118.28 7.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.674 -171.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 253' ' ' ARG . 37.8 t -63.89 120.58 64.9 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.477 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 16.5 Cg_exo -67.9 -12.43 35.28 Favored 'Trans proline' 0 CA--C 1.526 0.11 0 C-N-CA 122.964 2.443 . . . . 0.0 112.115 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 72.6 mt -96.02 -65.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.02 -173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.68 3.96 6.75 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.751 ' HG ' HD11 ' A' ' 320' ' ' ILE . 36.7 tp 57.1 30.01 17.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 111.319 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.407 ' OE2' ' SG ' ' A' ' 254' ' ' CYS . 16.4 pm0 -71.51 -17.39 62.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 253' ' ' ARG . 0.1 OUTLIER 50.52 69.74 0.59 Allowed 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.577 -1.192 . . . . 0.0 108.447 -173.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.624 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 7.1 ptt? -29.24 142.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 113.88 -1.509 . . . . 0.0 113.685 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.654 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -110.14 -29.01 8.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.643 0.735 . . . . 0.0 109.065 177.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -134.45 102.82 11.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.565 ' HB2' HG22 ' A' ' 272' ' ' THR . 44.0 Cg_endo -97.89 164.22 0.82 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.157 2.571 . . . . 0.0 113.434 -175.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.9 136.15 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.341 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.668 HG13 HG23 ' A' ' 272' ' ' THR . 0.7 OUTLIER -98.43 152.04 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.771 -176.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.912 HG22 HE21 ' A' ' 271' ' ' GLN . 20.4 m -135.5 -179.53 3.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 168.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.482 ' O ' ' HB ' ' A' ' 269' ' ' THR . 11.7 t -59.65 156.16 14.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 69.8 m 90.07 -29.46 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.847 0.859 . . . . 0.0 109.593 -169.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 95.0 22.97 21.66 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.072 176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.912 HE21 HG22 ' A' ' 267' ' ' VAL . 5.0 pp0? -77.47 150.9 34.89 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.882 176.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.668 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -145.49 100.67 3.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.725 177.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.519 ' HA ' ' SD ' ' A' ' 261' ' ' MET . 28.4 m-85 -129.24 177.8 6.89 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.649 ' O ' HG22 ' A' ' 278' ' ' ILE . 6.6 tm-20 -66.09 139.47 58.17 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 12.0 ttm180 -54.09 -43.23 70.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -171.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.547 ' O ' ' HB3' ' A' ' 280' ' ' LYS . 3.3 m -76.32 -16.87 59.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.859 0.362 . . . . 0.0 110.547 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 49.5 m -94.66 -23.71 17.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.854 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 274' ' ' GLU . 2.8 tp -94.92 -55.78 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.013 0.435 . . . . 0.0 111.254 174.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 275' ' ' ARG . 12.6 mm100 -66.99 -20.64 65.91 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -171.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 276' ' ' SER . 0.0 OUTLIER -69.88 -26.04 64.0 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.327 -178.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.666 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -98.14 -31.85 11.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.373 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 36.5 mt -65.75 -32.89 74.69 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -58.3 -34.71 70.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.784 174.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -70.8 -8.79 55.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.717 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 95.06 32.09 7.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.711 177.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.481 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 34.4 m-70 -106.99 166.5 10.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -153.76 61.09 0.73 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.735 0.779 . . . . 0.0 110.332 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.409 ' CA ' ' HG ' ' A' ' 296' ' ' LEU . 1.0 OUTLIER -145.86 151.54 38.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.983 178.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 32.1 p -81.61 151.63 68.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.666 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 73.2 Cg_endo -74.42 -5.05 16.36 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.599 2.199 . . . . 0.0 111.873 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -82.36 -67.57 0.77 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.199 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.486 ' HB2' ' HG3' ' A' ' 294' ' ' GLU . 0.6 OUTLIER -128.53 10.34 6.14 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 -175.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 54.04 44.77 28.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.404 0.621 . . . . 0.0 109.861 -175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.486 ' HG3' ' HB2' ' A' ' 292' ' ' SER . 38.2 mt-10 -70.61 8.93 0.73 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.576 -172.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 297' ' ' LEU . 3.6 m 63.05 114.64 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.528 0.68 . . . . 0.0 111.629 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.628 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 32.7 mt -83.32 -3.16 57.21 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.332 -177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.452 ' H ' HG22 ' A' ' 295' ' ' THR . 4.0 mm? 60.37 -93.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.395 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -102.32 110.85 22.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.3 92.58 5.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.317 0.58 . . . . 0.0 110.973 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -128.76 113.14 1.51 Allowed Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.515 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.1 tp -72.45 122.18 20.82 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.47 0.652 . . . . 0.0 110.501 -172.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.563 ' HB ' HG22 ' A' ' 266' ' ' ILE . 95.2 m -118.09 119.53 33.38 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.232 -177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.47 123.55 10.64 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.061 1.841 . . . . 0.0 111.941 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -113.08 140.64 47.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.473 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -91.1 -32.06 16.0 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.188 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 5.9 p -47.58 -48.87 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 311' ' ' ILE . 11.6 tp -86.49 -33.03 20.47 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 120.398 -0.521 . . . . 0.0 112.196 -166.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.525 ' HA ' ' CG1' ' A' ' 311' ' ' ILE . 14.5 ptpt -63.7 -30.37 71.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.294 -174.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 11.3 m -66.87 -26.96 67.15 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.176 0.512 . . . . 0.0 110.543 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.76 ' HG ' ' CE2' ' A' ' 251' ' ' TYR . 4.2 mm? -94.62 -48.69 5.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.68 -177.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 307' ' ' LEU . 13.7 pt -65.44 -35.57 75.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.812 0.339 . . . . 0.0 111.371 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 316' ' ' GLU . . . -71.24 -12.43 61.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.279 177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.484 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.0 OUTLIER -83.66 -35.66 24.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.333 176.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 3.2 t90 -75.61 -49.89 17.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 -176.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 17.3 p -70.91 -13.23 61.94 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.11 0.481 . . . . 0.0 111.04 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 312' ' ' ALA . 11.7 tp10 -83.12 -29.97 28.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.251 0.548 . . . . 0.0 109.747 176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 9.0 t -72.54 -51.34 20.33 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.87 119.24 28.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.312 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -58.24 100.74 0.16 Allowed Glycine 0 N--CA 1.451 -0.307 0 O-C-N 123.577 0.548 . . . . 0.0 112.329 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.751 HD11 ' HG ' ' A' ' 258' ' ' LEU . 13.8 tt -127.95 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.28 -179.605 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.782 ' HB2' ' HG3' ' A' ' 249' ' ' PRO . 3.4 m -92.17 106.16 16.71 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 245' ' ' SER . 2.6 Cg_endo -80.67 -19.73 8.45 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.936 2.424 . . . . 0.0 113.712 -172.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.5 -97.4 0.08 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -172.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.648 ' CE1' ' HD2' ' A' ' 253' ' ' ARG . 62.5 m-85 -133.57 75.17 69.49 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.788 ' HG2' ' HB2' ' A' ' 252' ' ' PHE . 97.5 Cg_endo -97.45 153.57 0.98 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.005 2.47 . . . . 0.0 111.205 168.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -76.16 11.09 1.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 O-C-N 122.159 -0.338 . . . . 0.0 111.64 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.821 ' HA ' HD13 ' A' ' 307' ' ' LEU . 35.4 p90 -118.6 13.85 13.46 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.657 175.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.788 ' HB2' ' HG2' ' A' ' 249' ' ' PRO . 0.9 OUTLIER -140.79 -87.11 0.18 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 178.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.648 ' HD2' ' CE1' ' A' ' 248' ' ' PHE . 7.1 ttm180 -88.86 122.63 32.45 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.31 -169.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.556 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 43.7 t -65.58 114.48 16.03 Favored Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.617 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.86 4.75 3.89 Favored 'Trans proline' 0 CA--C 1.527 0.152 0 C-N-CA 122.943 2.428 . . . . 0.0 112.525 -175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.694 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 56.3 mt -96.6 -66.17 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.381 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.2 m -104.46 4.4 33.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.6 -173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 1.5 tt 51.81 55.81 8.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.752 0.787 . . . . 0.0 110.414 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 261' ' ' MET . 1.5 pp20? -121.33 153.61 37.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 1.032 ' HB2' HG21 ' A' ' 320' ' ' ILE . 0.2 OUTLIER -87.41 22.95 2.01 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -172.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.944 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 73.5 mtm 55.97 176.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.816 0.817 . . . . 0.0 112.531 -178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.436 ' HB2' ' HE2' ' A' ' 262' ' ' LYS . 17.6 mtmm -149.61 -48.62 0.14 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.201 1.0 . . . . 0.0 108.589 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -134.13 102.6 11.97 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 113.716 -1.584 . . . . 0.0 106.865 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.731 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.3 Cg_endo -93.37 129.33 0.72 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 122.583 2.189 . . . . 0.0 112.68 -172.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.417 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 8.2 m -105.6 128.61 59.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.505 0.669 . . . . 0.0 110.982 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.8 tt -91.06 148.18 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 114.931 -1.032 . . . . 0.0 108.897 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.584 HG12 ' H ' ' A' ' 268' ' ' SER . 2.3 t -135.66 178.46 5.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.584 ' H ' HG12 ' A' ' 267' ' ' VAL . 6.1 p -59.5 154.16 17.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 268' ' ' SER . 57.4 m 85.59 -18.72 0.35 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.283 0.633 . . . . 0.0 110.198 -172.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 97.58 19.91 23.69 Favored Glycine 0 CA--C 1.511 -0.196 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.092 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.665 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 15.3 tt0 -77.33 131.52 38.14 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.194 -0.503 . . . . 0.0 111.527 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.731 HG22 ' HB2' ' A' ' 264' ' ' PRO . 3.7 m -134.78 102.47 5.27 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.362 174.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.649 ' CE2' ' HG3' ' A' ' 271' ' ' GLN . 25.9 m-85 -132.76 176.5 8.41 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.944 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 0.9 OUTLIER -81.44 137.12 35.68 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -178.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 40.5 mtp180 -51.88 -46.06 64.36 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 27.7 t -65.85 -17.89 64.96 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.838 -174.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 63.7 m -95.35 -49.6 5.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.567 175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.8 tp -82.67 -46.22 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -173.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.443 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 10.8 mm100 -76.54 -14.68 60.0 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 121.218 0.532 . . . . 0.0 110.34 -173.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -58.66 -43.99 90.03 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.944 172.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.694 ' HZ3' HD13 ' A' ' 256' ' ' ILE . 0.0 OUTLIER -98.87 -33.08 11.01 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.391 -177.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.8 mt -59.03 -39.79 83.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.672 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -68.36 -23.22 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.257 0.551 . . . . 0.0 110.449 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -75.33 -7.37 53.8 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.424 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.48 47.91 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.12 174.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.48 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 20.3 m-70 -100.43 91.67 4.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.393 0.616 . . . . 0.0 110.123 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 287' ' ' LYS . 7.7 pttp -93.61 76.78 4.36 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.907 -174.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.53 HG22 ' HA ' ' A' ' 295' ' ' THR . 13.2 p -145.81 142.75 29.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.734 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 271' ' ' GLN . 0.8 OUTLIER -67.32 144.18 97.89 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 120.463 0.173 . . . . 0.0 110.737 174.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.96 0.92 9.4 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.825 2.35 . . . . 0.0 112.423 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.427 ' HE2' ' SG ' ' A' ' 289' ' ' CYS . 48.3 mtmt -86.68 -60.15 2.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.057 -174.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.475 ' C ' HE21 ' A' ' 293' ' ' GLN . 5.4 m -133.04 13.76 4.27 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.509 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 65.69 30.67 10.21 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.608 -178.233 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -57.27 109.82 0.74 Allowed 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 172.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.53 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.4 m -61.32 113.87 2.86 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.863 -175.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.489 HD21 ' SG ' ' A' ' 289' ' ' CYS . 4.2 mt -74.92 88.67 2.34 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 34.9 tp -45.18 -65.55 0.52 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.704 0.628 . . . . 0.0 111.942 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 31.3 m170 -108.46 111.44 23.32 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.75 92.58 4.82 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.214 0.53 . . . . 0.0 110.162 -178.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -115.64 90.82 0.54 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.542 HD12 HG22 ' A' ' 267' ' ' VAL . 8.1 tp -64.1 120.26 11.73 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -173.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.528 ' HB ' ' CG2' ' A' ' 266' ' ' ILE . 56.3 m -125.32 129.7 24.38 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.687 -173.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 302' ' ' THR . 38.8 Cg_exo -61.72 118.78 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.438 2.092 . . . . 0.0 112.426 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 44.7 t-20 -97.22 114.11 25.8 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -89.63 -5.36 57.2 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.591 HG22 ' OD1' ' A' ' 304' ' ' ASN . 13.7 m -70.31 -50.11 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.821 HD13 ' HA ' ' A' ' 251' ' ' TYR . 2.4 pt? -96.34 -7.75 34.38 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -169.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 312' ' ' ALA . 35.2 ttmt -55.76 -39.22 70.89 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 118.624 0.647 . . . . 0.0 110.122 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 16.3 t -74.04 -29.75 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.141 0.495 . . . . 0.0 110.137 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.812 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.3 mm? -72.11 -56.78 5.01 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.399 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.736 ' HB ' ' O ' ' A' ' 260' ' ' LEU . 11.0 pt -60.08 -27.74 39.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.325 0.584 . . . . 0.0 110.344 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -63.5 -30.08 71.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.262 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.812 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 3.9 pp -86.67 -31.65 20.95 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 111.633 0.235 . . . . 0.0 111.633 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.599 ' HB3' ' HG ' ' A' ' 260' ' ' LEU . 1.9 t90 -82.37 -44.23 16.41 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.833 -174.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.655 ' HB2' ' HB3' ' A' ' 260' ' ' LEU . 44.1 t -67.67 -15.64 63.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.569 0.699 . . . . 0.0 109.825 176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -77.98 -44.59 26.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.004 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.2 t -66.36 -39.47 89.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.895 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -133.53 138.48 46.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.414 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -69.75 86.59 0.28 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 1.032 HG21 ' HB2' ' A' ' 260' ' ' LEU . 12.2 tt -92.79 -21.03 6.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -173.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.365 177.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.768 0 N-CA-C 111.989 -0.444 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.33 -53.75 17.08 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.31 123.96 12.25 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.255 1.97 . . . . 0.0 112.164 178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.556 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 1.6 mp0 -52.32 160.62 0.77 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.019 -177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.52 ' HD1' ' HD2' ' A' ' 253' ' ' ARG . 77.1 t80 -112.4 90.18 13.91 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.996 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.704 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.3 Cg_endo -90.39 148.03 4.34 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.182 2.588 . . . . 0.0 111.459 172.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -70.34 -24.28 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.17 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.774 ' HA ' HD11 ' A' ' 307' ' ' LEU . 12.2 p90 -90.06 18.86 5.4 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.461 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.704 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 3.7 m-85 -130.56 -80.52 0.54 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.786 0.327 . . . . 0.0 111.834 177.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.52 ' HD2' ' HD1' ' A' ' 248' ' ' PHE . 56.2 mtt85 -70.23 138.89 52.08 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 121.07 0.462 . . . . 0.0 111.215 -175.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.659 ' HB2' ' H ' ' A' ' 261' ' ' MET . 48.8 t -77.92 115.96 54.59 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.361 -0.836 . . . . 0.0 108.917 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 273' ' ' TYR . 34.5 Cg_exo -65.05 14.14 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 123.731 2.954 . . . . 0.0 113.933 -178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.952 HG21 ' HB3' ' A' ' 277' ' ' SER . 16.1 mm -88.88 -57.72 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 122.325 -0.234 . . . . 0.0 110.582 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.1 t -155.85 26.51 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.614 HD12 HD11 ' A' ' 320' ' ' ILE . 66.1 tp 64.47 35.84 9.18 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.146 0.974 . . . . 0.0 109.869 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.508 ' OE1' ' HB3' ' A' ' 254' ' ' CYS . 0.7 OUTLIER -98.95 -6.87 27.95 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.601 -179.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.609 HD13 HG21 ' A' ' 320' ' ' ILE . 4.2 tt 39.21 90.88 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 O-C-N 124.982 1.426 . . . . 0.0 112.39 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.659 ' H ' ' HB2' ' A' ' 254' ' ' CYS . 5.9 ptt? -40.08 137.17 1.03 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.846 174.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.666 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.1 OUTLIER -105.34 -40.08 5.95 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.689 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -125.07 102.38 31.14 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.648 ' HB2' HG22 ' A' ' 272' ' ' THR . 61.3 Cg_endo -92.19 147.89 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 122.597 2.198 . . . . 0.0 112.938 -170.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 272' ' ' THR . 14.9 p -112.59 130.07 67.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.468 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 11.0 tt -92.79 141.93 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.32 159.48 43.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 269' ' ' THR . 1.6 p -60.49 129.75 43.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 123.3 0.375 . . . . 0.0 110.071 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.704 HG21 ' SG ' ' A' ' 289' ' ' CYS . 9.5 m 126.72 -35.23 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 O-C-N 125.374 1.671 . . . . 0.0 108.065 -168.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.92 37.07 3.03 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.481 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.894 HE22 HG12 ' A' ' 278' ' ' ILE . 4.4 tt0 -98.47 141.59 31.14 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.132 -0.534 . . . . 0.0 111.112 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.648 HG22 ' HB2' ' A' ' 264' ' ' PRO . 8.6 m -142.67 109.2 5.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.854 0.297 . . . . 0.0 110.334 168.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.502 ' CD1' ' HD2' ' A' ' 255' ' ' PRO . 48.1 m-85 -132.85 177.88 7.3 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.972 0.415 . . . . 0.0 111.109 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.2 tp10 -67.13 131.37 45.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.651 171.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -60.66 -38.53 85.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.798 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.429 ' O ' ' HE2' ' A' ' 280' ' ' LYS . 4.2 m -67.04 -17.29 64.84 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 -177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.952 ' HB3' HG21 ' A' ' 256' ' ' ILE . 9.5 m -95.79 -48.52 5.72 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.518 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.894 HG12 HE22 ' A' ' 271' ' ' GLN . 6.1 tp -79.7 -48.8 20.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -175.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 278' ' ' ILE . 12.1 mt-30 -64.89 -29.0 69.93 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -173.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 276' ' ' SER . 2.8 ttmm -52.1 -46.64 65.34 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.097 -1.411 . . . . 0.0 111.484 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.415 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.46 -25.46 14.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.578 -177.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 282' ' ' LEU . 11.6 mt -67.12 -41.27 86.47 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.116 174.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.11 -24.49 67.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.254 0.55 . . . . 0.0 110.049 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -65.32 -18.58 65.43 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.567 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.67 19.48 7.37 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.784 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.415 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 44.1 m-70 -93.1 169.09 10.67 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 122.668 -0.313 . . . . 0.0 110.274 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -155.29 48.29 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 111.607 -176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.513 ' HB ' ' NE2' ' A' ' 293' ' ' GLN . 3.1 p -143.64 146.35 33.18 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.704 ' SG ' HG21 ' A' ' 269' ' ' THR . 0.9 OUTLIER -92.2 149.36 38.43 Favored Pre-proline 0 C--O 1.233 0.196 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.098 175.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 7.9 Cg_exo -72.92 -13.93 26.47 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.221 2.614 . . . . 0.0 112.454 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.428 ' HB2' ' HE3' ' A' ' 291' ' ' LYS . 31.1 mtmt -61.31 -67.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.534 -175.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 22.3 m -142.88 18.55 1.97 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.325 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.513 ' NE2' ' HB ' ' A' ' 288' ' ' THR . 0.1 OUTLIER 59.08 39.67 22.95 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.051 178.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.62 -7.93 12.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.083 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 288' ' ' THR . 7.5 m 68.28 112.99 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 O-C-N 123.563 0.539 . . . . 0.0 110.868 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.522 HD21 ' HB3' ' A' ' 289' ' ' CYS . 5.7 mt -80.35 81.84 6.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.35 127.6 32.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 11.5 p80 38.69 86.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 124.451 1.095 . . . . 0.0 111.053 -170.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -76.54 99.05 4.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.607 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -107.58 127.04 8.58 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.024 175.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.501 ' HB3' HG21 ' A' ' 265' ' ' VAL . 21.4 mt -84.42 116.1 22.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.337 0.589 . . . . 0.0 110.885 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 266' ' ' ILE . 23.1 m -124.5 126.4 25.45 Favored Pre-proline 0 C--O 1.213 -0.828 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.357 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -61.12 127.59 22.65 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.258 1.972 . . . . 0.0 112.694 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.654 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 36.3 t-20 -99.01 116.26 30.85 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -88.94 -7.84 55.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.583 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.4 p -72.6 -31.48 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 121.545 0.688 . . . . 0.0 109.973 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 251' ' ' TYR . 5.0 tp -94.96 -41.14 9.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.299 -171.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -51.38 -42.61 61.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.747 0.819 . . . . 0.0 111.56 -176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 9.8 m -64.21 -30.33 71.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.828 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.834 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 4.0 mm? -94.28 -50.65 5.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 0.0 111.545 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.564 HG22 ' HA ' ' A' ' 252' ' ' PHE . 8.2 pt -59.66 -36.12 63.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.811 0.339 . . . . 0.0 111.616 -177.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.91 -20.25 65.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.162 -173.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.834 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -85.18 -25.03 27.66 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.37 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -77.0 -47.89 19.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.559 ' HA ' HG22 ' A' ' 320' ' ' ILE . 8.2 p -71.88 -9.07 57.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.266 0.555 . . . . 0.0 110.777 177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -83.6 -31.31 26.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.348 0.594 . . . . 0.0 109.539 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 49.6 m -73.89 -49.34 25.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.223 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -128.46 141.53 51.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.346 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -74.06 67.77 1.73 Allowed Glycine 0 C--N 1.33 0.197 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.286 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.614 HD11 HD12 ' A' ' 258' ' ' LEU . 13.5 tt -82.73 82.5 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 122.223 1.011 . . . . 0.0 110.999 -177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 C--O 1.252 1.234 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.177 177.542 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.605 -0.198 . . . . 0.0 112.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.2 m 66.33 91.44 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.214 0 C-N-CA 123.393 0.677 . . . . 0.0 111.94 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.99 150.47 29.9 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.328 2.685 . . . . 0.0 111.653 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.92 -33.79 70.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.999 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 54.03 73.53 0.89 Allowed Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.534 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.01 -58.47 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.237 1.958 . . . . 0.0 111.085 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.686 ' HG3' ' H ' ' A' ' 251' ' ' TYR . 6.4 tp10 -179.84 -169.35 0.13 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.686 ' H ' ' HG3' ' A' ' 250' ' ' GLU . 44.9 p90 50.27 29.92 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.232 1.013 . . . . 0.0 112.961 176.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.493 ' HA ' HG22 ' A' ' 311' ' ' ILE . 12.6 m-85 -132.01 -77.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.792 0.33 . . . . 0.0 111.429 176.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.546 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 0.0 OUTLIER -87.53 152.37 22.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.801 0.334 . . . . 0.0 111.263 -175.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.543 ' SG ' ' HG2' ' A' ' 259' ' ' GLU . 28.3 p -85.38 126.07 68.01 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 171.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 21.1 Cg_exo -66.33 -1.28 5.28 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.876 2.384 . . . . 0.0 112.987 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 54.5 mt -90.27 -41.15 13.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.388 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.2 p -145.01 -5.66 0.69 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -172.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 258' ' ' LEU . 36.3 tp 56.28 40.21 29.96 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.718 0.771 . . . . 0.0 110.059 -171.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.543 ' HG2' ' SG ' ' A' ' 254' ' ' CYS . 3.6 pt-20 -82.88 -14.98 53.23 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.79 ' HB3' HG21 ' A' ' 320' ' ' ILE . 3.2 tt 47.18 88.9 0.02 OUTLIER 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.291 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.948 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -47.59 142.22 4.6 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.662 -1.153 . . . . 0.0 112.3 -176.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.545 ' H ' ' HE3' ' A' ' 262' ' ' LYS . 0.0 OUTLIER -101.13 -32.11 10.72 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 173.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -140.77 104.09 6.33 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.374 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.538 ' HD3' HD11 ' A' ' 311' ' ' ILE . 65.3 Cg_endo -92.77 157.7 2.82 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.124 2.549 . . . . 0.0 113.659 -171.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 6.8 m -121.74 127.28 75.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.733 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.771 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -92.21 143.61 10.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.234 175.16 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 301' ' ' LEU . 17.9 m -136.56 -178.26 2.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 172.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 t -58.5 159.76 6.07 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 20.5 m 84.04 -27.97 0.1 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.675 0.79 . . . . 0.0 109.948 -169.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 93.08 35.99 6.15 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.876 175.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.594 HE22 HG12 ' A' ' 278' ' ' ILE . 7.0 pt20 -87.39 154.11 20.92 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.771 HG23 HG13 ' A' ' 266' ' ' ILE . 0.2 OUTLIER -141.36 99.21 3.52 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.084 0.469 . . . . 0.0 110.257 172.076 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 291' ' ' LYS . 33.6 m-85 -132.52 178.67 6.66 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.948 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 7.5 tt0 -85.89 148.31 25.85 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.62 0.724 . . . . 0.0 110.735 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 279' ' ' GLN . 65.9 mtm180 -55.09 -32.94 62.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.3 -1.318 . . . . 0.0 112.862 -175.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.425 ' HB3' ' OE1' ' A' ' 259' ' ' GLU . 24.7 t -66.38 -26.01 67.05 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.848 0.356 . . . . 0.0 110.871 -173.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 74.3 m -94.73 -36.13 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.126 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.594 HG12 HE22 ' A' ' 271' ' ' GLN . 4.8 tp -94.73 -50.34 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.482 ' HG2' HD21 ' A' ' 301' ' ' LEU . 21.7 mt-30 -65.51 -24.07 67.04 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.401 0.619 . . . . 0.0 110.21 -176.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.4 -45.09 62.39 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.774 174.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.439 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -100.08 -31.73 11.28 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.646 -179.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 10.6 mt -60.22 -46.58 89.25 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.227 -0.296 . . . . 0.0 111.303 175.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.8 OUTLIER -71.34 -13.81 61.99 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.573 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -73.05 -16.0 61.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.563 172.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 101.93 47.59 1.46 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 113.218 176.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 72.9 m-70 -128.28 166.54 18.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.912 0.356 . . . . 0.0 110.074 178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -145.56 57.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.042 0.448 . . . . 0.0 111.685 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 2.8 p -141.24 132.22 26.1 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.28 -0.262 . . . . 0.0 110.858 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.517 ' HB3' ' HE3' ' A' ' 291' ' ' LYS . 1.0 OUTLIER -70.96 156.31 92.21 Favored Pre-proline 0 C--O 1.235 0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.522 177.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.27 3.96 7.42 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.075 2.516 . . . . 0.0 113.166 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE3' ' HB3' ' A' ' 289' ' ' CYS . 0.0 OUTLIER -85.62 -61.76 1.69 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.716 0.293 . . . . 0.0 111.362 -178.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 23.4 t -143.66 14.55 1.76 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.075 0.464 . . . . 0.0 109.854 -175.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 62.38 43.73 7.88 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.452 -178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -60.26 -11.14 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.386 -175.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 11.9 m 69.69 114.87 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.416 0.627 . . . . 0.0 111.129 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.11 81.85 8.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.643 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 298' ' ' HIS . 10.8 mp -58.86 115.93 3.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.264 174.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 297' ' ' LEU . 35.8 m-70 70.78 78.41 0.18 Allowed 'General case' 0 C--O 1.233 0.205 0 O-C-N 124.046 0.841 . . . . 0.0 109.837 -168.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.54 93.2 4.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.306 0.574 . . . . 0.0 110.439 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -144.51 141.29 9.96 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.361 -1.095 . . . . 0.0 110.361 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 267' ' ' VAL . 7.0 mp -91.38 128.81 37.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.798 0.809 . . . . 0.0 111.7 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 22.8 m -120.59 112.23 34.18 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.564 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.08 130.92 42.84 Favored 'Trans proline' 0 CA--C 1.527 0.171 0 C-N-CA 122.563 2.176 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.631 HD21 HG12 ' A' ' 306' ' ' VAL . 20.7 t-20 -108.86 122.34 46.99 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.609 -174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -90.47 -24.72 20.61 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.631 HG12 HD21 ' A' ' 304' ' ' ASN . 9.9 p -59.99 -35.95 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.332 0.586 . . . . 0.0 110.267 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.604 HD21 ' HE3' ' A' ' 261' ' ' MET . 15.8 tp -83.04 -45.29 14.21 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.235 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 262' ' ' LYS . 2.3 tmtp? -48.45 -54.31 14.64 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.087 0.955 . . . . 0.0 111.877 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 19.8 m -65.94 -21.03 66.4 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.618 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 98.5 mt -94.48 -42.04 9.05 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.017 0.437 . . . . 0.0 111.169 -177.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 307' ' ' LEU . 7.8 pt -72.37 -33.6 46.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.941 0.4 . . . . 0.0 111.325 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.99 -15.16 63.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.996 -174.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.6 pp -94.91 -26.48 16.13 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.842 178.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.443 ' N ' HD12 ' A' ' 313' ' ' LEU . 2.6 t90 -82.86 -47.77 11.49 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.458 -175.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.598 ' HB3' HD22 ' A' ' 260' ' ' LEU . 21.0 p -59.58 -36.79 76.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.24 0.543 . . . . 0.0 109.851 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -67.38 -38.35 84.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.305 176.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 11.8 t -67.56 -36.28 80.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.299 -176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -109.08 -63.27 1.37 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 111.06 96.43 2.35 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -168.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.79 HG21 ' HB3' ' A' ' 260' ' ' LEU . 5.2 tp -110.93 -155.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -171.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.546 ' H ' HG13 ' A' ' 320' ' ' ILE . 42.1 mt-10 . . . . . 0 C--O 1.247 0.967 0 CA-C-O 117.699 -1.143 . . . . 0.0 110.658 -172.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' ' 246' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 14.3 m -82.47 107.26 8.44 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.864 0.364 . . . . 0.0 110.665 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 244' ' ' GLY . 93.6 Cg_endo -93.23 53.9 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.995 2.463 . . . . 0.0 111.833 -177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.546 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.6 mt-10 -70.13 126.16 28.87 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -102.61 107.09 52.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.73 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.717 ' HG2' ' CE1' ' A' ' 251' ' ' TYR . 1.8 Cg_endo -86.9 -166.62 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.421 2.747 . . . . 0.0 110.895 169.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -73.11 -19.39 61.16 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.717 ' CE1' ' HG2' ' A' ' 249' ' ' PRO . 16.5 p90 -91.77 25.33 2.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.572 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.79 -82.2 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.867 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 1.8 tmm_? -74.65 109.88 8.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.987 -169.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 255' ' ' PRO . 53.4 t -61.71 113.04 7.17 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.163 174.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 254' ' ' CYS . 3.0 Cg_exo -75.73 12.27 1.45 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.433 2.755 . . . . 0.0 112.812 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.7 mt -95.94 -56.17 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.378 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.419 ' HB2' ' OE2' ' A' ' 259' ' ' GLU . 50.4 m -139.31 13.12 2.59 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.495 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.867 ' HG ' ' HD3' ' A' ' 253' ' ' ARG . 0.7 OUTLIER 53.83 42.41 31.76 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.18 0.514 . . . . 0.0 110.736 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.2 pm0 -89.65 -20.03 24.17 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.877 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.581 ' HB2' HD13 ' A' ' 320' ' ' ILE . 0.1 OUTLIER 65.06 97.49 0.04 OUTLIER 'General case' 0 C--N 1.334 -0.108 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -172.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.806 ' HB3' ' HB2' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -48.97 155.95 0.56 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.404 -174.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.691 ' HE2' ' SG ' ' A' ' 315' ' ' CYS . 29.9 mmtp -115.29 -34.91 4.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.328 175.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -131.49 101.48 15.87 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.563 ' HB2' HG22 ' A' ' 272' ' ' THR . 64.5 Cg_endo -93.78 128.6 0.63 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 122.965 2.443 . . . . 0.0 112.773 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 15.9 m -105.18 133.63 48.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.381 177.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 0.2 OUTLIER -82.92 139.39 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 172.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.618 HG12 ' H ' ' A' ' 268' ' ' SER . 5.2 t -131.87 176.6 8.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.618 ' H ' HG12 ' A' ' 267' ' ' VAL . 9.0 m -58.73 154.6 14.38 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 22.8 m 82.62 -27.35 0.12 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.541 0.737 . . . . 0.0 109.904 -167.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.96 29.72 6.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.794 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.715 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 10.2 pt20 -85.14 150.39 24.86 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 122.679 -0.307 . . . . 0.0 110.956 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -136.66 100.19 4.26 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 175.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.677 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 42.7 m-85 -138.09 175.15 9.84 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.834 -175.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.806 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 11.9 tp10 -61.64 120.42 10.58 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.033 0.444 . . . . 0.0 110.957 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 265' ' ' VAL . 3.3 tmt_? -55.88 -39.44 71.55 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.493 -177.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 4.6 m -71.1 -20.14 62.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.077 0.465 . . . . 0.0 110.481 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.3 m -96.52 -39.0 9.76 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.177 -179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -78.93 -47.0 23.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.614 -176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.577 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 27.8 mt-30 -72.81 -20.0 61.23 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-O 121.429 0.633 . . . . 0.0 109.847 -177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -54.26 -43.66 71.15 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.268 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.504 ' CH2' ' HB3' ' A' ' 290' ' ' PRO . 0.0 OUTLIER -99.16 -31.72 11.6 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.264 179.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.1 mt -59.21 -46.35 88.66 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 120.882 0.372 . . . . 0.0 110.605 176.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 279' ' ' GLN . 0.9 OUTLIER -73.99 -13.85 60.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.875 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -72.42 -29.19 63.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.69 -2.99 4.58 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.487 -0.863 . . . . 0.0 113.323 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.548 ' O ' ' HA ' ' A' ' 282' ' ' LEU . 38.2 m-70 -106.22 129.31 54.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.074 0.437 . . . . 0.0 109.879 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -124.04 81.15 1.89 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.506 0.67 . . . . 0.0 111.429 -176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.439 ' O ' ' HZ2' ' A' ' 281' ' ' TRP . 7.2 p -145.2 143.14 30.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.551 ' SG ' HD21 ' A' ' 296' ' ' LEU . 1.3 m -60.96 134.52 92.76 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.469 172.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.504 ' HB3' ' CH2' ' A' ' 281' ' ' TRP . 45.5 Cg_endo -69.47 -1.86 8.97 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.16 2.574 . . . . 0.0 113.225 -177.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.407 ' H ' ' HG2' ' A' ' 291' ' ' LYS . 12.7 pttt -95.19 -60.05 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -175.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 1.4 p -134.55 8.68 3.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.874 0.368 . . . . 0.0 111.633 -177.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 56.48 58.11 4.42 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.59 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.53 -8.19 44.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.046 176.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 26.6 m 71.06 108.45 0.06 Allowed 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.645 0.591 . . . . 0.0 111.074 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.551 HD21 ' SG ' ' A' ' 289' ' ' CYS . 10.3 mt -83.87 86.14 7.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.779 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.68 115.55 7.38 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 61.04 86.54 0.1 Allowed 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 123.802 0.689 . . . . 0.0 110.301 -173.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.62 94.23 4.99 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.321 -175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -90.49 114.45 4.42 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.621 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.497 HD13 HG22 ' A' ' 267' ' ' VAL . 3.8 mm? -78.04 109.08 11.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.193 0.52 . . . . 0.0 110.588 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.562 ' HB ' HG22 ' A' ' 266' ' ' ILE . 99.4 m -125.44 96.81 38.06 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.62 -177.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 51.0 Cg_exo -55.63 119.19 6.16 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.518 2.145 . . . . 0.0 113.166 -176.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.483 HD22 ' CD1' ' A' ' 266' ' ' ILE . 52.1 t-20 -96.0 117.18 30.16 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 177.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -82.45 -5.12 58.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.13 -30.11 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 110.474 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.627 ' O ' HG12 ' A' ' 311' ' ' ILE . 18.2 tp -93.99 -29.41 15.25 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.001 -168.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 262' ' ' LYS . 0.4 OUTLIER -57.57 -41.05 80.3 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.739 0.415 . . . . 0.0 110.291 -175.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.1 m -67.45 -39.98 85.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.956 0.407 . . . . 0.0 110.948 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 78.5 mt -73.27 -47.03 46.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.46 -174.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.627 HG12 ' O ' ' A' ' 307' ' ' LEU . 5.5 pt -68.81 -27.7 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.137 0.494 . . . . 0.0 110.589 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 308' ' ' LYS . . . -62.39 -36.54 82.63 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.326 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.5 pp -81.34 -26.79 35.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.0 -175.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.48 ' N ' HD12 ' A' ' 313' ' ' LEU . 11.9 t90 -76.42 -43.73 39.05 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.684 -175.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.691 ' SG ' ' HE2' ' A' ' 262' ' ' LYS . 6.7 m -63.89 -12.19 34.49 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.035 0.445 . . . . 0.0 110.71 178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 313' ' ' LEU . 12.6 tp10 -76.37 -42.95 42.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.998 173.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 8.7 t -64.7 -28.33 69.53 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.481 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -148.95 130.1 14.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.783 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -66.48 79.22 0.12 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 260' ' ' LEU . 21.2 tt -88.25 -25.13 5.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.525 -0.337 . . . . 0.0 111.669 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.651 ' HB2' ' O ' ' A' ' 259' ' ' GLU . 2.8 tm-20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 109.048 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 13.8 m -103.79 107.98 58.27 Favored Pre-proline 0 C--N 1.32 -0.704 0 O-C-N 122.73 -0.277 . . . . 0.0 110.313 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.38 -76.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.482 2.122 . . . . 0.0 110.883 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 44.82 42.53 6.13 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.795 0.685 . . . . 0.0 112.655 172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 253' ' ' ARG . 41.7 m-85 -64.73 122.28 78.04 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.186 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.26 -17.48 31.01 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.456 2.104 . . . . 0.0 111.724 177.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -136.82 -167.22 2.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.916 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.677 ' HD2' ' HD1' ' A' ' 252' ' ' PHE . 0.3 OUTLIER 65.18 -103.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.774 178.347 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.677 ' HD1' ' HD2' ' A' ' 251' ' ' TYR . 40.8 p90 -123.78 9.61 8.89 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -165.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' A' ' 260' ' ' LEU . 3.7 tmt_? -95.19 103.98 15.86 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.563 ' HB2' ' HG3' ' A' ' 261' ' ' MET . 13.8 t -58.57 115.09 10.38 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.697 -178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.506 ' HA ' HH11 ' A' ' 253' ' ' ARG . 12.2 Cg_exo -71.79 -0.41 8.33 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.557 2.838 . . . . 0.0 113.628 -176.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 277' ' ' SER . 44.3 mt -84.92 -63.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.342 -176.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.1 m -129.4 12.46 5.97 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.584 -178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.78 HD22 HD11 ' A' ' 320' ' ' ILE . 0.4 OUTLIER 62.03 29.42 17.67 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -175.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 321' ' ' GLU . 1.0 OUTLIER -76.15 -13.31 60.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.738 179.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.565 HD22 HG21 ' A' ' 320' ' ' ILE . 4.2 tp 69.46 -8.1 0.78 Allowed 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.365 173.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.734 ' HG2' ' HB2' ' A' ' 274' ' ' GLU . 69.3 mtm 67.32 141.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.343 0.592 . . . . 0.0 112.263 -178.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.588 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -106.63 -40.49 5.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.36 0.6 . . . . 0.0 109.668 174.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -145.39 103.27 4.32 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 176.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.636 ' HB2' HG22 ' A' ' 272' ' ' THR . 88.1 Cg_endo -92.1 146.28 2.98 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.707 2.271 . . . . 0.0 113.978 -166.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.55 HG21 HD23 ' A' ' 301' ' ' LEU . 2.4 m -110.2 128.35 66.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.25 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 6.2 tt -92.46 148.33 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.686 175.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.479 HG22 ' HG ' ' A' ' 301' ' ' LEU . 0.5 OUTLIER -140.37 179.17 2.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.758 ' HB2' ' HB2' ' A' ' 298' ' ' HIS . 26.9 t -59.54 158.53 9.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 268' ' ' SER . 25.7 m 88.71 -29.97 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.832 0.708 . . . . 0.0 110.277 -173.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 103.62 39.71 2.5 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.719 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 9.3 tt0 -100.94 140.32 35.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.192 -0.504 . . . . 0.0 111.852 -176.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.0 m -142.33 109.95 5.75 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 170.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 271' ' ' GLN . 70.3 m-85 -139.28 176.34 8.79 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.727 0.298 . . . . 0.0 110.987 -178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.734 ' HB2' ' HG2' ' A' ' 261' ' ' MET . 9.9 tp10 -77.35 137.62 38.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.252 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 275' ' ' ARG . 63.1 mtt180 -57.88 -42.43 84.58 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 123.248 0.342 . . . . 0.0 111.463 -174.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.584 ' O ' ' HD2' ' A' ' 280' ' ' LYS . 5.7 m -65.6 -21.01 66.54 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.923 0.392 . . . . 0.0 110.587 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . 0.405 ' HB3' HG21 ' A' ' 256' ' ' ILE . 2.4 m -97.67 -23.33 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.01 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 274' ' ' GLU . 6.7 tp -113.57 -52.14 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.41 ' N ' HG23 ' A' ' 278' ' ' ILE . 7.2 mm100 -60.74 -22.81 64.41 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.097 0.475 . . . . 0.0 110.683 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 276' ' ' SER . 12.2 ptmm? -55.04 -45.42 75.23 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.348 177.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 284' ' ' ALA . 0.0 OUTLIER -99.37 -32.94 10.91 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.438 -178.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 287' ' ' LYS . 14.9 mt -58.85 -52.25 66.53 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.863 173.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 -17.95 61.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.193 0.521 . . . . 0.0 109.803 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 281' ' ' TRP . . . -62.07 -29.92 70.64 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.655 175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.13 34.43 0.33 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.361 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.417 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 82.4 m-70 -136.1 172.32 13.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.095 0.474 . . . . 0.0 110.291 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.56 ' HA ' HD22 ' A' ' 282' ' ' LEU . 13.3 ptpt -156.3 81.2 0.98 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.418 ' HB ' ' HG2' ' A' ' 293' ' ' GLN . 11.6 p -146.24 147.36 31.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.851 -176.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.67 ' SG ' ' HE3' ' A' ' 291' ' ' LYS . 2.4 t -84.78 136.66 38.84 Favored Pre-proline 0 N--CA 1.444 -0.726 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 172.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 289' ' ' CYS . 32.6 Cg_endo -64.23 -9.69 20.71 Favored 'Trans proline' 0 N--CA 1.474 0.376 0 C-N-CA 123.184 2.589 . . . . 0.0 113.203 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.67 ' HE3' ' SG ' ' A' ' 289' ' ' CYS . 6.3 mtmp? -77.0 -51.86 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.817 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 47.2 m -146.27 9.21 1.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.667 0.27 . . . . 0.0 111.229 -174.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.418 ' HG2' ' HB ' ' A' ' 288' ' ' THR . 0.0 OUTLIER 58.25 45.92 16.5 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.609 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.11 -8.93 42.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.02 -177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 95.4 m 68.71 108.22 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.767 0.794 . . . . 0.0 111.044 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 8.0 mt -78.26 93.37 4.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.724 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . . . . . . . . . 41.7 tp -53.48 -43.4 68.14 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.523 0.515 . . . . 0.0 111.017 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . 0.758 ' HB2' ' HB2' ' A' ' 268' ' ' SER . 18.2 m170 -96.23 87.26 4.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.021 177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.75 92.72 5.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.601 0.715 . . . . 0.0 109.274 175.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -169.33 93.87 0.1 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 265' ' ' VAL . 7.0 mp -75.8 141.6 42.47 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.769 0.795 . . . . 0.0 112.37 -164.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 266' ' ' ILE . 12.2 m -124.9 128.28 24.91 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.013 -173.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.16 119.18 6.26 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.092 1.861 . . . . 0.0 112.134 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 266' ' ' ILE . 33.8 t-20 -91.74 110.66 22.0 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.37 -12.08 59.62 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -173.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.585 ' O ' HD23 ' A' ' 310' ' ' LEU . 7.9 p -68.82 -36.25 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.23 0.538 . . . . 0.0 110.592 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.562 ' HB3' ' HG3' ' A' ' 264' ' ' PRO . 5.1 tp -95.59 -29.88 14.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.107 -168.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.06 -37.17 71.43 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 122.919 0.488 . . . . 0.0 110.737 -175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 13.0 m -71.16 -43.24 67.9 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 110.998 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.632 HD13 HD21 ' A' ' 313' ' ' LEU . 4.5 mm? -70.47 -43.25 70.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.647 -175.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 252' ' ' PHE . 10.0 pt -69.83 -35.82 66.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.091 0.472 . . . . 0.0 110.438 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.19 -44.74 91.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.758 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.632 HD21 HD13 ' A' ' 310' ' ' LEU . 4.5 pp -67.27 -30.85 70.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.437 -177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.458 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.8 t90 -85.52 -43.36 13.6 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.285 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.614 ' HA ' HG22 ' A' ' 320' ' ' ILE . 27.7 p -66.71 -19.39 65.75 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.354 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -62.72 -26.62 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.577 174.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 42.0 t -94.02 5.22 52.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.148 -173.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.78 -36.51 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.402 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 76.86 52.71 5.68 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -168.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.78 HD11 HD22 ' A' ' 258' ' ' LEU . 5.9 tt -93.58 126.97 45.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.386 0.612 . . . . 0.0 112.302 -171.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 259' ' ' GLU . 32.4 tt0 . . . . . 0 C--O 1.244 0.815 0 CA-C-N 114.293 -1.321 . . . . 0.0 109.23 174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 112.204 -0.359 . . . . 0.0 112.204 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 43.2 m -75.9 152.32 84.62 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 120.505 0.193 . . . . 0.0 110.492 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.32 -20.27 66.42 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.589 2.193 . . . . 0.0 112.456 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.57 ' O ' ' HD3' ' A' ' 249' ' ' PRO . 44.1 tt0 71.72 154.72 0.14 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.121 0.568 . . . . 0.0 110.2 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -109.66 93.62 14.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.79 0.328 . . . . 0.0 110.847 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.761 ' HG2' ' HD2' ' A' ' 252' ' ' PHE . 5.0 Cg_exo -83.57 133.63 6.21 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.883 2.389 . . . . 0.0 111.087 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 250' ' ' GLU . 0.9 OUTLIER -77.31 -5.37 49.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.466 -175.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.737 ' HA ' HD11 ' A' ' 307' ' ' LEU . 40.4 p90 -101.72 22.95 12.0 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.825 0.345 . . . . 0.0 110.999 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.761 ' HD2' ' HG2' ' A' ' 249' ' ' PRO . 8.2 m-85 -131.21 -64.73 0.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.967 0.413 . . . . 0.0 112.086 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.615 ' HD3' ' HG ' ' A' ' 258' ' ' LEU . 37.3 ttm180 -97.95 139.66 33.46 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -166.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . . . . . . . . . 50.1 t -81.31 124.27 80.72 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.774 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -77.57 15.39 1.25 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 123.285 2.657 . . . . 0.0 113.525 -176.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 48.9 mt -96.81 -57.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.701 -178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 1.5 m -126.18 9.17 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.105 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.628 HD23 HD11 ' A' ' 320' ' ' ILE . 1.5 tt 68.31 28.28 6.32 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 141.61 28.74 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 320' ' ' ILE . 0.3 OUTLIER -104.34 124.47 49.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.477 176.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.462 ' CB ' HD12 ' A' ' 311' ' ' ILE . 26.7 mtm -68.84 161.87 27.67 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.039 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 262' ' ' LYS . 0.2 OUTLIER -126.88 -41.42 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -124.96 101.78 32.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 70.5 Cg_endo -91.57 137.24 1.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.551 2.168 . . . . 0.0 113.229 -169.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 13.8 m -105.57 122.58 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-O 121.852 0.834 . . . . 0.0 111.142 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 271' ' ' GLN . 8.5 tt -96.77 154.89 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.121 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.498 HG21 HD13 ' A' ' 296' ' ' LEU . 17.5 m -139.33 178.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 172.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.445 ' O ' ' HB ' ' A' ' 269' ' ' THR . 23.0 t -61.14 157.3 16.28 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.524 HG21 ' SG ' ' A' ' 289' ' ' CYS . 25.0 m 89.4 -17.78 0.23 Allowed 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.874 0.734 . . . . 0.0 110.151 -174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 91.85 30.51 10.31 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.28 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 4.0 tt0 -92.3 131.55 37.41 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.831 -0.184 . . . . 0.0 111.144 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.603 HG22 ' HB2' ' A' ' 264' ' ' PRO . 5.4 m -134.18 100.53 4.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.733 0.302 . . . . 0.0 110.41 169.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -125.3 178.08 5.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.713 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.629 ' O ' HG22 ' A' ' 278' ' ' ILE . 9.3 tp10 -79.28 145.84 33.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 177.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -56.58 -38.22 71.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.855 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.447 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 7.0 m -61.69 -21.2 64.25 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.851 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.03 -53.77 3.55 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.383 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.629 HG22 ' O ' ' A' ' 274' ' ' GLU . 3.3 tp -77.44 -46.98 27.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.715 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.524 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 31.9 mt-30 -74.29 -16.71 60.93 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.506 0.669 . . . . 0.0 109.601 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 276' ' ' SER . 11.3 ttmt -58.43 -43.9 88.92 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.117 173.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.5 ' HD1' ' HB2' ' A' ' 286' ' ' HIS . 0.1 OUTLIER -98.55 -29.3 13.16 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.671 -178.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 14.5 mt -58.07 -43.61 87.05 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.473 172.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.28 -25.89 67.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.542 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -71.9 -17.21 62.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.02 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.34 21.62 14.64 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.322 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 45.3 m-70 -106.83 148.95 27.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.8 0.333 . . . . 0.0 110.589 178.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -137.32 62.43 1.59 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.066 -176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 1.4 p -142.88 119.8 11.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.069 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 269' ' ' THR . 1.2 p -61.95 140.76 95.7 Favored Pre-proline 0 N--CA 1.454 -0.267 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 289' ' ' CYS . 5.0 Cg_exo -74.46 4.1 4.75 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 112.434 -172.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE3' ' OE2' ' A' ' 294' ' ' GLU . 44.1 mtmt -77.35 -60.0 2.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.689 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 51.3 m -146.2 17.54 1.37 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 109.961 177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 58.45 40.93 23.54 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.582 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.574 ' OE2' ' HE3' ' A' ' 291' ' ' LYS . 4.5 mp0 -59.91 -10.4 4.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.697 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 27.2 m 72.8 121.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.581 0.705 . . . . 0.0 111.626 173.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.498 HD13 HG21 ' A' ' 267' ' ' VAL . 2.4 mt -92.97 93.87 8.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 297' ' ' LEU . 0.6 OUTLIER -57.45 -61.13 2.71 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.486 0.491 . . . . 0.0 110.528 -173.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 51.7 m170 -88.15 99.62 12.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.401 175.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.78 92.72 4.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.531 0.681 . . . . 0.0 109.59 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -143.16 95.92 0.19 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 10.6 tp -63.97 130.33 43.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.128 0.49 . . . . 0.0 110.344 -174.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.541 ' O ' HG22 ' A' ' 266' ' ' ILE . 54.7 m -133.22 136.13 26.79 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.422 -175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.1 119.85 6.85 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.207 1.938 . . . . 0.0 111.806 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.644 ' OD1' HG12 ' A' ' 306' ' ' VAL . 46.4 t-20 -89.37 123.37 33.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.058 0.456 . . . . 0.0 110.389 -178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -89.68 -22.3 22.32 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.33 -175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.644 HG12 ' OD1' ' A' ' 304' ' ' ASN . 8.5 p -69.54 -29.78 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.201 0.524 . . . . 0.0 111.218 -175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.737 HD11 ' HA ' ' A' ' 251' ' ' TYR . 4.2 tp -92.68 -38.01 12.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.674 -169.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -51.22 -43.17 61.38 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.185 0.594 . . . . 0.0 112.366 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.3 t -66.09 -26.15 67.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.758 0.313 . . . . 0.0 111.226 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.521 ' HB3' ' CE1' ' A' ' 252' ' ' PHE . 3.6 mm? -95.24 -53.52 3.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.832 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 307' ' ' LEU . 20.9 pt -58.21 -37.66 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.001 0.429 . . . . 0.0 111.913 -176.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -71.46 -12.56 61.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 110.472 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.435 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -90.38 -36.72 14.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.228 178.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.725 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.0 t90 -77.97 -38.74 44.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.788 0.328 . . . . 0.0 110.778 -174.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.558 ' HA ' HG22 ' A' ' 320' ' ' ILE . 23.6 p -73.77 -12.79 60.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.305 0.574 . . . . 0.0 110.129 178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -76.12 -33.58 59.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.621 0.724 . . . . 0.0 109.623 173.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 50.8 m -71.33 -52.61 17.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.84 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . 0.454 ' O ' HG22 ' A' ' 320' ' ' ILE . 24.1 t30 -126.92 124.12 38.8 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.108 176.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -61.28 89.1 0.04 OUTLIER Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.045 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.731 HD13 HD13 ' A' ' 260' ' ' LEU . 10.0 tt -116.19 125.84 73.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.208 0.528 . . . . 0.0 111.473 -171.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.364 -179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.519 -0.633 . . . . 0.0 111.519 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . 0.7 ' HB3' ' HD3' ' A' ' 246' ' ' PRO . 35.5 t -60.71 -51.7 77.79 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 117.006 0.403 . . . . 0.0 110.46 178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 245' ' ' SER . 57.4 Cg_endo -101.4 166.2 0.35 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.942 2.428 . . . . 0.0 111.447 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -73.08 144.3 47.1 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -119.34 89.47 40.21 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -96.44 -164.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.098 2.532 . . . . 0.0 110.869 169.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.16 26.29 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.437 0.637 . . . . 0.0 110.03 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -95.26 -17.16 21.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.735 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 310' ' ' LEU . 57.4 m-85 -149.93 -55.22 0.17 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.542 0.687 . . . . 0.0 110.794 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.46 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 1.7 tmm_? -81.52 124.39 29.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.972 -169.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.778 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.4 t -73.42 113.92 26.84 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.11 12.68 0.73 Allowed 'Trans proline' 0 N--CA 1.473 0.314 0 C-N-CA 123.169 2.579 . . . . 0.0 113.318 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.551 HD13 ' HZ3' ' A' ' 281' ' ' TRP . 73.2 mt -96.79 -54.34 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.467 -176.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.53 -0.54 3.95 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.322 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 62.05 35.47 15.91 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -171.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 321' ' ' GLU . 1.2 pm0 -76.42 -26.93 56.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.106 178.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.455 ' HB3' HG23 ' A' ' 320' ' ' ILE . 5.6 tt 54.19 93.99 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.688 -176.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.778 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -43.38 155.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.021 -1.445 . . . . 0.0 113.79 -175.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 261' ' ' MET . 0.6 OUTLIER -103.85 -37.41 7.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 172.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -132.71 102.23 13.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.429 176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.769 ' HB2' HG22 ' A' ' 272' ' ' THR . 86.7 Cg_endo -91.14 136.03 1.92 Allowed 'Trans proline' 0 N--CA 1.446 -1.269 0 C-N-CA 122.554 2.169 . . . . 0.0 113.318 -172.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 303' ' ' PRO . 16.0 m -109.86 133.51 54.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.316 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.665 HG13 HG23 ' A' ' 272' ' ' THR . 0.3 OUTLIER -91.66 143.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.891 176.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 268' ' ' SER . 42.3 t -136.03 166.76 26.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 174.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 267' ' ' VAL . 0.1 OUTLIER -59.8 147.04 39.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 268' ' ' SER . 92.5 m 101.04 -24.37 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.697 1.248 . . . . 0.0 108.286 -164.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 92.67 24.37 23.61 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.446 176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 266' ' ' ILE . 1.4 pp0? -84.52 149.64 25.79 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.219 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.769 HG22 ' HB2' ' A' ' 264' ' ' PRO . 0.2 OUTLIER -139.67 99.4 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 171.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.437 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 20.3 m-85 -126.15 177.93 6.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.764 ' HB2' ' HB3' ' A' ' 261' ' ' MET . 10.3 tp10 -79.79 144.69 33.33 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -60.0 -39.68 86.58 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.215 -176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.6 m -63.25 -18.51 63.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.548 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 2.2 m -95.41 -52.82 3.99 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.267 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 274' ' ' GLU . 4.0 tp -76.94 -50.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -68.86 -24.19 64.32 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.147 0.498 . . . . 0.0 110.14 -173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -54.18 -45.51 72.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.094 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.722 ' CH2' ' HD3' ' A' ' 290' ' ' PRO . 0.1 OUTLIER -97.27 -26.98 14.72 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.866 -176.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 20.3 mt -60.34 -41.49 93.69 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.264 0.554 . . . . 0.0 109.554 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -60.55 -31.35 70.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.887 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -69.83 -17.59 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.421 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 99.97 32.62 5.53 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.393 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.506 ' HB2' ' HD1' ' A' ' 281' ' ' TRP . 21.8 m-70 -116.04 126.35 53.67 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.019 0.438 . . . . 0.0 110.141 177.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 295' ' ' THR . 44.8 pttt -109.46 42.46 1.46 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.944 -169.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.456 HG21 HE21 ' A' ' 293' ' ' GLN . 15.8 p -137.37 153.98 50.1 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.812 -0.177 . . . . 0.0 110.977 -179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.727 ' HB2' ' OE1' ' A' ' 294' ' ' GLU . 4.9 m -79.91 158.21 73.02 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 171.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . 0.722 ' HD3' ' CH2' ' A' ' 281' ' ' TRP . 82.4 Cg_endo -76.44 4.79 5.18 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.003 2.469 . . . . 0.0 112.478 -176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -92.73 -67.2 0.87 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 19.0 m -128.08 5.5 5.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.456 HE21 HG21 ' A' ' 288' ' ' THR . 0.0 OUTLIER 59.05 58.45 3.13 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.951 0.881 . . . . 0.0 109.922 -176.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.727 ' OE1' ' HB2' ' A' ' 289' ' ' CYS . 5.7 mp0 -82.69 -18.54 40.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.159 -1.382 . . . . 0.0 110.161 -172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 297' ' ' LEU . 13.4 m 70.66 110.95 0.06 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.024 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.476 HD21 ' SG ' ' A' ' 289' ' ' CYS . 12.1 mt -71.53 -6.85 43.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.512 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 295' ' ' THR . 93.4 mt 56.67 59.94 3.32 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.01 178.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 70.16 105.92 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.072 -178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.57 101.18 7.28 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.4 -167.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -100.56 109.08 3.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 169.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 8.9 mp -74.7 134.98 41.87 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.798 0.808 . . . . 0.0 111.914 -172.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . . . . . . . . . 47.8 m -136.2 100.26 10.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.755 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 265' ' ' VAL . 39.5 Cg_exo -58.03 119.19 6.28 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.317 2.011 . . . . 0.0 111.787 -178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' A' ' 306' ' ' VAL . 9.5 t-20 -102.01 138.58 38.78 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.046 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -89.3 -16.36 31.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -172.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.587 HG12 ' OD1' ' A' ' 304' ' ' ASN . 7.6 p -61.77 -42.98 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.473 -176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.602 HD22 ' HB ' ' A' ' 272' ' ' THR . 22.0 tp -78.81 -33.24 46.32 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.401 -171.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.48 ' HA ' HD11 ' A' ' 311' ' ' ILE . 40.2 ttmt -58.1 -46.92 84.69 Favored 'General case' 0 C--O 1.22 -0.456 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -33.17 75.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.733 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 95.0 mt -74.73 -56.76 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.026 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 307' ' ' LEU . 4.5 pt -61.53 -32.27 53.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.075 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.27 -40.1 95.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.423 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 4.2 pp -75.01 -31.09 61.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.895 0.378 . . . . 0.0 110.551 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.441 ' HZ2' ' CG ' ' A' ' 246' ' ' PRO . 1.7 t90 -77.57 -46.47 22.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.774 -175.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.583 ' HA ' HG22 ' A' ' 320' ' ' ILE . 26.4 p -66.61 -25.47 66.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.156 0.503 . . . . 0.0 110.194 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -73.19 -16.12 61.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.384 0.611 . . . . 0.0 110.219 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 48.1 m -97.91 -29.25 13.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.11 -177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -139.91 17.12 2.48 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.615 -0.434 . . . . 0.0 112.026 -172.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 320' ' ' ILE . . . 75.6 -90.63 0.85 Allowed Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.94 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.765 HD11 HD22 ' A' ' 258' ' ' LEU . 1.1 tp 58.0 109.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 122.77 1.272 . . . . 0.0 114.039 172.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.55 ' HA ' ' O ' ' A' ' 259' ' ' GLU . 29.8 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 113.666 -1.607 . . . . 0.0 109.222 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.539 0 N-CA-C 112.419 -0.272 . . . . 0.0 112.419 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 32.6 t -97.54 148.42 34.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 175.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.7 8.97 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.65 2.233 . . . . 0.0 112.965 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.87 94.41 1.82 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.235 176.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.428 ' HB2' ' HB2' ' A' ' 253' ' ' ARG . 16.8 m-85 -97.37 123.47 52.45 Favored Pre-proline 0 C--N 1.323 -0.562 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.358 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.505 ' HB2' ' HD1' ' A' ' 251' ' ' TYR . 23.4 Cg_exo -66.43 -179.66 1.63 Allowed 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 122.368 2.046 . . . . 0.0 110.671 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 273' ' ' TYR . 12.5 pt-20 -79.91 14.72 1.67 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -173.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.965 ' HA ' HD11 ' A' ' 307' ' ' LEU . 9.1 p90 -98.41 5.87 47.74 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.166 0.507 . . . . 0.0 109.825 172.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.533 ' HA ' HG22 ' A' ' 311' ' ' ILE . 1.0 OUTLIER -138.3 -67.86 0.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.207 176.406 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.428 ' HB2' ' HB2' ' A' ' 248' ' ' PHE . 5.3 tmm_? -84.29 124.76 31.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.456 -171.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.732 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 36.9 t -84.81 127.67 63.99 Favored Pre-proline 0 C--N 1.326 -0.442 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.402 ' HD3' ' CE1' ' A' ' 273' ' ' TYR . 67.3 Cg_endo -84.65 7.12 5.36 Favored 'Trans proline' 0 C--O 1.23 0.101 0 C-N-CA 123.06 2.507 . . . . 0.0 113.096 -174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 66.2 mt -90.28 -50.63 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.052 -175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.07 5.83 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.563 176.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.798 HD22 HD11 ' A' ' 320' ' ' ILE . 0.5 OUTLIER 54.87 38.34 30.16 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -168.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 259' ' ' GLU . 1.2 pm0 -74.83 -18.94 60.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.4 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.65 HD13 HG21 ' A' ' 320' ' ' ILE . 3.7 tt 52.68 87.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.32 -176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.732 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -44.06 147.13 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.323 -173.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.538 ' HE2' ' O ' ' A' ' 260' ' ' LEU . 0.0 OUTLIER -110.01 -35.32 6.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.004 175.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -131.11 102.29 15.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.564 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' A' ' 307' ' ' LEU . 63.9 Cg_endo -96.88 161.97 1.07 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.918 2.412 . . . . 0.0 112.992 -174.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.62 144.97 36.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.812 174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.748 HG13 HG23 ' A' ' 272' ' ' THR . 1.0 OUTLIER -104.74 139.68 25.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.766 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.507 HG22 ' HG3' ' A' ' 271' ' ' GLN . 13.3 m -132.5 179.9 3.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -59.44 154.22 17.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 11.9 m 87.58 -22.17 0.16 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.801 0.84 . . . . 0.0 109.77 -168.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 88.33 28.18 23.22 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.103 173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.693 HE22 HG12 ' A' ' 278' ' ' ILE . 1.4 pp0? -82.8 149.12 27.39 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.748 HG23 HG13 ' A' ' 266' ' ' ILE . 1.1 m -139.14 99.08 3.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.292 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.463 ' CE2' ' HD2' ' A' ' 291' ' ' LYS . 42.2 m-85 -139.22 177.95 7.54 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.598 0.237 . . . . 0.0 111.509 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.651 ' O ' HG22 ' A' ' 278' ' ' ILE . 10.7 tp10 -61.31 126.18 26.42 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.695 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -62.95 -36.09 82.31 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.486 -173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.2 m -73.8 -16.68 61.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.905 0.383 . . . . 0.0 110.419 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 22.7 m -95.39 -39.8 9.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.062 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.693 HG12 HE22 ' A' ' 271' ' ' GLN . 3.3 tp -78.44 -49.68 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.596 0.236 . . . . 0.0 111.385 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -68.87 -21.46 64.26 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.057 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.32 -44.77 68.69 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.505 174.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.99 -30.16 12.87 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.489 -178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.78 -42.6 99.21 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.514 175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -64.7 -24.54 67.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.187 0.518 . . . . 0.0 111.07 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -67.65 -22.94 65.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.985 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 116.82 51.58 0.37 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.145 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -143.04 166.63 24.12 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -158.25 70.35 0.54 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.569 0.7 . . . . 0.0 111.332 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 295' ' ' THR . 14.2 p -136.66 158.49 44.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 293' ' ' GLN . 28.7 p -89.53 149.26 42.08 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-N 118.225 0.466 . . . . 0.0 110.209 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.2 -0.05 8.6 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.533 2.155 . . . . 0.0 113.645 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.463 ' HD2' ' CE2' ' A' ' 273' ' ' TYR . 0.0 OUTLIER -99.08 -69.25 0.77 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.173 0.511 . . . . 0.0 111.025 -177.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . . . . . . . . . 4.2 p -99.18 -6.67 27.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.794 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 289' ' ' CYS . 0.0 OUTLIER 62.34 28.52 16.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.297 -176.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.59 131.21 43.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.567 173.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.709 HG22 ' H ' ' A' ' 297' ' ' LEU . 25.8 m -59.59 125.95 25.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.771 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 267' ' ' VAL . 21.0 mt -67.49 -14.66 63.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.834 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.709 ' H ' HG22 ' A' ' 295' ' ' THR . 0.1 OUTLIER 71.4 -76.81 0.06 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.913 -179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -102.17 112.04 24.56 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -79.15 92.59 5.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.367 0.603 . . . . 0.0 110.102 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -142.16 136.29 7.18 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.498 ' HA ' HG12 ' A' ' 267' ' ' VAL . 10.9 mp -96.49 119.19 34.51 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.396 0.617 . . . . 0.0 111.913 -174.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.463 ' HB ' HG22 ' A' ' 266' ' ' ILE . 82.9 m -99.6 114.02 65.34 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.241 171.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.71 121.29 8.64 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.841 1.694 . . . . 0.0 111.743 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . 0.579 ' HB2' HG12 ' A' ' 306' ' ' VAL . 8.7 p30 -104.24 127.48 51.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.606 -176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -92.27 -5.19 52.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.89 0.376 . . . . 0.0 111.015 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.579 HG12 ' HB2' ' A' ' 304' ' ' ASN . 6.7 p -66.66 -43.08 90.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.935 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.965 HD11 ' HA ' ' A' ' 251' ' ' TYR . 1.6 tp -89.78 -37.49 14.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -169.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 312' ' ' ALA . 0.1 OUTLIER -55.21 -40.68 71.08 Favored 'General case' 0 C--O 1.223 -0.31 0 O-C-N 123.246 0.341 . . . . 0.0 110.495 -174.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 17.2 m -67.3 -23.52 65.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.771 0.32 . . . . 0.0 111.732 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 313' ' ' LEU . 92.9 mt -94.14 -57.19 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 307' ' ' LEU . 8.3 pt -58.53 -34.69 51.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.97 0.414 . . . . 0.0 111.54 -178.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.462 ' HB2' ' HE3' ' A' ' 308' ' ' LYS . . . -69.84 -11.2 60.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.483 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 310' ' ' LEU . 0.9 OUTLIER -85.4 -36.05 20.93 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -81.66 -47.58 12.81 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.621 ' HA ' HG22 ' A' ' 320' ' ' ILE . 31.5 p -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.02 -175.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -70.28 -27.67 64.59 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.971 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 12.6 t -73.09 -54.88 7.4 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.482 -173.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -91.94 -38.33 12.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.163 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . 95.65 96.41 1.75 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 -170.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.798 HD11 HD22 ' A' ' 258' ' ' LEU . 13.7 tt -144.69 107.34 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.741 0.781 . . . . 0.0 111.28 -174.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 320' ' ' ILE . 39.3 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.42 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 112.019 -0.432 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 67.2 m 71.64 135.64 0.05 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 123.22 0.608 . . . . 0.0 111.125 -176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.36 -66.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.631 2.221 . . . . 0.0 112.622 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 57.25 81.01 0.15 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.561 0.538 . . . . 0.0 112.077 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 249' ' ' PRO . 29.6 p90 -155.63 118.2 2.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.118 0.485 . . . . 0.0 111.498 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 248' ' ' PHE . 8.1 Cg_exo -75.26 -172.83 1.39 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.56 2.84 . . . . 0.0 112.145 173.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.77 70.09 4.09 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.715 0.769 . . . . 0.0 112.04 -177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.684 ' HA ' HD11 ' A' ' 307' ' ' LEU . 42.8 p90 -147.22 2.48 0.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.88 163.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.529 ' O ' HD13 ' A' ' 260' ' ' LEU . 16.9 m-85 -130.59 4.75 4.66 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.649 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . 0.503 ' C ' ' HD2' ' A' ' 253' ' ' ARG . 1.8 tmm_? -125.22 128.28 48.07 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.685 -174.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' CYS . . . . . 0.683 ' HB2' ' SD ' ' A' ' 261' ' ' MET . 42.1 t -103.61 119.46 54.69 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 168.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -77.89 3.54 6.88 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.73 2.286 . . . . 0.0 112.548 -172.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.65 -49.01 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.743 -176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 2.6 m -135.04 1.4 2.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.164 176.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 53.55 40.13 30.99 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -167.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 321' ' ' GLU . 1.7 pm0 -81.03 -32.71 34.0 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.178 -0.919 . . . . 0.0 108.874 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.704 ' HG ' ' SG ' ' A' ' 315' ' ' CYS . 11.1 tp 66.67 102.07 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 122.221 1.01 . . . . 0.0 109.65 -172.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . 0.683 ' SD ' ' HB2' ' A' ' 254' ' ' CYS . 0.0 OUTLIER -45.04 156.59 0.09 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.312 -1.767 . . . . 0.0 114.305 -177.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LYS . . . . . 0.772 ' NZ ' ' HB3' ' A' ' 321' ' ' GLU . 0.0 OUTLIER -101.34 -44.92 5.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.979 0.895 . . . . 0.0 109.195 170.779 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -132.85 102.68 13.4 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . 0.535 ' HB2' HG22 ' A' ' 272' ' ' THR . 85.7 Cg_endo -93.11 151.83 2.59 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.452 2.101 . . . . 0.0 113.047 -171.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.453 ' HB ' ' HG ' ' A' ' 301' ' ' LEU . 10.6 m -122.78 130.15 74.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.723 174.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.697 HG13 HG23 ' A' ' 272' ' ' THR . 0.4 OUTLIER -87.53 141.26 14.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.482 179.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 301' ' ' LEU . 21.6 t -127.55 169.04 19.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 267' ' ' VAL . 19.2 t -60.1 169.55 1.52 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 296' ' ' LEU . 6.5 m 81.42 -32.03 0.1 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.451 0.7 . . . . 0.0 109.553 -168.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 102.11 48.28 1.36 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.596 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLN . . . . . 0.689 ' HB2' ' CE2' ' A' ' 273' ' ' TYR . 10.1 pt20 -106.93 148.29 28.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.859 0.361 . . . . 0.0 110.942 177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . 0.697 HG23 HG13 ' A' ' 266' ' ' ILE . 0.6 OUTLIER -144.55 100.83 3.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.102 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 271' ' ' GLN . 40.7 m-85 -137.08 174.88 10.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.769 0.318 . . . . 0.0 111.467 -173.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.588 ' O ' HG22 ' A' ' 278' ' ' ILE . 11.6 tp10 -63.43 123.47 18.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.392 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -57.41 -40.65 78.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.735 -173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.407 ' O ' ' HE3' ' A' ' 280' ' ' LYS . 13.6 p -73.43 -13.58 61.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.136 0.493 . . . . 0.0 110.95 -177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 50.5 m -96.21 -42.43 8.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.486 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 274' ' ' GLU . 5.0 tp -82.8 -50.95 15.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 282' ' ' LEU . 9.6 mm100 -71.35 -23.63 61.95 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-O 121.274 0.559 . . . . 0.0 110.007 -172.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 276' ' ' SER . 9.5 ttmt -51.08 -41.83 60.19 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.324 174.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' TRP . . . . . 0.471 ' CD1' ' HB2' ' A' ' 286' ' ' HIS . 0.0 OUTLIER -99.63 -30.5 12.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.441 -0.503 . . . . 0.0 111.803 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 279' ' ' GLN . 15.4 mt -63.8 -38.64 91.87 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.821 -0.549 . . . . 0.0 111.419 176.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -66.4 -30.42 70.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.329 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ALA . . . . . . . . . . . . . . . -61.63 -46.57 89.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.737 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 138.72 44.03 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.801 175.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' HIS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 281' ' ' TRP . 88.9 m-70 -114.86 172.32 7.12 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 174.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 295' ' ' THR . 4.2 tppt? -151.05 49.31 0.85 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.606 -170.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 8.3 p -146.37 154.0 41.14 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -177.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 271' ' ' GLN . 1.7 m -80.76 132.09 58.72 Favored Pre-proline 0 C--O 1.225 -0.205 0 C-N-CA 122.564 0.346 . . . . 0.0 110.786 176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.06 -27.06 78.83 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.886 2.391 . . . . 0.0 113.077 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.563 ' HG3' ' H ' ' A' ' 292' ' ' SER . 5.2 pttt -62.73 -66.78 0.49 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' SER . . . . . 0.563 ' H ' ' HG3' ' A' ' 291' ' ' LYS . 48.6 m -124.61 4.87 8.24 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.861 -0.154 . . . . 0.0 111.371 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 66.46 83.45 0.17 Allowed 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 122.36 1.076 . . . . 0.0 111.611 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -125.15 121.81 35.28 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 113.619 -1.628 . . . . 0.0 108.321 178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 287' ' ' LYS . 59.9 m -55.92 115.14 2.23 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.429 0.456 . . . . 0.0 111.143 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.544 ' HA ' ' OG1' ' A' ' 269' ' ' THR . 18.1 mt -66.65 99.55 0.6 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.816 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LEU . . . . . 0.468 HD13 ' CD2' ' A' ' 298' ' ' HIS . 1.3 tm? -64.01 102.9 0.53 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' HIS . . . . . 0.468 ' CD2' HD13 ' A' ' 297' ' ' LEU . 11.4 m170 70.6 97.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.751 0.657 . . . . 0.0 110.174 -172.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ALA . . . . . . . . . . . . . . . -78.73 92.89 4.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 110.28 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . -127.5 128.74 6.21 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 175.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 267' ' ' VAL . 7.0 tp -82.69 119.14 23.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.206 0.527 . . . . 0.0 110.064 -175.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' THR . . . . . 0.609 ' HB ' HG22 ' A' ' 266' ' ' ILE . 97.6 m -116.68 111.55 41.35 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.206 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.08 120.01 7.23 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.111 1.874 . . . . 0.0 111.99 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -107.51 137.27 45.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.512 -176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -90.74 -26.56 19.45 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.298 -0.251 . . . . 0.0 111.676 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -50.58 -46.32 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.684 HD11 ' HA ' ' A' ' 251' ' ' TYR . 3.8 tp -87.32 -30.73 20.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.984 -167.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -57.37 -48.29 79.42 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -62.4 -31.34 72.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.292 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.455 ' O ' ' HB3' ' A' ' 313' ' ' LEU . 87.3 mt -83.11 -51.36 7.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ILE . . . . . 0.497 HD11 ' HD3' ' A' ' 264' ' ' PRO . 10.1 pt -63.69 -35.17 71.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.855 0.359 . . . . 0.0 110.781 -178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.19 -17.36 64.68 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.48 0.657 . . . . 0.0 110.523 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LEU . . . . . 0.455 ' HB3' ' O ' ' A' ' 310' ' ' LEU . 0.2 OUTLIER -87.35 -36.65 17.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.327 -179.461 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.553 ' HB3' HD21 ' A' ' 260' ' ' LEU . 5.4 t90 -81.61 -45.11 16.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.44 -172.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' CYS . . . . . 0.704 ' SG ' ' HG ' ' A' ' 260' ' ' LEU . 3.8 m -63.84 -26.51 68.65 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.331 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.87 -30.89 67.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.849 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' SER . . . . . . . . . . . . . 29.5 t -78.94 -43.82 23.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.546 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -134.33 126.66 30.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.043 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLY . . . . . . . . . . . . . . . -59.03 100.08 0.16 Allowed Glycine 0 N--CA 1.453 -0.233 0 O-C-N 123.559 0.537 . . . . 0.0 112.256 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.561 HG21 HD23 ' A' ' 260' ' ' LEU . 19.9 tt -116.87 -35.13 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.806 0.336 . . . . 0.0 110.642 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.772 ' HB3' ' NZ ' ' A' ' 262' ' ' LYS . 2.6 tm-20 . . . . . 0 C--O 1.244 0.776 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.739 . . . . . . . . 1 1 . 1 stop_ save_